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ABSTRACT
Observational studies are important for evaluating treatment effects, especially
when randomization of treatments is unethical or expensive. Without randomiza-
tion, valid inferences about treatment effects can only be drawn by controlling for
confounders. Propensity scores (PS) – the probability of treatment assignment as a
function of covariates – are often used to control for confounders. PS-based methods
are vulnerable to bias and inefficiency when outcome or propensity score models are
misspecified or there is limited overlap in the propensity score distributions between
treatment groups. In this dissertation, we develop new robust methods for estimat-
ing causal effects from observational studies and address two closely related topics on
causal inference – the problem of limited overlap and variable selection for propensity
score model.
In Chapter 2, we propose a robust multiple imputation based approach to causal
inference called Penalized Spline of Propensity Methods for Treatment Comparison
(PENCOMP). PENCOMP estimates causal effects by imputing missing potential
outcomes with flexible spline models, and draws inference based on imputed and
observed outcomes. Under the standard causal inference assumptions, PENCOMP
is doubly robust, that is, yields consistent estimates of causal effects if either the
propensity or the outcome model is correctly specified. Simulations suggest that it
tends to outperform doubly-robust marginal structural modeling, especially when the
weights are highly variable. We apply our method to the Multicenter AIDS Cohort
study (MACS) to estimate the short term effect of antiretroviral treatment on CD4
counts in HIV+ patients.
xix
In Chapter 3, we address the issue of limited overlap in the propensity score distri-
butions across treatment groups. We investigate appropriate restrictions of the causal
estimand, and compare alternative estimation methods, including various simple and
augmented inverse propensity weighting approaches, matching and PENCOMP. We
demonstrate the flexibility of PENCOMP for estimating different estimands. We
apply these methods to the MACS dataset to estimate the effects of antiretroviral
treatment on CD4 counts in HIV+ patients.
In Chapter 4, we consider variable selection techniques that seek to restrict pre-
dictors in the propensity model to true confounders, thus improving overlap in the
propensity distributions and increasing efficiency. We also propose a new version of
PENCOMP via bagging, which can be advantageous when the data are noisy. We
examine by simulation studies the impact of various variable selection techniques,
including an extension of the adaptive lasso, on inferences from PENCOMP and
weighting methods. We demonstrate our methods and variable selection techniques
using the MACS dataset.
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CHAPTER I
Introduction
Randomized experiments allow researchers to measure the impact of an interven-
tion on the outcome of interest since it can balance the covariate distributions across
treatment groups. Unfortunately, randomization is not always feasible or ethical. In
such cases, observational studies can provide some valuable information about the ef-
fectiveness of an intervention. However, without randomization, valid inference about
causal effects can only be drawn by controlling for confounders. In 1983, Rosenbaum
and Rubin introduced the idea of using propensity scores to estimate causal effects
from observational studies. Since then, propensity scores (PS) – the probability of
treatment assignment as a function of covariates – are often used. The propensity
score has the balancing property: conditional on the propensity score, the observed
covariates and treatment assignment are conditionally independent. The balancing
property of propensity score implies that adjusting for the propensity score can re-
move bias due to the observed covariates (Rosenbaum and Rubin, 1983).
Inference about causal effects involves speculation about what would have hap-
pended if a subject receives some other treatment that’s different from the assigned.
Suppose there are two treatments denoted as 1 or 0, a subject has both an outcome
under treatment 1 and an outcome under treatment 0. This describes the widely
adopted Rubin’s (1974) potential outcome framework in causal inference literature,
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which was first introduced by Neyman’s (1923). Potential outcomes are defined as
potentially observable outcomes under different treatments or exposure groups. In-
dividual causal effects are defined as comparisons of the potential outcomes for that
subject. However, only the potential outcome corresponding to the treatment actu-
ally assigned is observed for any subject. This is the fundamental problem of causal
inference (Holland, 1986). Thus, to make causal inference, three assumptions are
required: 1) SUTVA (Angrist, Imbens and Rubin, 1996) states that a) the observed
outcome under the assigned treatment is the same as the potential outcome asso-
ciated with that treatment, and b) the potential outcomes for a given subject are
not influenced by the treatment assignments of other subjects (Rubin, 1980; Angrist,
Imbens, Rubin, 1996); 2) positivity states that each subject has a positive probabil-
ity of being assigned to each of the compared treatments; 3) ignorability states that
treatment assignment is as if randomized conditional on all the past histories.
PS-based methods are based on estimating the propensity of treatment assign-
ment, given potential confounding variables, and then using the estimated propensity
to match, stratify or weight subjects. In matching, the treated and control subjects
are selected to form matched pairs and simple matched pair analyses can be per-
formed to obtain causal effects. In stratification, subjects are divided into strata
based on their propensity scores and comparisons are performed within each stratum
and causal effects are estimated by averaging across strata. Weighting each subject
by the inverse of the propensity of receiving the observed treatment can also adjust
for confounding variables because the weights in effect create a pseudo-population
that is free of treatment confounders.
For PS-based methods to work correctly, the propensity score model should be
correctly specified. Thus, more robust methods such as the ones that incorporate the
outcome models can protect against misspecification of the propensity score model.
One difficult but less addressed problem in causal inference is controlling for time-
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dependent confounders. For example, in a longitudinal study, subjects are observed
over time and intermediate outcomes are measured. If these intermediate outcomes
are also used to determine concomitant treatment assignments, they are both interme-
diate outcomes of past treatments and confounders of future treatment assignments-
the phenomenon known as confounding by indication. Including these variables in
standard regression models to control them as confounders does not work since they
are also mediators of earlier treatment effects. For example, the Multicenter AIDS
cohort study (MACS) (Kaslow et al, 1987) saw the introduction of the first antiretro-
vial therapy (zidovudine or AZT) at a time when no effective treatment for human
immunodeficiency virus existed. Hence, early administration was based on availabil-
ity and biomarkers of disease severity such as CD4 count, with sicker patients more
likely to be treated. As HIV infection progresses, the number of CD4 cells decreases,
and when the CD4 count was too low, patients started antiretroviral treatment to
control the virus and increase the CD4 count. The CD4 count is a time-dependent
confounder because it is both an intermediate outcome of past treatments and a
confounder of future treatments.
The existing methods for controlling time-dependent confounders include the in-
verse probability treatment weighted (IPTW), the augmented IPTW (AIPTW), and
g computation. The IPTW estimators are consistent if the propensity score mod-
els are correct. The AIPTW estimators are doubly robust, that is, consistent if the
propensity models or all the outcome and intermediate outcome models are correct
(Scharfstein, Rotnitzky, and Robins 1999; Yu and van der Laan, 2006). Finally, the
g-computation provides a consistent estimator of potential outcomes and thus causal
effects if all the conditional distributions relating outcomes to covariates are correctly
specified (Robins, 1987). The IPTW and AIPTW estimators can result in highly vari-
able estimates when there are extreme weights, which are common in observational
studies. This is a particularly serious issue with longitudinal data with many possible
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treatment combinations. In addition, the weighted estimators are arguably hard to
understand for applied researchers. The AIPTW estimators are doubly robust, but
very hard to implement for applied researchers. The g-computation is more intuitive
but not doubly robust.
Whether in a single or multiple time-point treatments, for PS methods to work
reliably, there should be a sufficient overlap in the propensity score distributions be-
tween the compared treatment groups. This avoids extrapolating outside the overlap
region and hence is less vulnerable to model misspecification. Restricting estimation
of causal effects to a subpopulation where there is more balance in the propensity dis-
tributions between the treatment groups could reduce the sensitivity of causal effect
estimates to model misspecification (Rosenbaum and Rubin, 1984). Most literature
focuses on using propensity scores for assessing overlap. Cochran and Rubin (1973)
suggest caliper matching when some units are left unmatched due to poor match qual-
ity based on some criteria. Gutman and Rubin (2013, 2015) propose dropping units
outside of the overlap region of estimated propensity scores between the treatment
groups. Dehejia and Wahba (1999) drop all control units whose estimated propensity
scores are less than the smallest estimated propensity scores among the treated. Ho,
Imai, King and Stuart (2005) propose a two-stage approach. In the first stage, all the
treated units are paired with their closest control units, and only the matched units
are included in the second stage. Crump et al (2009) propose trimming off extreme
propensity values below α and above 1− α. Li, Morgan and Zaslavsky (2017) define
an estimand that weights cases to balance the weighted distributions of the covariates
between treatment groups that minimizes the asymptotic variance of the estimated
treatment effect.
In addition to sufficient overlap, one assumption needed for PS methods to make
valid inference about causual effects is that all the confounders are observed and
included in the propensity model. Since excluding important confounders in the
4
model can lead to biased estimates, many covariates are often included, for fear of
excluding some important confounders. Rubin (2007) notes that only pretreatment
covariates should be included in the propensity model and argues that the model
should be selected without accounting for the relationship between covariates and
outcome. This approach helps maintain objectivity when making inference from
nonrandomized studies. Furthermore, the variables included in the model can directly
affect the degree of overlap. For example, including strong predictors of the treatment
that are not predictive of the outcome in the propensity model could potentially shrink
the overlap region. Recent work has also shown that including such covariates can
inflate the variance of the causal estimate and may also induce bias (Brookhard et al,
2006). On the contrary, including covariates that are associated only with the outcome
can improve efficiency, since it reduces random covariate imbalance in finite samples
(Brookhard et al, 2006). Glymour et al (2008) argues for controlling only common
causes of the treatment and outcome. VanderWeele and Shpitser (2011) propose
controlling for covariates that are causes of the treatment and/or outcome. Thus,
a propensity model based only on the treatment can be inefficient, as it prioritizes
variables associated with treatment but not necessarily with outcome. Balancing
such covariates using propensity score is unnecessary since these covariates are not
confounders.
In this dissertation, we develop new statistical methods for estimating causal ef-
fects from nonrandomized studies and address two closely related topics on causal
inference – the problem of limited overlap in the propensity score distributions be-
tween treatment groups and variable selection for propensity score models. In Chapter
2, we propose a simple and straightforward approach to causal inference that does
not rely on weighting, is less sensitive to extreme weights, and has a double robust-
ness property for causal effects, called Penalized Spline of Propensity Methods for
Treatment Comparison (PENCOMP). PENCOMP estimates causal effects by im-
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puting missing potential outcomes with flexible spline models, and draws inference
based on imputed and observed outcomes. We compare PENCOMP with the existing
weighting methods and g computation in simulation studies. We apply our method to
the Multicenter AIDS Cohort study (MACS) to estimate the effect of antiretroviral
treatment on CD4 counts in HIV infected patients.
In Chapter 3, we address the issue of limited overlap in the propensity score distri-
butions across treatment groups. We investigate appropriate restrictions of the causal
estimand, and compare alternative estimation methods, including various simple and
augmented inverse propensity weighting approaches, matching and PENCOMP. We
demonstrate the flexibility of PENCOMP for estimating different estimands when
necessary. We apply these methods to the MACS dataset to estimate the effects of
antiretroviral treatment on CD4 counts in HIV+ patients.
In Chapter 4, we turn our focus to model selection for the propensity score model.
We consider variable selection techniques that seek to restrict predictors in the propen-
sity model to true confounders, thus improving overlap in the propensity distributions
and increasing efficiency. We also propose a new version of PENCOMP via bagging
that also incorporates the variability of model selection, which can be advantageous
when the data are noisy. We examine by simulation studies and the MACS dataset the
impact of various variable selection techniques, including an extension of the adaptive
lasso, on inferences from both versions of PENCOMP, AIPTW and IPTW. Finally
in Chapter 5, we summarize our findings and suggest future directions to explore for
PENCOMP.
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CHAPTER II
Penalized Spline of Propensity Methods for
Treatment Comparison
2.1 Introduction
Observational studies are important for evaluating treatment effects, particularly
when randomization of treatments is unethical or expensive. In the absence of ran-
domization, valid inferences about treatment effects can only be drawn by controlling
for confounders. However, controlling for time-dependent confounders using stan-
dard regression methods can fail. For example, in a longitudinal study, subjects are
observed over time and intermediate outcomes are measured. If these intermediate
outcomes are also used to determine concomitant treatment assignments, they are
both intermediate outcomes of past treatments and confounders of future treatment
assignments-the phenomenon known as confounding by indication. Including these
variables in standard regression models to control them as confounders does not work
since they are also mediators of earlier treatment effects. Similar issues arise in studies
with sequential randomization.
We adopt Rubin’s (1974) potential outcome framework for estimating causal ef-
fects. Potential outcomes are defined as potentially observable outcomes under dif-
ferent treatments or exposure groups. Individual causal effects are defined as com-
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parisons of the potential outcomes for that subject. Only the potential outcome cor-
responding to the treatment actually assigned is observed for any subject. Therefore
we estimate causal effects by imputing the potential outcomes that are not observed.
We propose a robust multiple imputation based approach to causal inference in
this setting, called Penalized Spline of Propensity Methods for Treatment Comparison
(PENCOMP), which builds on the Penalized Spline of Propensity Prediction method
(PSPP) for missing data problems (Little and An, 2004; Zhang and Little, 2009). We
first illustrate our approach for the simple case of assessing the causal effect of two
treatments, Z1 = 0 or 1 and a function of subject level covariates X1. Our approach
estimates the propensity to be assigned Z1 given the observed covariates X1, using
a method such as logistic regression appropriate for a binary outcome Z1. It then
estimates regression models for the potential outcome Y Z1=z1 under each treatment
Z1 on (a) a spline of the logit of the propensity to be assigned that treatment, and
(b) other covariates predictive of Y . These regression models are then used to predict
the individual outcomes of treatments not assigned. We then draw inferences based
on comparisons of the imputed and observed outcomes between treatment groups.
Our approach shares some similarities with the MITSS method (Gutman and Rubin,
2015). At the first stage, they partition the subjects into subclasses based on esti-
mated propensity scores and ensures that at least three units from each treatment
group are in each subclass. At the second stage, they fit a regression spline with knots
fixed at the borders of the subclasses and impute the missing potential outcomes for
all the subjects and estimate the causal effects by combining the imputed datasets
with Rubin’s combining rule. We extend PENCOMP to longitudinal treatments,
which is not considered in Gutman and Rubin (2015).
As discussed in Section 2.2 and in Appendix A.1, under the stable unit treatment
value (SUTVA), positivity and ignorability assumptions, PENCOMP has a double
robustness property, resulting from the balancing property of the propensity score
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(Rosenbaum and Rubin, 1983). Specifically, if the relationship between Y and the
logit of the propensity score is modeled correctly, the relationship between Y and other
covariates can be misspecified without biasing estimates of marginal parameters of
interest, namely the marginal means of Y under each treatment. This idea can be
generalized to multiple time points, including the situation where variables are both
mediators of initial treatments and confounders of later treatments.
Our motivating dataset is from the Multicenter AIDS Cohort study (MACS)
(Kaslow et al, 1987). The MACS was started in 1984, and a total of 4,954 gay
and bisexual men were enrolled in the study and followed up semi-annually. At each
visit, data from physical examination, questionnaires about medical and behavioral
history, and blood test results were collected. The primary outcome of interest was
the CD4 count, a continuous measure of how well the immune system functions. As
HIV infection progresses, the number of CD4 cells decreases, and when the CD4 count
was too low, patients started antiretroviral treatment to control the virus and increase
the CD4 count. The CD4 count is a time-dependent confounder because it is both
an intermediate outcome of past treatments and a confounder of future treatments.
The MACS public data set was released by the Center for Analysis and Management
of Multicenter AIDS Cohort Study. We used this dataset to analyze the short term
(1 year) effects of using antiretroviral treatment on the disease progression between
visit 7 and 21, the period after the first antiretroviral drug, zidovudine, was available,
and before the advent of highly active antiretroviral therapy (HAART).
Throughout this paper, we consider longitudinal data at T+1 discrete time points.
For subject i at time t = 1, . . . , T + 1, let Xt(i) denote the vector of covariates ob-
served, and Zt(i) the binary treatment indicator. X¯t(i) and Z¯t(i) are the covariate
and treatment history, up to and including time t. The final outcome of interest Y (i)
is observed at time point T+1, after the last treatment ZT (i). For example, in the ap-
plication, we are interested in estimating the final CD4 count Y (i) after 1 year, i.e, in
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a three-visit window. Xt(i) contains, for example, the blood count measures, such as
CD4 count, at time t, for t = 1, 2, and 3. Y (i) = X3(i) is the final outcome of interest
for subject i measured at time t = 3, a year from baseline. We compare results from
PENCOMP with results from three versions of marginal structural models (MSMs):
inverse-probability-treatment-weighted estimators, and augmented IPTW (AIPTW)
estimators (Yu and van der Laan, 2006), and g-computation (Robins, 1987). The
extended nature of the MACS trials allows comparison of methods on a set of causal
estimands, allowing some capability of observing patterns of performance.
The IPTW method controls for confounding by weighting subjects by the inverse
of the probability of receiving the observed treatment sequence. The weights in ef-
fect create a pseudo-population that is free of treatment confounders, providing the
capability for the MSMs to adjust for both time-dependent and time-independent
confounders. As for PENCOMP, this method assumes SUTVA, positivity, and ig-
norability. The IPTW estimators are consistent if the treatment propensity model is
correct. On the other hand, g-computation directly simulates counterfactuals of in-
terest of each treatment sequence based on conditional distribution of covariates and
outcomes estimated from the data, so provides a consistent estimator of potential
outcomes and thus causal effects if all the conditional distributions relating outcomes
to covariates are correctly specified (Robins, 1987). Finally, the AIPTW estimator
consistently estimates causal effects if the treatment propensity models are correct, or
all the conditional distributions relating outcomes to covariates are correctly specified
(Scharfstein, Rotnitzky, and Robins 1999; Yu and van der Laan, 2006).
As in g-computation, PENCOMP draws the counterfactuals of interest for each
treatment sequence. However, PENCOMP utilizes the observed outcomes and only
imputes the missing potential outcome to draw inference on causal effects. Also,
PENCOMP has the double robustness property that g-computation lacks, since PEN-
COMP, like AIPTW, incorporates both the propensity and prediction models.
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The compared methods are valid alternative approaches, but we argue that PEN-
COMP has the following attractive properties. First, it avoids weighting, which
may require careful monitoring to avoid a small number of cases receiving very high
weights, resulting in highly variable estimates. This is a particularly serious issue
with longitudinal data sets with many possible treatment combinations. Second,
PENCOMP is conceptually simple since it relies purely on regression models for pre-
diction, with the prediction of potential outcomes addressing the issue of confounding
by indication. Third, Bayesian versions of PENCOMP allow for inferences that are
not asymptotic, and properly reflect uncertainty in parameter estimates. Saarela et
al. (2015) propose an approach to confounding by indication that has Bayesian as-
pects, but since it involves weighting we regard it as a hybrid approach – see the
discussion in Elliott and Little (2015).
The rest of the paper is structured as follows. In Section 2.2, we first briefly
introduce PSPP, the method on which PENCOMP was built. We then describe
PENCOMP for the simple case of treatment assigned at a single point in time, and
for the situation where treatments are assigned at two time points, and intermediate
outcomes after the first time point are used to assign treatments at the second time
point. In Section 2.3, we briefly describe IPTW, AIPTW and g-computation. In
Section 2.4, we compare PENCOMP with the MSM approaches in simulation studies,
assessing empirical bias, root mean squared error, 95% confidence interval coverage,
and width of confidence intervals. In Section 2.5, we apply our method to the MACS
dataset to evaluate the short term effect of antiretroviral treatment on CD4 counts in
HIV+ infected patients. In Section 2.6, we presents conclusions and topics for future
research. In particular, for simplicity we restrict attention here to the situations with
up to two treatment assignments, one at baseline and one at an intermediate time
point. In Section 6, we also outline how PENCOMP might be applied in cases with
more than two assignments, as when assessing longer term treatment impacts in the
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MACS study.
2.2 Penalized Spline of Propensity Methods for Treatment
Comparisons
2.2.1 Penalized Spline of Propensity Prediction (PSPP) for Missing Data
Zhang and Little (2009), refining earlier work by Little and An (2004), proposed
the following Penalized Spline of Propensity Prediction (PSPP) method for missing-
data problems. The objective is to estimate the mean, say µ, of a variable Y with
missing values. Let R denote the response indicator for Y , taking the value 1 if
Y is observed and 0 if Y is missing. Let X = (X1, ..., Xp) denote a set of p fully-
observed variables. PSPP first estimates the propensity to respond given X, using
a method appropriate for a binary outcome such as logistic regression. The method
then predicts the missing values of Y using a linear model that includes as predictors
a penalized spline of the estimated propensity to respond and a linear function of
other covariates X that are predictive of Y .
Assuming the missing data are missing at random (Rubin, 1976; Little and Rubin,
2002), Zhang and Little (2009) show that this method has the following double ro-
bustness property for normal linear models: the estimate of µ is consistent if either (a)
the regression model for Y is correctly specified, or (b) the model for the propensity
to respond and the relationship between Y and the propensity are correctly specified.
The latter assumption can be met under relatively weak conditions by regressing Y
on the spline of the logit of the propensity, since the spline does not impose strong
assumptions on the functional form of the relationship between Y and the propen-
sity. Zhang and Little (2009) and Yang and Little (2015) describe simulation studies
suggesting that PSPP compares favorably with alternative doubly-robust methods.
The PSPP method has three principle variants: (a) maximum likelihood (ML)
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(PSPP-ML), where parameters are estimated by ML and standard errors computed
using the information matrix or the bootstrap; (b) Bayes (PSPP-B), where parameters
are drawn from the posterior distribution and inference about µ is based on draws
from its posterior distribution; and (c) multiple imputation (MI) (PSPP-MI), where
draws of the missing values are multiply imputed, and inferences based on Rubin’s
(1987) MI combining rules. In the next section we describe adaptations of PSPP for
causal inference problems.
2.2.2 PENCOMP for Treatments at a Single Time Point
We first consider PENCOMP in the simple setting of a trial where treatments are
assigned at a single time point. Suppressing indexing by subject, Z1 ∈ {0, 1} denotes
assignment to control (0) or treatment (1), Y Z1 denotes the potential outcome as-
sociated with a given level of Z1, measured after treatment Z1, and X1 denotes the
vector of pretreatment covariates. Our inferential goal is to obtain the marginal aver-
age effect of treatment on the outcome, denoted ∆ = E(Y 1−Y 0), where expectation
is taken with respect to a specified population of interest. Figure 1 frames inference
about ∆ as a missing data problem (Rubin, 1974; Elliott and Little, 2015): note that
X1 and Z1 are fully observed, but Y
0 is observed only for the n0 subjects assigned to
control, while Y 1 is observed only for the n1 subjects assigned to treatment. Table 2.1
thus emphasizes the fundamental problem of causal inference (Holland, 1986): since
Y 1 and Y 0 are never observed simultaneously, inference about ∆ based on directly
observing Y 1 − Y 0 is impossible.
To make progress in the face of this missing data problem, we make the follow-
ing three assumptions. First, the stable unit treatment value assumption (SUTVA),
assumes Y = Z1Y
Z1 + (1 − Z1)Y 1−Z1 , so that a) the observed outcome Y under a
specific treatment is equal to the potential outcome associated with that treatment,
and b) the potential outcomes for a given subject are not influenced by the treatment
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assignment of other subjects (Rubin, 1980; Angrist, Imbens, Rubin, 1996). Next, we
make the positivity assumption: 0 < P (Z1 = 1|X1) < 1 for all subjects, so that all
subjects have a non-zero probability of being assigned to treatment or control. In
practice, this assumption is satisfied by restricting the analysis to treatments with
enough cases to make the relevant regressions estimable and excluding subjects with
extreme propensity, for example. Finally, we make the ignorable treatment assump-
tion (Y 1, Y 0) |= Z1|X1, so that, given covariates, treatment assignment is independent
of the potential outcomes of interest, i.e. no unmeasured confounders. The plau-
sibility of SUTVA assumption can usually be assessed in a given context, while the
ignorable treatment assumption may or may not be reasonable given the study design
and the set of available covariates. Taken together, these assumptions allow the unob-
served potential outcomes for subjects receiving treatment Z1 = z1 in Figure 1 to be
imputed using the observed outcomes from subjects receiving treatment Z1 = 1− z1
. Specifically, we can use an imputation approach with bootstrapping to propagate
uncertainty in parameter estimates (Heitjan and Little, 1991).
A potential shortcoming of the prediction approach is that it assumes correct spec-
ification of the model for the distribution of the outcome conditional on the covariates.
Our proposed PENCOMP method weakens this assumption by exploiting the dou-
ble robustness property of penalized spline propensity prediction, PSPP (Little and
An, 2004; Zhang and Little, 2009). PENCOMP applies the idea of PSPP to the
causal inference setting, with the propensity of response replaced by the propensity
of treatment assignment and the missing data being the outcomes under unassigned
treatments. We estimate the propensity to be assigned to each treatment by a regres-
sion method suitable for a categorical outcome, for example by logistic regression if
there are two treatments, or polytomous regression if there are more than two treat-
ments. We then predict the potential outcomes for the treatments not assigned to
subjects using regression models that include splines on the logit of the propensity to
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be assigned that treatment and other covariates that are predictive of the outcome;
separate models are fitted for each treatment group. Under the assumptions stated
above, PENCOMP has a double robustness property for causal effects, as shown in
Appendix A.1.
As with PSPP, there are ML, Bayesian and MI versions of PENCOMP: PENCOMP-
ML estimates parameters by ML and calculated standard errors using an information
matrix or the bootstrap, and PENCOMP-B simulated draws of the parameters and
missing observations from their posterior distributions. PENCOMP-MI is analogous
to the PSPP-MI algorithm for missing data, and is given as follows:
(a) For d = 1, · · · , D, generate a bootstrap sample S(d) from the original data S
by sampling units with replacement, stratified on treatment group. Then carry out
steps (b)-(d) for each sample S(d):
(b) Estimate a logistic regression model for the distribution of Z1 given X1, with
regression parameters γz1 . Estimate the propensity to be assigned treatment Z1 = z1
as Pˆz1(X1) = Pr(Z1 = z1|X1, γˆ(d)z1 ), where γˆ(d)z1 is the ML estimate of γz1 . Define
Pˆ ∗z1 =log[Pˆz1(X1)/(1− Pˆz1(X1))].
(c) For each z1 = 0, 1, using the cases assigned to treatment group z1, estimate a
normal linear regression of Y z1 on X1, with mean
E(Y z1|X1, Z1 = z1, θz1 , βz1) = s(Pˆ ∗z1|θz1) + gz1(X1; βz1), (2.1)
where s(Pˆ ∗z1 |θz1) denotes a penalized spline with fixed knots (Eilers and Marx, 1996;
Ngo and Wand, 2004; Wand, 2003), with parameters θz1 , and gz1() represents a para-
metric function of other covariates predictive of the outcome, indexed by parameters
βz1 . One of the covariates might need to be omitted to avoid collinearity in the co-
variates in Eq. (2.1). A simple form is to assume linear additive function of the
covariates X1, but models with interactions between the covariates and Pˆ ∗z1 are also
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allowed. Other forms of splines are possible in Eq. (2.1), as are generalized linear
mixed models for non-normal outcomes Y z1 . Note that a different spline function in
Eq. (2.1) is fitted for each treatment group, since there is no a priori reason to assume
that the relationship between the potential outcomes under different treatment arms
and the propensity of treatment assignment is the same.
In particular, for a penalized spline with truncated linear basis, s(Pˆ ∗z1|θz1) =
θ0 + θ1Pˆ ∗z1 +
∑K
k=1 θ1k(Pˆ
∗
z1 −Kk)+, where K1, · · · , KK are fixed knots, and (Pˆ ∗z1 −
Kk)+ = (Pˆ ∗z1 −Kk) if Pˆ ∗z1 > Kk ; and = 0 if Pˆ ∗z1 ≤ Kk.
In the linear additive form for g, define the design matrices C1 = [1, Pˆ ∗z1 , x1],
C2 = [(Pˆ ∗z1 −K1)+, · · · , (Pˆ ∗z1 −KK)+], and C = [C1, C2]. Then spline model can be
expressed as a linear mixed model (Wand, 2003),
Y z1 = C1β + C2θ + ,
 θ

 ∼

 0
0
 ,
 σ2θI 0
0 σ2 I

 , (2.2)
where β = (β0, β1, β2, · · · , βp) denote fixed effects, and θ = (θ11, · · · , θ1K) are random
basis coefficients. REML estimates of the parameters of this model can be easily
fitted in statistical software, such as PROC MIXED in SAS or lme in R. The fitted
values of Y z1 are yˆz1 = C(CTC+λˆD)−1CTy, where λˆ = σˆ2/σˆ
2
θ is the REML estimator
of λ and
D =
 0(p+1)×(p+1) 0
0 IK×K

(d) For z1 = 0, 1, impute the values of Y
z1 for subjects in treatment group 1− z1
in the original data set with draws from the predictive distribution of Y z1 given X1
from the regression in (c), with ML estimates θˆ
(d)
z1 , βˆ
(d)
z1 substituted for the parameters
θz1 , βz1 , respectively. Let ∆ˆ
(d) and W (d) denote the difference in treatment means and
associated pooled variance estimate, based on the observed and imputed values of Y
in each treatment group.
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(e) The MI estimate of ∆ is then ∆¯D =
1
D
∑D
d=1 ∆ˆd, and the MI estimate of
the variance of ∆¯D is TD = W¯D + (1 + 1/D)BD, where W¯D =
∑D
d=1W
(d)/D,BD =∑D
d=1
(
∆ˆ(d) − ∆¯D
)2
/(D−1). The estimate ∆ is t distributed with degree of freedom
v, (∆− ∆¯D)T
−1
2
D ∼ tv, where v = (D − 1)(1 + W¯D/((D + 1)×BD))2.
We apply this PENCOMP-MI method in the application and simulations in this
article.
Table 2.1: Observed and missing outcomes for treatment at a single time point
Subjects X1 Z1 Y
0 Y 1
1 0 ?
2 0 ?
· · · 0 ?
n0 0 ?
n0 + 1 1 ?
· · · 1 ?
n = n0 + n1 1 ?
2.2.3 PENCOMP with Longitudinal Treatment Assignments
We now consider a longitudinal study with treatments assigned at multiple time
points t = 1, . . . , T . Suppressing indexing by subject, let X¯t and Z¯t denote the covari-
ate and treatment history, respectively, up to and including time point t. Let X Z¯tt+1
denote the potential intermediate outcome under treatment regime Z¯t = (Z1, · · · , Zt).
Let Y Z¯T denote the final potential outcome under the entire treatment regime Z¯T =
(Z1, · · · , ZT ), measured at time point T + 1 after the assignment of last treatment
ZT . Assume at each time t ≥ 2, the intermediate outcome Xt is both an outcome of
treatment Zt−1 and confounder for treatment Zt+1. Supposed we want to estimate
the overall treatment effects as a function of treatment regime Z¯T , relative to Z¯
′
T . To
estimate causal effect ∆Z¯T = E(Y
Z¯T )−E(Y Z¯′T ), we make the following assumptions.
1) SUTVA (Angrist, Imbens and Rubin, 1996) states that a) the observed out-
comes under a specific treatment regime is equal to the potential outcomes associated
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with that treatment regime, and b) the potential outcomes for a given subject are
not influenced by the treatment assignments of other subjects (Rubin, 1980; Angrist,
Imbens, Rubin, 1996)
2) Positivity states that each subject has a positive probability of being assigned
to each treatment zt at each time point t: 0 < Pr(Zt = zt|X¯t−1, Z¯t−1) < 1.
3) Sequential ignorable treatment assumption states that
(Y Z¯T , X Z¯tt+1) |= Zt|(Z¯t−1, X¯t)
for every z¯T ∈ A : at every time t, where A denote the set of all possible treatment
combinations, that is, at each time t, treatment assignment Zt is as if randomized
conditional on all the past treatment and covariate history.
For simplicity, we illustrate a longitudinal study with two time points and binary
treatments. In such setting, there are four possible treatment regimes. Let XZ12 de-
note the potential intermediate outcome if subject received treatment Z1, and Y
Z¯2
the potential outcome of interest if subject received treatment regime Z¯2. Our in-
ferential goal is to estimate the overall treatment effects as a function of Z1 and Z2,
relative to no treatment at both time points, namely ∆z¯2 = E(Y
Z¯2 − Y 00), where
expectation is taken with respect to a specified population of interest. In this case,
we are interested in inference about ∆11,∆10, and ∆01. Table 2.2 frames inference
about the causal effects as a missing-data problem (Rubin, 1974; Elliott and Little,
2015). In this setting, values of the intermediate and final outcomes are only observed
for the treatment combination actually assigned. Thus, for example, values of X12 are
missing for cases assigned to Z1 = 0, and values of Y
10, Y 01 and Y 11 are missing for
cases assigned to (z1, z2) = (0, 0); and similarly for the other treatment combinations.
The missing values of the intermediate outcomes X02 and X
1
2 are imputed using
the method described in Section 2.2.2. Conditional on the values of X1, Z1 and
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the observed or imputed values of X2, the propensity that Z2 = 1 given X¯2, Z1 is
estimated based on a logistic regression of Z2 on X¯2, Z1. The missing values of Y
jk
are draws from the regression model of Y jk on X¯2, Z¯2, and a spline on the logit of the
propensity score. A distinct regression model is fitted for each outcome Y jk. More
specifically, the steps for PENCOM-MI are as follows:
(a) For d = 1, · · · , D, generate a bootstrap sample S(d) from the original data S
by sampling units with replacement, stratified on treatment group. Then carry out
steps (b)-(g) for each sample d:
(b) Estimate a logistic regression model for the distribution of Z1 given baseline
covariates X1, with regression parameters γz1 . Estimate the propensity to be assigned
treatment Z1 = z1 as Pˆz1(X1) = Pr(Z1 = z1|X1, γˆ(d)z1 ), where γˆ(d)z1 is the ML estimate
of γz1 . Define Pˆ
∗
z1
=log [Pˆz1(X1)/(1− Pˆz1(X1))].
(c) Using the cases assigned to treatment group Z1 = z1, estimate a normal linear
regression of Xz12 on X1, with mean
E(Xz12 |X1, Z1 = z1, θz1 , βz1) = s(Pˆ ∗z1|θz1) + gz1(X1; βz1), (2.3)
where s(Pˆ ∗z1|θz1) denotes a penalized spline with fixed knots with parameters θz1 , and
gz1() represents a parametric function of other predictors of the outcome, indexed
by parameters βz1 . As for PSPP, one of the covariates might be omitted to avoid
collinearity in the covariates in Eq. (2.3). Note that a different spline model of the
form (2.3) is fitted for each treatment regimen.
(d) For z1 = 0, 1, impute the values of X
z1
2 for subjects in treatment group 1− z1
in the original data set with draws from the predictive distribution of Xz12 given X1
from the regression in (c), with ML estimates θˆ
(d)
z1 , βˆ
(d)
z1 substituted for the parameters
θz1 , βz1 .
(e) Estimate a logistic regression model for the distribution of Z2 givenX1, Z1, X2 =
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(X02 , X
1
2 ), with regression parameters γz2 and missing values of X2 imputed from
step (d). Estimate the propensity to be assigned treatment Z2 = z2 given Z1, X¯2
as Pˆz2(X¯2, Z1) = Pr(Z2 = z2|X¯2, Z1 = z1, γˆ(d)z2 ) , where γˆ(d)z2 is the ML estimate
of γz2 . The probability of treatment regimen (Z1 = z1, Z2 = z2) is denoted as
Pˆz¯2 = Pˆz1(X1)Pˆz2(X¯2, Z1), and define Pˆ
∗
z¯2
=log[Pˆz¯2/(1− Pˆz¯2)].
(f) Using the cases assigned to treatment group (z1, z2), estimate a normal linear
regression of Y z¯2 on X¯2, Z¯2, with mean
E(Y z¯2|X¯2, Z1 = z1, Z2 = z2, θz¯2 , βz¯2),
= s(Pˆ ∗z¯2|θz¯2) + gz¯2(X¯2, Z¯2; βz¯2) (2.4)
where s(Pˆ ∗z¯2 |θz¯2) denotes a penalized spline with fixed knots with parameters θz¯2 , and
gz¯2() represents a parametric function of other predictors indexed by parameters βz¯2 .
One of the covariates might need to be omitted from gz¯2() to avoid collinearity in
the covariates. Note that a distinct model of form (2.4) is fitted for each treatment
regimen.
(g) For each combination of z¯2 = (z1, z2), impute the values of Y
z¯2 for subjects
not assigned this treatment combination in the original data set with draws from the
predictive distribution of Y z¯2 in (f), with ML estimates θˆ
(d)
z¯2 , βˆ
(d)
z¯2 substituted for the
parameters θz¯2 , βz¯2 . Let ∆ˆ
(d)
jk , (j, k) = (1, 1), (1, 0) and (0,0) denote the average treat-
ment effects, with associated pooled variance estimates W
(d)
jk , based on the observed
and imputed values of Y for each treatment regimen.
(h) The MI estimate of ∆jk is then ∆¯jkD =
∑D
d=1 ∆ˆ
(d)
jk , and the MI estimate of the
variance of ∆¯jkD is TD = W¯jkD+(1+1/D)BjkD, where W¯jkD =
∑D
d−1W
(d)
jk /D,BjkD =∑D
d=1
(
∆ˆ
(d)
jk − ∆¯jkD
)2
/(D − 1). As described in (e) of single treatment setting, draw
inference about ∆jk by assuming a t-distribution.
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Table 2.2: Observed and missing intermediate and final outcomes for treatment at
two time points
Subjects X1 Z1 X
0
2 X
1
2 Z2 Y
00 Y 01 Y 10 Y 11
1 0 ? 0 ? ? ?
· · · 0 ? 0 ? ? ?
n00 0 ? 0 ? ? ?
n00 + 1 0 ? 1 ? ? ?
· · · 0 ? 1 ? ? ?
n0 = n00 + n01 0 ? 1 ? ? ?
n0 + 1 1 ? 0 ? ? ?
· · · 1 ? 0 ? ? ?
n0 + n10 1 ? 0 ? ? ?
n0 + n10 + 1 1 ? 1 ? ? ?
· · · 1 ? 1 ? ? ?
n = n0 + n10 + n11 1 ? 1 ? ? ?
In a longitudinal study with more than two time points, the procedures are sim-
ilar to those described in the two time points setting. PENCOMP imputes the first
missing intermediate outcomes X2 first and continues forward to the final outcome
Y . Specifically, to impute the missing intermediate outcomes X z¯tt+1 for the subjects
whose treatment sequence did not match z¯t, we draw values from a mean model of
E(X z¯tt+1|X¯t, Z¯t = z¯t, θz¯t , βz¯t) = sxt+1(Pˆ ∗z¯t ; θz¯t) + gz¯t
[
X1, · · · , Xt; βz¯t
]
, where Xt can be
observed or imputed in the previous steps, and Pˆ ∗z¯t =log[
∏t
k=1 P (Zk = zk|Z¯k−1 =
z¯k−1, X¯k)/(1 −
∏t
k=1 P (Zk = zk|Z¯k−1 = z¯k−1, X¯k))], where
∏t
k=1 P (Zk = zk|Z¯k−1 =
z¯k−1, X¯k) represents the propensity of being assigned the treatment sequence z¯t con-
ditional on the past treatment and covariate history. As before, the propensity of
being assigned zk at time t = k, P (Zk = zk|Z¯k−1 = z¯k−1, X¯k−1, γzk) can be estimated
based on a logistic regression model. Under the assumptions stated above in section
2.2.3, PENCOMP has a double robustness property for causal effects in a longitudinal
study setting. The proof is outlined in Appendix A.1. The marginal mean from the
imputation model is consistent if
1) All the prediction models for the intermediate and final outcomes at each time
point t = 1, · · · , T + 1, conditional on the covariate and treatment history, denoted
as gz¯t , are correctly specified. OR
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2) The propensity models are correctly specified, and the relationship between
Xt+1 and Pˆ
∗
z¯t are correctly specified at each time point t = 1, · · · , T + 1. Note
Y = XT+1. Again, this assumption can be weakened by assuming only a smooth
functional form, such as a penalized spline as in PENCOMP.
2.2.4 Restricting cases in a treatment comparison to reduce disparity in
the distribution of estimated assignment propensities
The positivity assumption requires that cases have a propensity to be assigned
to any of the compared treatments that lie between zero and one. However, when
there are extreme propensity scores, the propensity score distributions tend to have
limited overlap. Some techniques have been proposed to address this issue. Cochran
and Rubin (1973) suggest caliper matching when some units are dropped due to poor
match quality. Rubin (1977) suggests dropping units with covariate values that have
either no treated or no control and estimate causal effects for the range of covariate
values that have both treated and control units. Dehejia and Wahba (1999) drop
control units whose estimated propensity scores are less than the smallest estimated
propensity scores among the treated when estimating the average treatment effects
for the treated. Crump et al (2009) propose a minimum variance approach to select an
optimal subpopulation for which the estimated causal effects have the least variance,
where the optimal subpopulation is obtained by excluding cases with propensity scores
outside of a range [α, 1− α]. Gutman and Rubin (2015) propose restricting included
cases to the overlap region of estimated propensity scores between the treatment
groups.
Comparison of the performance of those methods for dealing with limited overlap,
especially in the longitudinal treatments where lack of overlap can be very severe,
is a topic for future research. However, here we restrict the overlap region to avoid
extrapolation of the prediction model outside the range of estimated propensities and
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extend the overlap rule to longitudinal treatments. To illustrate in the general case
of ∆ZT , relative to the null treatment regime 0T , at a given time 1 ≤ t ≤ T , we first
obtain the set of observations At = AZt such as
AZt =
{
i : {zti = Zt, zti 6= Zt}, min
j:zti=Zt
(Pˆ ∗j,Zt) ≤ Pˆ ∗i,Zt ≤ max
j:zti=Zt
(Pˆ ∗j,Zt)
}
At corresponds to the set of observations that have an estimated propensity score for
treatment regime Zt that lies within the range of the observed propensities of subjects
who actually received Zt. We then obtain Bt = B0t as
B0t =
{
i : {zti = 0t, zti 6= 0t}, min
j:zti=0t
(Pˆ ∗j,0t) ≤ Pˆ ∗i,0t ≤ max
j:zti=0t
(Pˆ ∗j,0t)
}
Bt corresponds to the set of observations that have an estimated propensity score
for null treatment regime 0t that lies within the range of the observed propensities
of subjects who actually received the treatment regime 0t. Finally, we restrict our
analysis to the set of observations given by A1 ∩B1 ∩ · · · ∩ AT ∩BT . In this way we
assure that all observations used in the analysis have a common set of overlapping
estimated propensities that are actually observed in the data.
2.3 G-computation, IPTW and AIPTW
2.3.1 G-computation
In a longitudinal treatment scenario with T + 1 time points, let O = (X¯T , Z¯T , Y )
denote the observed data, as above. The likelihood of the observed data can be
factored into two components P (O) = Q0g0, where Q0 = P (Y |X¯T , Z¯T = z¯T )×∏T
t=1 P (Xt|X¯t−1, Z¯t−1 = z¯t−1) and g0 =
∏T
t=1 P (Zt = zt|Z¯t−1 = z¯t−1, X¯t−1). Un-
der SUTVA, positivity and ignorability assumptions, for a fixed treatment regime
z¯T = (z1, · · · , zT ), E(Y z¯T ) =
∑
X1,··· ,XT E(Y |X¯T , Z¯T = z¯T )×P (X1)×P (X2|X1, Z1 =
23
z1) · · · × P (XT |X¯T−1, Z¯T−1 = z¯T−1). For continuous Xs, the expectation can be
solved by using a Monte-Carlo algorithm (Robins 1987). For example, in a two-time
point setting with binary treatment at each time point, there are four possible treat-
ment combinations (0, 0), (0, 1), (1, 0), and (1, 1). First, draw baseline covariate x∗1
from the empirical distribution of X1. Set Z1 = z1 and generate a draw x
∗
2 from
Pˆ (X2|X1 = x∗1, Z1 = z1). Then setting Z1 = z1 and Z2 = z2, generate draws y∗
from Pˆ (Y |X1 = x∗1, Z1 = z1, X2 = x∗2, Z2 = z2). Repeat the procedure many times
to get the marginal distribution of the outcome of interest under each counterfactual
treatment history. The marginal treatment effects between (Z1 = z1, Z2 = z2) and
(Z1 = z
′
1, Z2 = z
′
2) can be estimated by the sample mean of the draws y
∗ under
(Z1 = z1, Z2 = z2) and the sample mean of the draws under (Z1 = z
′
1, Z2 = z
′
2). If all
the models are correctly specified, the g-computation estimator is consistent.
2.3.2 Inverse Probability Treatment Weighted Estimator
The IPTW estimator provides a consistent estimator of the parameter of the
marginal mean of E(Y z¯T ) = f(z¯T , β) by solving the estimating equations:
DIPTW (O|β, g0) = df(z¯T , β)
dβ
{ T∏
t=1
P (Zt = zt|Z¯t−1 = z¯t−1)/g0
}
(Y z¯T−f(z¯T , β)) = 0,
where g0 is defined in Section 2.3.1.
Under the assumptions stated in Section 2.2, the IPTW estimator is consistent if
the propensity score models that make up g0 are correctly specified. For example, in
a two time points treatment, the marginal structural model of interest is E(Y Z¯2) =
β0 + β1Z1 + β2Z2 + β3Z1Z2. Let h(Z¯2) =
dE(Y Z¯2 )
dβ
P (Z1 = z1)P (Z2 = z2|Z1 = z1),
where P (Z2 = z2|Z1 = z1) can be modeled as a logistic regression conditional on past
treatment history. We solve the following estimating equation:
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DIPTW (O|β, g0) = {h(Z¯2)/g0}
(
Y Z¯2 − (β0 + β1Z1 + β2Z2 + β3Z1Z2)
)
= 0,
where g0 = P (Z1 = z1|X1)P (Z2 = z2|Z1 = z1, X¯2)
2.3.3 Augmented Inverse Probability Treatment Weighted Estimator
With treatments assigned at two time points, the AIPTW estimator is obtained
by solving the following estimating equation.
DAIPTW (O|β, g0, Qo) = DIPTW (O|β, g0)−
t=2∑
t=1
EQ0,g0 [DIPTW (O|β, g0)|Z¯t, X¯t]− EQ0,g0 [DIPTW (O|β, g0)|X¯t] = 0
Under the assumptions stated in Section 2.2, the AIPTW estimator is consistent
if 1) the propensity score models are correctly specified or 2) all the conditional
distributions of the covariates and the outcomes are correctly-specified (Scharfstein,
Rotnitzky, and Robins 1999).
See appendix A for more detailed descriptions of our implementations of IPTW
and AIPTW.
2.4 Simulation Studies
2.4.1 Introduction
We conducted simulations to assess the finite sample performance of PENCOMP-
MI, compared with g-computation, IPTW and a Monte-Carlo AIPTW method (Yu
and van der Laan, 2006) in estimating treatment effects.
Our simulation study design considered five factors: a single point in time and
a two-point in time treatment with the second treatment confounded by indication;
three levels of confounding (low, moderate and high); linear vs. non-linear regression
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models for the outcomes; three sample sizes (200, 500 and 1000); and two forms
of model misspecification. We considered three sets of models for the AIPTW and
PENCOMP estimators: (A) correctly-specified propensity and prediction models, (B)
a correctly-specified propensity model only, and (C) a correctly-specified prediction
model only. The case with both models misspecified was not considered since none
of the compared methods yields consistent estimates in that case, and conclusions
from particular simulation conditions have limited generalizability. For the IPTW
estimator, there is no prediction model so we considered only a correctly-specified
or misspecified propensity model. One thousand simulated data sets were created
for sample size of 500, but to reduce computation burden, only 500 simulated data
sets were used for sample sizes of 200 and 1000 in the two-time point situation. For
PENCOMP, 200 complete datasets were created to estimate treatment effects and the
associated standard errors and confidence intervals. For IPTW and g-computation,
500 bootstrap samples were used to estimate standard errors and 95% confidence
intervals. For AIPTW, 500 bootstraps were used to calculate standard errors and
confidence intervals for sample size of 500, but to reduce computational burden, only
200 bootstraps were used for sample size 200 and 1000 in the two-time point case.
For the single time point treatment, 35 equally spaced knots were used, and for the
two-time point treatment, 15 equally spaced knots were used. A truncated linear
basis was used in both.
We compared performance in terms of bias, RMSE, average 95% confidence in-
terval width, and 95% confidence interval (non) coverage. To provide a more inter-
pretable scale for bias and RMSE, we present the ratio of the bias and RMSE to the
RMSE of IPTW for the correct propensity model. We also scaled the 95% confidence
interval width to the width of IPTW with the correct propensity model. In the main
paper, we presented the results for RMSE and 95% non-coverage. The complete
results are included in Appendix A.3.
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2.4.2 Simulations for a Treatment Assigned at a Single Time Point
Our simulation scenarios are the same as those in Glynn and Quinn (2010). Each
simulated data set contains five variables: X1a, X1b and X1c are baseline covariates,
independently and normally distributed as N(0, 1). The treatment is denoted as Z1
and is Bernoulli distributed with treatment assignment probability that depends on
X1a and X1b. The outcome of interest is denoted as Y and is normally distributed
with a mean that depends only on X1b and X1c and a variance of 1, so that X1b
confounds treatment and outcome. We considered two outcome models: linear and
nonlinear. The correctly-specified and misspecified treatment assignment mechanism
and the outcome models are described in Table 2.3. The data were generated based on
the true models shown in Table 2.3. The treatment effects under linear and nonlinear
outcome models were 5 and 9, respectively.
Table 2.3: Single Time Point Treatment Simulation Scenarios: γ = c(1.5, 1.5, 0.75),
c(1, 1, 0.5), c(0.1, 0.1, 0.05) corresponds to high, moderate, and low confounding, re-
spectively. The true coefficients associated with each model are listed next to each
model.
.
Linear Outcome
True logit(P (Z1 = 1|X¯, γ) = γ1X1a + γ2X1b + γ3X1aX1b γ = c(γ1, γ2, γ3) = c(1.5, 1.5, 0.75), c(1, 1, 0.5), or c(0.1, 0.1, 0.05)
E(Y1|X¯, β1) = β10 + β11X1b + β12X1c β1 = (β10, β11, β12) = (5, 3, 1)
E(Y0|X¯, β0) = β00X1b + β01X1c β0 = (β00, β01) = (1, 1)
Misspecified logit(P (Z1 = 1|X¯, λ) = λ0 + λ1X1a
E(Y1|X¯, α1) = α10 + α11X1c
E(Y0|X¯, α0) = α00 + α01X1c
NonLinear Outcome
True logit(P (Z1 = 1|X¯, γ)) = γ1X1a + γ2X1b + γ3X1aX1b γ = c(γ1, γ2, γ3) = c(1.5, 1.5, 0.75), c(1, 1, 0.5), or c(0.1, 0.1, 0.05)
E(Y1|X¯, β1) = β10 + β11X1b + β12X1c + β13X21b + β14X21c β1 = (β10, β11, β12, β13, β14) = (5, 3, 1, 2, 2)
E(Y0|X¯, β0) = β00X1b + β01X1c β0 = (β00, β01) = (1, 1)
Misspecified logit(P (Z1 = 1|X¯, λ)) = λ1X1a
E(Y1|X¯, α1) = α10 + α11X1c
E(Y0|X¯, α0) = α00 + α01X1c
Results for sample size 500 are shown in Figures 2.1-2.2 and Tables A.5-A.8 in
Appendix A.3. The RMSEs of the methods are shown in Figure 2.1, expressed as a
proportion of the RMSE of IPTW with a correct propensity model. Both AIPTW
and PENCOMP generally had substantially lower RMSEs than IPTW, especially for
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the linear outcome, with the ratio of RMSE to RMSE of IPTW with a correct propen-
sity model varying from 0.3 to 1 and with most of the ratios below 0.8. AIPTW and
PENCOMP had similar RMSE under low confounding or correctly specified predic-
tion models in the linear model, but PENCOMP had substantially lower RMSE than
AIPTW when the prediction model was misspecified and as the degree of confounding
increased and the weights became more variable. In the nonlinear outcome model,
PENCOMP and AIPTW had similar RMSE under all scenarios. Lastly, PENCOMP
had similar RMSEs to g-computation when the prediction model was correctly spec-
ified.
The 95% confidence interval non-coverage rates are shown in Figure 2.2. PEN-
COMP generally had close to nominal coverage of 95% when the prediction model was
correctly specified, and conservative (over-) coverage when the prediction model was
misspecified, especially for linear outcome model, with coverage rates close to 99%.
One exception is that in the nonlinear model under high confounding, PENCOMP
slightly undercovered, with a coverage rate of 90%. On the other hand, AIPTW and
IPTW displayed more evidence of undercoverage, especially in the linear outcome
model under high confounding, with coverage rates less than 90%.
Table A.5 in the Appendix displays the empirical bias of the three methods as
a fraction of RMSE of IPTW with a correct propensity score model. The IPTW
estimator had close to zero empirical bias when the propensity model was correctly
specified, but was substantially biased, with relative bias greater than 20% under
high confounding, when the propensity model was misspecified. G-computation had
negligible bias, when the prediction model was correct, but had substantial bias, with
relative bias over 20% in some scenarios, when the prediction model was misspeci-
fied. Both AIPTW and PENCOMP had small empirical bias, especially when the
prediction model was correctly specified or when confounding was low. The empirical
biases tended to be larger when the prediction model was misspecified, with AIPTW
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having slightly less empirical bias than PENCOMP in some scenarios. In general,
empirical bias for both PENCOMP and AIPTW represented a small fraction of the
RMSE of IPTW with a correct propensity score model.
The 95% confidence width are shown in Table A.8 in the Appendix. When the
prediction model was correctly specified, both AIPTW and PENCOMP had similar
confidence interval widths, which were smaller than those for IPTW. However, when
the prediction model was misspecified, PENCOMP tended to have a wider confidence
interval under low confounding, compared to AIPTW and IPTW with the correct
propensity model, a finding consistent with the over-coverage of PENCOMP in Figure
2.2. As confounding increased, both PENCOMP and AIPTW had similar confidence
interval widths as IPTW with the correct propensity model in the linear outcome.
In the nonlinear outcome, with the prediction model misspecified, both PENCOMP
and AIPTW had similar interval widths than IPTW with correct propensity model.
In addition, for all the estimators, the confidence intervals were wider when the
prediction model was misspecified.
The simulation results for sample sizes 200 and 1000 are given in Table A.1-A.4
and A.9-A.12 in Appendix A. As one would expect, the empirical biases of correctly-
specified IPTW, AIPTW and PENCOMP estimators decreased with increasing sam-
ple size, whereas the bias of the misspecified IPTW estimator was less dependent on
sample size. PENCOMP’s relative gains in RMSE over the other methods tended
to increase with increasing sample size, especially under moderate or high confound-
ing. Interval widths for PENCOMP decreased more dramatically when the prediction
model was misspecified as sample size increased. Confidence coverage of the methods
tended to be closer to nominal as sample size increased.
In summary, IPTW performed worse than AIPTW and PENCOMP, particularly
when confounding was high, since the doubly-robust estimators rely on both the pre-
diction model and the propensity model. PENCOMP had comparable performance
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to AIPTW when confounding was low and the prediction model was correct, and
tended to perform better than AIPTW when the prediction model was misspecified
and weights were highly variable.
Logit-transforming the propensity scores before fitting the PENCOMP model
works well in general, since the weight distribution is typically highly skewed, and
the logit transformation yields a more uniform distribution of propensity scores for
the fitting of the spline models. However, in cases where the weight distribution is
more uniformly distributed on the original scale, the logit transformation can actually
skew the weight distribution, leaving data points thinly distributed in some regions
so that it becomes harder to fit the model and make predictions. This is the cause of
the undercoverage of PENCOMP in the nonlinear model under high confounding. In
practice, examining the distribution of the propensity score with and without the logit
transformation is recommended. This issue becomes moot as sample size increases,
allowing for sufficient data to be available to fit the splines, as indicated by the fact
that coverage is approximately correct for the nonlinear model under high confound-
ing with sample sizes of 1000 (see Table A.11 in the Appendix). Lastly, including a
covariate that is a strong predictor of the treatment but not of the outcome can lead
to bias and inefficiency.
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Figure 2.1: Ratio of RMSE over RMSE of IPTW(A) with correct propenisty score
model across four methods-PENCOMP, AIPTW, IPTW and g-computation for treat-
ment effect ∆ in a linear and nonlinear outcome model. (A) correctly-specified
propensity and prediction models; (B) a correctly-specified propensity model only;
(C) a correctly-specified prediction model only; based on 1000 simulations with sam-
ple size of 500 and 500 bootstraps, and 200 complete datasets for PENCOMP.
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Figure 2.2: 95% noncoverage rate across four methods-PENCOMP, AIPTW, IPTW
and g-computation for treatment effect ∆ in a linear and nonlinear outcome model.
(A) Correctly-specified propensity and prediction models; (B) a correctly-specified
propensity model only; (C) a correctly-specified prediction model only; based on 1000
simulations with sample size of 500 and 500 bootstraps, and 200 complete datasets
for PENCOMP.
2.4.3 Simulations for Treatments Assigned at Two Time Points
In the two time-point treatment scenario, each simulated data set contains X1a,
X1b, Z1, X2a, X2b, Z2, and Y . X1a and X1b are two baseline covariates and normally
distributed with mean 0.2, variance 1. The first treatment Z1 is Bernoulli distributed
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with success probability that depends on the two baseline variables. The interme-
diate outcome X2a is normally distributed with a mean that depends on X1a, X1b
and Z1 and with a residual variance of 1. The other intermediate outcome X2b is
normally distributed with a mean that depends on X1b, X2a and Z1, and with a
residual variance of 1. The second treatment Z2 is Bernoulli distributed with success
probability that depends on all the covariate and treatment histories. Thus, X2a
and X2b both mediate and confound the relationship between Z1, Z2, and Y . The
coefficients in the second treatment assignment are varied to create three levels of
variability of the IPTW weights: low, moderate and high. The true first and sec-
ond treatment probability models are described in Table 2.4. Each outcome model
is normally distributed with a mean that depends on the covariate and treatment
histories, and a residual variance of 1, as shown in Table 2.4. The data were gen-
erated based on the true models in Table 2.4. Under the linear outcome model,
(∆11,∆10,∆01) were (22.35, 11.17, 10.45), respectively. Under the nonlinear outcome
model, (∆11,∆10,∆01) were (25.31, 12.69, 10.57), respectively.
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Table 2.4: Two Time Point Treatment Simulation Scenarios: setting (γ11, γ21, γ22, γ24) equal to (−0.5,−0.1, 0.2, 0.2),
(−0.8,−0.1, 0.6, 0.6), and (−0.8,−0.5, 1.1, 1.1) which corresponds to high, moderate, and low confounding, respectively.
.
Linear Outcome
True X1a ∼ N(0.2, 1)
X1b ∼ N(0.2, 1)
logit(P (Z1 = 1|X1, γ1)) = γ10 + γ11X1a + γ12X1b γ1 = (γ10, γ11, γ12) = (−0.01, γ11,−0.3)
logit(P (Z2 = 1|X¯2, Z1, γ2)) = γ20 + γ21(X2a −X1a) + γ22Z1(X2a −X1a) + γ23(X2b −X1b) + γ24Z1(X2b −X1b) γ2 = (γ20, γ21, γ22, γ23, γ24) = (−0.01, γ21, γ22,−0.1, γ24)
(X2a|Z1 = 0, X1a, X1b, ω0) ∼ N(ω00X1a + ω01X1b, 1) ω0 = (ω00, ω01) = (1, 0.5)
(X2a|Z1 = 1, X1a, X1b, ω1) ∼ N(ω10X1a + ω11Z1 + ω12X1a ∗ Z1 + ω13X1b, 1) ω1 = (ω10, ω11, ω12, ω13) = (1, 0.5, 0.5, 0.5)
(X2b|Z1 = 0, X1b, α0) ∼ N(α00X2a + α01X1b, 1) α0 = (α00, α01) = (0.3, 1)
(X2b|Z1 = 1, X1b, α1) ∼ N(α10X2a + α11X1b, 1) α1 = (α10, α11) = (0.4, 1)
E(Y11|X¯2, β11) = β110 + β111X1a + β112X2a + β113X1b + β114X2b β11 = (β110, β111, β112, β113, β114) = (25, 2, 2, 1.5, 1.5)
E(Y10|X¯2, β10) = β100 + β101X1a + β102X2a + β103X1b + β104X2b β10 = (β100, β101, β102, β103, β104) = (15, 2, 1, 1.5, 1)
E(Y01|X¯2, β01) = β010 + β011X1a + β012X2a + β013X1b + β014X2b β01 = (β010, β011, β012, β013, β014) = (15, 1, 2, 1, 1.5)
E(Y00|X¯2, β00) = β000 + β001X1a + β002X2a + β003X1b + β004X2b β00 = (β000, β001, β002, β003, β004) = (15, 1, 1, 1, 1)
Misspecified logit(P (Z2 = 1|X¯2, Z1, λ)) = λ0 + λ1X1a + λ2X2a + λ3X1b
E(Y11|X¯2, α11) = α110 + α111X1a + α112X1b
E(Y10|X¯2, α10) = α100 + α101X1a + α102X1b
E(Y01|X¯2, α01) = α010 + α011X1a + α012X1b
E(Y00|X¯2, α00) = α000 + α001X1a + α002X1b
NonLinear Outcome
True X1a ∼ N(0.2, 1)
X1b ∼ N(0.2, 1)
logit(P (Z1 = 1|X1, γ1)) = γ10 + γ11X1a + γ12X1b γ1 = (γ10, γ11, γ12) = (−0.01, γ11,−0.3)
logit(P (Z2 = 1|X¯2, Z1, γ2)) = γ20 + γ21(X2a −X1a) + γ22Z1(X2a −X1a) + γ23(X2b −X1b) + γ24Z1(X2b −X1b) γ2 = (γ20, γ21, γ22, γ23, γ24) = (−0.01, γ21, γ22,−0.1, γ24)
(X2a|Z1 = 0, X1a, X1b, ω0) ∼ N(ω00X1a + ω01X1b, 1) ω0 = (ω00, ω01) = (1, 0.5)
(X2a|Z1 = 1, X1a, X1b, ω1) ∼ N(ω10X1a + ω11Z1 + ω12X1a ∗ Z1 + ω13X1b, 1) ω1 = (ω10, ω11, ω12, ω13) = (1, 0.5, 0.5, 0.5)
(X2b|Z1 = 0, X1b, α0) ∼ N(α00X2a + α01X1b, 1) α0 = (α00, α01) = (0.3, 1)
(X2b|Z1 = 1, X1b, α1) ∼ N(α10X2a + α11X1b, 1) α1 = (α10, α11) = (0.4, 1)
E(Y11|X¯2, β11) = β110 + β111X1a + β112X2a + β113X1b + β114X2b + β115X2a ∗X2b β11 = (β110, β111, β112, β113, β114, β115) = (25, 2, 2, 1.5, 1.5, 1.6)
E(Y10|X¯2, β10) = β100 + β101X1a + β102X2a + β103X1b + β104X2b + β105X2a ∗X2b β10 = (β100, β101, β102, β103, β104, β105) = (15, 2, 1, 1.5, 1, 1)
E(Y01|X¯2, β01) = β010 + β011X1a + β012X2a + β013X1b + β014X2b + β015X2a ∗X2b β01 = (β010, β011, β012, β013, β014, β015) = (15, 1, 2, 1, 1.5, 0.8)
E(Y00|X¯2, β00) = β000 + β001X1a + β002X2a + β003X1b + β004X2b + β005X2a ∗X2b β00 = (β000, β001, β002, β003, β004, β005) = (15, 1, 1, 1, 1, 0.7)
Misspecified logit(P (Z2 = 1|X¯2, Z1, λ)) = λ0 + λ1X1a + λ2X2a + λ3X1b
E(Y11|X¯2, α11) = α110 + α111X1a + α112X1b
E(Y10|X¯2, α10) = α100 + α101X1a + α102X1b
E(Y01|X¯2, α01) = α010 + α011X1a + α012X1b
E(Y00|X¯2, α00) = α000 + α001X1a + α002X1b
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Results for RMSE and 95% confidence interval noncoverage for sample size 500
are shown in Figure 2.3-2.6; other results are given in Tables A.17-A.20 in Appendix
A. The RMSEs of the methods are presented in Figure 2.3 for the linear outcome
model and in Figure 2.4 for the nonlinear outcome model, expressed as a propor-
tion of the RMSE of IPTW with a correct propensity model. The AIPTW and
PENCOMP methods had substantially lower RMSEs than IPTW, with the ratio of
RMSEs less than 0.7 in most scenarios. The RMSEs for PENCOMP were similar
to or lower than the corresponding RMSEs for AIPTW, with some substantial gains
over AIPTW when the prediction models were misspecified. Lastly, g-computation
had similar RMSE to PENCOMP when the prediction model was correctly speci-
fied, but markedly, higher RMSE than PENCOMP when the prediction model was
misspecified.
Non-coverage rates of the 95% intervals are shown in Figure 2.5-2.6. Coverage for
IPTW was markedly below nominal when the prediction models were misspecified.
PENCOMP tended to have close to nominal or conservative coverages. AIPTW
had close to nominal or anti-conservative coverages, and tended to undercover in
situations with high confounding, particularly when the prediction model was severely
misspecified and the weights were highly variable. For example, for estimation of ∆10
in the nonlinear regressions, as confounding increased, AIPTW and IPTW’s coverage
rates dropped dramatically to about 60%, while PENCOMP maintained a coverage
rate of 97%.
Table A.17 displays empirical biases as a fraction of RMSE of IPTW with cor-
rectly specified propensity score model for the linear and nonlinear outcome models,
respectively. As in the one time point case, IPTW had moderate empirical bias
when the propensity model was correctly specified under high confounding, and was
highly biased when the propensity model was misspecified, especially with moderate
and high degrees of confounding. On the other hand, g-computation had negligible
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biases, with relative bias of less than 1% when the prediction model was correctly
specified, but was highly biased when the prediction model was misspecified. AIPTW
and PENCOMP had lower empirical bias under low confounding scenarios or when
the prediction model was correctly specified. As confounding increased, the estimated
biases became larger. However, both AIPTW and PENCOMP had relative bias of
less than 5% in most cases. In terms of the RMSE of IPTW with a correct propensity
model, the bias of AIPTW and PENCOMP represented a very small fraction of the
RMSE, with the fractions varying from approximately 0 to 0.25.
The 95% confidence intervals widths are shown in Table A.20. In both linear
and nonlinear outcome models, both AIPTW and PENCOMP had similar confidence
interval widths, which were substantially smaller than IPTW. As confounding in-
creased, PENCOMP tended to have smaller confidence interval widths than IPTW
with correctly-specified propensity model and still covered better. On the other hand,
AIPTW tended to undercover under high confouding. Lastly, PENCOMP tended to
have similar RMSEs and mean confidence interval widths as g-computation with cor-
rectly specified prediction models.
Results for sample size 200 and 1000 are in Table A.13-A.16, A.21-A.24 in Ap-
pendix A. In general, changes in sample sizes had similar effects on the two-time point
simulations as for the single time point simulations, with the finite sample bias for
the robust estimators decreasing as the sample size increased. Changes in sample size
had very little impact on RMSE comparisons. Coverage rates for the robust estima-
tors were slightly improved under larger sample sizes. Confidence interval widths for
PENCOMP tended to shrink as sample sizes increased, while other interval widths
remained the same.
Overall, PENCOMP outperforms the other methods in terms of RMSE and cov-
erage probability and efficiency in these simulations, although it has slightly larger
bias than AIPTW in some cases-though very small as a fraction of RMSE of IPTW
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with a correct propensity model.
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Figure 2.3: Ratio of RMSE over RMSE of IPTW(A) with correct propenisty score
model across four methods-PENCOMP, AIPTW, IPTW and g-computation for three
treatment effects ∆11, ∆10, and ∆01 in a linear outcome model. (A) Correctly-specified
propensity and prediction models; (B) a correctly-specified propensity model only; (C)
a correctly-specified prediction model only; based on 1000 simulations with sample
size of 500 and 500 bootstraps, and 200 complete datasets for PENCOMP.
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Figure 2.4: Ratio of RMSE over RMSE of IPTW(A) with correct propenisty score
model across four methods-PENCOMP, AIPTW, IPTW and g-computation for three
treatment effects ∆11, ∆10, and ∆01 in a nonlinear outcome model. (A) Correctly-
specified propensity and prediction models; (B) a correctly-specified propensity model
only; (C) a correctly-specified prediction model only; based on 1000 simulations with
sample size of 500 and 500 bootstraps, and 200 complete datasets for PENCOMP.
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Figure 2.5: 95% noncoverage rate across four methods-PENCOMP, AIPTW, IPTW
and g-computation for three treatment effects ∆11, ∆10, and ∆01 in a linear outcome
model. (A) Correctly-specified propensity and prediction models; (B) a correctly-
specified propensity model only; (C) a correctly-specified prediction model only; based
on 1000 simulations with sample size of 500 and 500 bootstraps, and 200 complete
datasets for PENCOMP.
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Figure 2.6: 95% noncoverage rate across four methods-PENCOMP, AIPTW, IPTW
and g-computation for three treatment effects ∆11, ∆10, and ∆01 in a nonlinear
outcome model. (A) Correctly-specified propensity and prediction models; (B) a
correctly-specified propensity model only; (C) a correctly-specified prediction model
only; based on 1000 simulations with sample size of 500 and 500 bootstraps, and 200
complete datasets for PENCOMP.
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2.5 Application
We applied our method to the Multicenter AIDS Cohort study (MACS) to analyze
the effect of antiretroviral treatment on CD4 counts. We restrict our analyses to the
period between visit 7 and 21, after the first antiretroviral treatment zidovudine
(AZT) was approved for use and before the advent of highly active antiretroviral
therapy (HAART). During the period between visit 14 and 17 didanosine (ddI) and
zalcitabine (ddC) also became available. Then around visit 21, new treatments-
stavudine (d4t) and lamivudine (3tc) were approved. We estimate the short-term (1
year) effects of using any antiretroviral treatment for HIV+ subjects. Treatment was
coded to 1 if the patient reported taking any of the four mentioned antiretroviral
treatment (ART) or enrolling in clinical trials of such drugs. That is, starting with
visit 7, for every three-visit window we estimated the effects of using ART drugs
on CD4 counts. We excluded subjects with missing values on any of the covariates
included in the models. We also used the square root of the blood count variables in
this analysis.
For each three-visit window, we denoted time t = 1, 2, and 3. Let Xt(i) denote
square root of subject i’s blood count measures at time t, and Zt(i) be one if subject
i received antiretroviral treatment during the period between time t and t + 1, and
zero if otherwise, for t = 1, 2. Let Y (i) = X3(i) be the square root of CD4 count
for subject i measured a year after baseline at time t = 3. We defined dosage as
the number of times a subject went on treatment previously, i.e. from the start of
enrollment to the baseline at time t = 1 of each three-visit window. For the outcome
and propensity models, we considered baseline blood count measures, dosage, and
intermediate CD4 count as potential covariates. The baseline blood count measures
included CD4 count, CD8 count, white blood cell count (WBC), red blood cell count
(RBC), and platelets. Specifically, the intermediate outcome models included all the
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baseline blood measures. The final outcome model included the baseline blood count
measures and intermediate CD4 count. For sample size less than 50, especially for
treatment regimes (1, 0) and (0, 1), the final outcome models included only prior CD4
count. The first treatment assignment Z1 was modeled as a logistic regression with
baseline blood count measures and dosage. Race, age, and education level were not
included because including them seemed to increase the variance of the estimates
while the estimates stayed about the same. The second treatment Z2 was modeled as
a logistic regression with the same baseline covariates as those in the first treatment
model, intermediate CD4 count and Z1. The models used to estimate the numerator
of the stabilized weights excluded all covariates, except treatment indicator Z1 and
intercept. When calculating the total dosage for subjects, we assumed that subjects
with missed visits did not change treatment at the missing time points. For each
three-visit window starting with visit 7, we estimated the treatment effects ∆11, ∆10,
and ∆01, provided sufficient data were available to model the relevant outcomes. The
number of subjects with observed treatment sequence (Z1, Z2) = (1, 0) was very small
for some of the three-visit windows, as shown in Table A.25 in Appendix A.4. The
data suggested that patients tended to stay on treatment once they started. As the
three-visit window moved across time, more patients got on treatments, and fewer
patients switched off treatment, since there were more treatment options available
if resistance or severe side effects developed with one treatment. Consequently, the
number of subjects with treatment sequence (1, 0) was much smaller than that with
(1, 1), (0, 1), or (0, 0).
In both the Monte Carlo steps of AIPTW and the imputation steps in PENCOMP,
we replaced the simulated/imputed transformed CD4 values that were < 0 with 0 (i.e.
below detection level). The stabilized weights were still highly variable, as shown
in Table A.26, so we truncated the weights at the 1st and 99th percentiles when
calculating the estimates of AIPTW and IPTW estimators. Although the variances of
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the estimates reduced, the estimates became more biased toward the naive estimates,
as seen in Figure A.1 in Appendix A.4. The results without truncation are in Figure
2.8 (See Zubizarreta (2015) for an alternative that minimizes weight variance while
retaining covariate balance). For PENCOMP, we chose a mininum of 35 and 1/4
of unique data points as the number of knots. Equally spaced knots and truncated
linear basis were used. In addition, for estimating outcomes for a particular treatment
regimen Zt, we excluded cases where the propensity of Zt lay outside the observed
ranges of the propensity of Zt as described in Section 2.2.4, to avoid extrapolating
the regression model predictions outside the shared range of propensities.
For example, to calculate the treatment effect of ∆z1z2 , we estimated the probabil-
ity of getting treatment Z1 = z1 conditional of the baseline covariate history, denoted
as Pˆ (Z1 = z1|X¯1), and the probability of receiving treatment Z2 = z2, conditional
the past covariate history and Z1 = z1, denoted as Pˆ (Z2 = z2|Z1 = z1, X¯1). De-
note the probability of treatment regime (z1, z2) as Pˆz¯2 = Pˆ (Z1 = z1|X¯1) ∗ Pˆ (Z2 =
z2|Z1 = z1, X¯2). At t = 1, subjects were divided into two groups using indicators
I(Zobs1 = z1) and I(Z
obs
1 6= z1). We removed subjects whose estimated propen-
sity scores Pˆ (Z1 = z1|X¯1) lay outside the overlapping regions of the propensity
scores. Similarly, at t = 2, subjects were divided into two groups using indicators
I{(Zobs1 , Zobs2 ) = (z1, z2)} and I{(Zobs1 , Zobs2 ) 6= (z1, z2)}. Again, we removed subjects
whose estimated propensity scores Pˆz¯2 lay outside of the overlapping regions of the
propensity scores. We then repeated this process for z1 = z2 = 0, and took for
analysis the set of observations that had not been dropped as a result of all of these
comparisons. Figure 2.7 illustrates the overlapping regions of the propensity scores
for one window. We repeat the same procedures for each set of time points and each
treatment. The fraction of subjects that was included in each analysis varied from
25% to 89% of the total sample, shown in Table A.25. One possible reason for fewer
subjects being included in later windows was that later windows included more newly
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infected subjects, as well as infected subjects who had survived for years; these two
groups of subjects were probably very different.
One important step in building the propensity score models is to check for bal-
ance in the covariates. At t = 1, for the two groups of subjects I(Zobs1 = z1) and
I(Zobs1 6= z1), we checked whether the distributions of the baseline covariates were
similar between the two groups. Similarly, at t = 2, we checked whether the dis-
tributions of the baseline and the intermediate covariates were similar between the
two groups I{(Zobs1 , Zobs2 ) = (z1, z2)} and I{(Zobs1 , Zobs2 ) 6= (z1, z2)}. As a measure
of imbalance, we used the standardized difference between the two groups, which is
the difference in means between the two groups divided by an estimate of the pooled
standard deviation:
d =
∣∣∣∣(x¯(z1z2) − x¯ 6=(z1z2))/
√
s2(z1z2) + s
2
6=(z1z2)
2
∣∣∣∣
If the propensity score models are adequately specified, the covariate distributions
between the (z1z2) and 6= (z1z2) groups should be similar, conditional of the estimated
propensity scores. Specifically, to check the balance of covariate x, we regressed x
on the spline of the propensity scores and compared the residuals between treatment
groups using t-test. Table 2.5 shows an example for covariate balance before and
after adjusting for propensity scores. The standardized differences between treatment
groups for most blood count measures and the t statistics were reduced dramatically.
In addition, we assessed the degree of overlap in the propensity score distributions
between treatment groups (Imbens and Rubin, 2015). For example, we measured
the proportion of subjects in the 6= (z1, z2) group whose propensity scores of (z1, z2)
are between the 1− α and α quantiles of the propensity score distribution of (z1, z2)
group, denoted as pi1−α(z1,z2) = F 6=(z1,z2)(F
−1
(z1,z2)
(1−α))−F 6=(z1,z2)(F−1(z1,z2)(α)), where F is
the cumulative distribution. Inside this region it is easier to impute missing potential
44
outcomes Y z1z2 because there are more observations. The low degree of overlap for
this dataset suggested some difficulty in imputing the missing potential outcomes, as
shown in Figure 2.7 and Table A.27 in Appendix A.4.
We estimated the short term effect of antiretroviral treatment on CD4 count us-
ing four methods: naive crude estimate, g-computation, IPTW, AIPTW, and PEN-
COMP. The results are summarized in Figure 2.8. The standard errors were obtained
using 500 bootstrap samples. For PENCOMP, 200 complete datasets were created.
For all the three-visit windows, the naive estimators were negative, suggesting a
harmful effect of antiretroviral treatment on CD4 count. This is likely due to un-
controlled confounding by indication, in that sicker subjects with lower CD4 counts
were more likely to be assigned to treatment. The treatment effects estimated by
IPTW, AIPTW and PENCOMP all suggest less harmful effects, with PENCOMP
in particular having slightly negative to slightly positive effects, and IPTW having
positive effects in most windows. When the weights were not variable in window 1-3,
and 15-16 and the means of the stablized weights were close to one, the treatment
effects obtained from all four methods were similar. The similarity of PENCOMP to
the other estimates indicate that our proposed method is addressing the bias from
confounding by indication. Further, when the weights became variable, the PEN-
COMP estimates were more stable across time, and generally had smaller standard
errors than either AIPTW or IPTW, a finding that is consistent with the findings in
the simulation study. Lack of stronger positive effects of treatment may be due to
the inability of the observed covariates to remove all confounding.
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Figure 2.7: Distributions of the propensity scores in subjects whose observed treat-
ment sequence is (z1, z2) and subjects whose observed treatment sequence is not
(z1, z2) for window 4.
Table 2.5: Balance of covariates between subjects with observed treatment sequence
(1, 1) and everybody else before and after adjusting for propensity scores for window
8, without removing subjects outside of the overlapping regions. We regressed each
covariate on the spline of the logit of the propensity score, Pˆ ∗11. Truncated linear basis
with 10 equally spaced knots was used. ∗∗ significant at 0.005 level, and ∗ significant
at 0.05 level.
.
Before Adjusting After Adjusting
Covariate d T Stats d T stats
RBC 1.83 25.23∗∗ 0.016 0.22
CD4 1.11 15.28∗∗ 0.0048 0.067
WBC 0.59 8.11∗∗ 0.028 0.39
CD8 0.0012 0.017 0.032 0.44
PLATE 0.10 1.37 0.044 0.61
CD4 at t = 2 1.12 15.28∗∗ 0.017 0.23
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Figure 2.8: For each of the three-visit windows 1, · · · , 15, the estimates and stan-
dard errors (SE) of the treatment effects ∆11, ∆10, and ∆01 of the four methods:
PENCOMP, AIPTW, IPTW, and Naive. For some windows, AIPTW had very large
bootstrap standard errors because of a few extreme bootstrap estimates.
2.6 Discussion
We have proposed PENCOMP as a new, straightforward method to estimate treat-
ment effects in point treatment situations and in two-time point treatment situations
with time dependent confounders. The method uses the doubly-robust imputation
methodology of Zhang and Little (2009) to impute the unobserved potential outcomes
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and compute the causal treatment effects of interest. As with other doubly-robust
methods, PENCOMP offers the analyst two chances to make correct inferences about
treatment effects, either by correctly specifying the propensity score model or by cor-
rectly specifying the prediction models. The robustness of PENCOMP to model
misspeciffication is borne out by our simulation studies.
Three main versions of PENCOMP are PENCOMP-ML, which is based on ML
with information-based or bootstrap standard errors, PENCOMP-B, which based
inference on posterior distributions of the causal parameters, and PENCOMP-MI,
which multiply imputes the outcomes for treatments not assigned, and uses MI com-
bining rules for inference. For PENCOMP we considered distinct outcome models for
each treatment combination in this paper. Specifically, suppose we are interested in
treatment sequence z¯T , at each time point t, the outcome model was fitted using only
the subjects with z¯t that matched with z¯T up to time point t. However, when the
observed data are sparse, outcome models with interactions between treatment and
covariates, as well as interactions between treatment and splines (Coull, 2001), can
be fitted to borrow strength across different treatment sequences. However, adding
interactions between treatment and splines could increase complexity when there are
many treatment sequences. We fitted the spline on the propensity score on the proba-
bility scale and on the logit scale but found that the logit scale worked much better in
most cases, especially when the propensity scores were too extreme on the probability
scale. Lastly, we considered PENCOMP-MI in our empirical work, but it would be
interesting to compare it with the alternative versions, particularly PENCOMP-B,
which as a Bayesian method might have attractive small-sample properties.
A natural competitor to PENCOMP is the AIPTW estimator, which like PEN-
COMP has a double robustness property. In our simulation studies, the performance
of PENCOMP is similar to that of AIPTW estimator when the confounding is low.
However, when the confounding is moderate or high and the weights in AIPTW are
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highly variable, PENCOMP tends to outperform the version of AIPTW considered
in this study with respect to mean square error, interval coverage, and interval width.
Kang and Schafer (2007) also show drawbacks of AIPTW in small samples, espe-
cially when the weights are highly variable. The version of AIPTW we considered is
based on Monte Carlo simulations and is computationally intensive. Consequently,
PENCOMP is not only statistically more efficient, but is also computationally more
efficient than this AIPTW estimator. Other versions of AIPTW have been suggested,
and we have not compared our method with these versions; however, we expect that
instability from highly-variable weights is likely to be an issue with other forms of
AIPTW as well. The PENCOMP method avoids this problem by using the propensity
as a predictor, rather than as a weight.
We have focused here on situations with treatment assignments at just two time
points. An important question is how PENCOMP can be applied to longitudinal
data sets with more than two assignment points. In the MACS data we analyzed,
data are available at 16 time points, so there are over 30,000 (215) possible treat-
ment combinations, nearly all of which are not seen in the data; providing simple
and interpretable causal conclusions in such a setting requires careful thought and
modeling. An initial step is to analyze the set of treatment combinations that arise
in the data set, and restrict inference to the subset of ”relevant combinations” judged
to have sufficient data to provide meaningful estimates. Propensity models can then
be fitted sequentially over time on historical data, including prior treatment assign-
ments and outcomes as potential covariates. The outcomes of relevant combinations
can then be imputed as a function of a spline of the propensity and other predictive
covariates in the history, with the propensity for each relevant combination obtained
by multiplying the sequence of propensities at the set of earlier time points. Some
modeling of the resulting treatment effects is likely to be needed to provide parsimo-
nious inferences; for example a plot of treatment effects against the number of prior
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”dosages” may suggest a model with a parametric form for the treatment effect as a
function of dosage. To maintain stable estimates and enhance interpretability, some
form of dimension reduction and variable selection, for example, a summary measure
of treatments and other time varying covariates, will typically required. Implement-
ing such strategies is outside the scope of this article, and a topic for future research.
We note that proliferation of treatment regimens is a characteristic of the problem,
not the statistical method; MSM models are faced with similar challenges.
In our simulation study, we considered the standard g-computation based on the
full covariate history. However, when the dimension of the covariate is high, such as
in longitudinal treatments, it becomes hard to check and fix the models, if they are
misspecified. Achy-Brou et al (2010) proposed using a g-computation approach based
on the longitudinal propensity scores as regressors, instead of the full covariate history,
exploiting the fact that the sequential ignorability assumption remains true given the
longitudinal propensity score history. They stratified patients based on quintiles
of the propensity scores at each time point, and fitted a proportional odds logistic
regression models based on the propensity quintiles for the transition probabilities
between strata. PENCOMP is similar to Achy Brou’s method in the sense that both
methods model the outcome based on propensity scores. However, while Achy Brou’s
approach uses the propensity scores in quintiles, PENCOMP uses a penalized spline
to model the relationship between the outcome and the propensity score. This relaxes
the parametric assumptions between the outcome and the propensity score and gives
PENCOMP the double robustness property. PENCOMP also includes other variables
in the prediction models to improve efficiency.
Here we considered a smooth relationship between the outcome and the propen-
sity score. If there are thought to be discontinuities, approaches that allow for this
possibility might improve on PENCOMP. Koo (1997) considers models that allow
discontinuities at the knots. An adaptive regression spline approach to PENCOMP
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could potentially address the issues of jump discontinuity and sharp jumps (Di Mat-
teo, Genovesem and Kass, 2001). In addition, we have focused on estimating causal
effects for a continuous and normally distributed outcome. Extensions to non-normal
outcomes are straightforward in principle, by replacing the normal linear mixed mod-
els discussed here with generalized linear mixed models. For example, a logistic mixed
effects regression with random effects for the spline on the propensity could be fitted
when Y is a binary outcome. Gutman and Rubin (2012) examine the performace
of a similar spline method for binary outcome in one time point treatment. How-
ever, the performance of such extensions to non-normal outcomes for time-dependent
confounding is a topic for future research.
In summary, our simulation studies suggest that PENCOMP is a viable alternative
to IPTW and AIPTW estimators. Although we focus on observational studies in
this study, PENCOMP can also be used in randomized trials, where randomization
at later time points are based on intermediate outcomes from earlier randomized
treatments, sequential multiple assignment: randomized trials or SMART (Murphy,
2005; Nahum-Shani et al, 2012). Correct methods typically use the semi-parametric
likelihood approach similar to that employed in AIPTW; use of a robust fully model-
based approach similar to that of PENCOMP might provide advantages similar to
those described here.
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CHAPTER III
Addressing Disparities in the Assignment
Propensity Distributions for Treatment
Comparisons from Observational Studies
3.1 Introduction
Observational studies for inference about causal effects are valuable when ran-
domization is not feasible or unethical. Valid causal inferences in this setting requires
adjustment for differences in the distribution of confounders between the treatment
groups. For example, the Multicenter AIDS cohort study (MACS) (Kaslow et al,
1987) saw the introduction of the first antiretrovial therapy (zidovudine or AZT) at a
time when no effective treatment for human immunodeficiency virus existed. Hence,
early administration was based on availability and biomarkers of disease severity
such as CD4 count, with sicker patients more likely to be treated. To deal with con-
founding, propensity score - the probability of treatment assignment as a function of
covariates - is often used. The balancing property of propensity score implies that
adjusting for the propensity can remove the bias due to differences in all observed
confounders between the treatment groups (Rosenbaum and Rubin, 1983). Propen-
sity score-based methods to estimate causal effects from observational studies include
inverse propensity weighting, matching, stratification and regression adjustment on
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the propensity score. However, for these methods to work reliably, there should be
a sufficient overlap in the propensity score distributions for the compared treatment
groups. Estimating the causal effects for units outside the overlap region depends
entirely on extrapolation, and hence is vulnerable to model misspecification. Fur-
thermore, restricting estimation of causal effects to a subpopulation where there is
more balance in the propensity distributions between the treatment groups could re-
duce the sensitivity of causal effect estimates to model misspecification (Rosenbaum
and Rubin, 1984).
Techniques have been proposed to address disparities in covariate distributions.
Rubin (1977) considers a single covariate setting and suggests dropping all units with
covariate values that have either no treated or no control units and restricting causal
effects to covariate values that have both treated and control units. Gutman and
Rubin (2013, 2015) propose dropping units outside of the overlap region of estimated
propensity scores between the treatment groups. Cochran and Rubin (1973) and
Dehejia and Wahba (1999) propose discarding unmatched subjects. Ho, Imai, King
and Stuart (2005) propose a two-stage approach. In the first stage, all the treated
units are paired with their closest control units, and only the matched units are
included in the second stage for further adjustment. Similarly, Rosenbaum (2012)
proposes an algorithm for choosing an optimal set of treated subjects, where some
treated subjects are dropped due to poor matching quality. Crump et al (2009)
propose restricting the analysis to an optimal subpopulation defined by trimming
off extreme propensity values below α and above 1 − α. Li, Morgan and Zaslavsky
(2017) define an estimand that weights cases to balance the weighted distributions of
the covariates between treatment groups in a fashion that minimizes the asymptotic
variance of the estimated treatment effect.
The propensity scores are often used to determine the common support region
and subjects are simply discarded or down-weighted. Discarding units reduces the
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effective sample size and thus increases the variance of the estimated treatment effect.
However, a subject with low probability of selection in a given arm is usually not well
estimated on that arm if unobserved, since it is likely that there are only a few
observed subjects on that arm with similar covariate distributions as the subject.
Trimming off subjects with extreme propensities changes the estimand, since the
causal effect for the subpopulation is usually not the same as that for the entire
population. As the sample size increases, there are more observed subjects in the
treatment and control groups with similar covariate distributions and thus the casual
effects can be estimated more accurately. Therefore, it is intuitive that the range of
propensities where causal effects can be estimated should depend on sample size.
The remainder of the paper is structured as follows. In Section 3.2, we discuss
alternative definitions of the estimands to address limited overlap. In Section 3.3, we
describe six methods for estimating causal effects. In Section 3.4, we describe propen-
sity score estimation procedures and diagnostic checks for balance. In Section 3.5,
we study in simulation studies the performance of alternative propensity score-based
estimation methods, for a variety of estimands chosen to reduce covariate imbalance.
In Section 6, we illustrate our methods to the MACS data and provide guidance for
practice.
3.2 Alternative Causal Estimands
In a study with treatments administered as a single time point, let Xi and Zi de-
note the vector of baseline covariates and a binary treatment for subject i = 1, · · · , N ,
respectively. Let Zi ∈ (0, 1) denote a binary treatment with Zi = 1 for treatment
and Zi = 0 for control. Let Y
Zi
i denote the potential outcome under Zi for subject i.
Suppose we are interested in making causal inference about a population from which
the sample is drawn. Under Rubin’s causal model, the treatment effect for a subject
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is defined as the difference between the potential outcomes under the two treatments.
The average treatment effect defined on the entire population is the ATE estimand,
E(Y 1 − Y 0). The ATE estimand is widely used and the target population by the
estimand is easy to interpret.
Since only one potential outcome is observed for each subject, to estimate the
causal effects, we make the following three assumptions.
1) Stable Unit Treatment Value Assumption, SUTVA (Angrist, Imbens and Rubin,
1996): a) the observed outcome under the assigned treatment is the same as the
potential outcome under that treatment, and b) the potential outcomes for a given
subject are not influenced by the treatment assignments of other subjects (Rubin,
1980; Angrist, Imbens, Rubin, 1996)
2) Positivity: each subject has a positive probability of being assigned to either
treatment of interest: 0 < Pr(Zi = zi|Xi) < 1.
3) Ignorable treatment assignment: (Y 1, Y 0) |= Z|X; that is, treatment assignment
is independent of the potential outcomes, given the covariates.
In this paper, we focus attention on the positivity assumption (2) by defining
restricted definitions of the target populations and analysis methods to ensure that
this condition holds and robust causal inferences are possible. The positivity assump-
tion is violated when there exists neighborhoods of covariate space where there are
subjects belonging to just one of the treatment groups being compared. Causal esti-
mation for the subjects in this neighborhood depends on extrapolation, and can be
imprecise and highly sensitive to model specifications. In order to obtain more credi-
ble causal estimates, we restrict analysis to a subpopulation where there is overlap in
the propensity distributions of the treatment groups. We define such subpopulations
as follows.
One alternative estimand is based on truncation of propensity score. For unit
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i in the population with covariate values Xi, let Pz(Xi) = Pr(Zi = z|Xi) denote
the propensity of receiving treatment z, for z = {0, 1}. The positivity condition
holds for the set of units S(0) where S(0) = {i : Pz(Xi) > 0}. To eliminate units
where the propensity to receive one treatment is small, we may further restrict the
subpopulation to units within S(0) where propensities for all treatments are above
the αth quantile of the propensity distribution. Specifically, within S(0), let Fz()
denote the cumulative distribution of the propensity of receiving treatment z, that
is, Fz(a) = Pr(Pz(Xi) ≤ a). Then we restrict inferences to the subpopulation S(α)
of S(0) where S(α) = {i : Pz(Xi) > F−1z (α), for z = {0, 1}}. In addition, we can
also restrict inferences to the subpopulation S∗(α) of S(0), where the probability of
all treatment assignments is greater than a pre-defined level of α directly, that is
S∗(α) = {i : Pz(Xi) > α, for z = {0, 1}}. We can assess the sensitivity of causal
effect estimates to changes in the α level. When the sample size increases, the α level
can be reduced since there would be more subjects in the tails of the distributions and
there would be more subjects with similar covariates available in the other treatment
groups even at the tails.
Samuels (2017) formally defines an estimand called ATM as the average treatment
effect on a evenly matchable set, M . An unit is called evenly matchable if, within
a small propensity score stratum centered around the unit, there are at least as
many units from the other group as from its own group. Suppose we divide the
range of the propensity score into many small strata. Within each stratum, if there
are equal numbers of units from both groups, all the units are evenly matchable;
otherwise, only the units from the least prevalent group are evenly matchable. The
evenly matched set is the union of all the matchable units from all the strata. The
estimand ATM is defined as the average treatment effect on the evenly matchable set
M , E(Y 1−Y 0|M). ATM can also be defined as the weighted average treatment effect
E[Wiδi]/E[Wi], where the weight Wi =min{P1(Xi), P0(Xi)}, and δi is the individual
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conditional treatment effect for subject i (Li and Greene, 2013).
Li et al (2017) defines another estimand called ATO, the average treatment effect
on the overlap population. The overlap population is created by down-weighting the
units with extreme propensity scores and up-weighting the units with propensity score
close to 0.5. The target population is “the units whose combination of characteristics
could appear with substantial probability in either treatment group.” The ATO esti-
mand is defined as the weighted average treatment effect E[Wiδi]/E[Wi], where the
weight Wi = ZiP0(Xi)+(1−Zi)P1(Xi), and δi is the individual conditional treatment
effect for subject i. Although the population targeted by ATO is theoretically more
balanced in the covariates between the treated and control groups, it is arguably less
interpretable than the original population.
The ATM and ATO estimands are fixed regardless of sample size. As the sample
size increases, more units with extreme propensity scores appear in the sample. This
suggests reducing the α level for the truncated estimand as the sample size increases.
Thus, the estimand defined by trimming off the tails would eventually approaches to
the ATE. The estimands can be very different when there are heterogeneous treatment
effects.
3.3 Methods
We consider three methods for utilizing propensity scores in combination with
matching and truncation methods: 1) the inverse-probability-treatment-weighted es-
timator (IPTW), 2) the augmented IPTW (AIPTW) estimator (Scharfstein, Rot-
nitzky, and Robins, 1999), 3) penalized spline of propensity method for treatment
comparison (PENCOMP) (Zhou, Elliott and Little, 2018). Under the assumptions
stated in Section 3.2, the IPTW estimators are consistent if the propensity models are
correct. Under the same assumptions, the latter two methods are “doubly robust”.
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The AIPTW estimators are consistent if either the propensity models or the outcome
models are correctly specified. PENCOMP consistently estimates the causal effect of
the treatment if either 1) the model for the propensity score and the relationship be-
tween the outcome and the propensity score are correctly specified through penalized
spline or 2) the outcome model is correct. We then implement each of these methods
in combination with either pair matching or propensity score truncation. We also
consider the standard and doubly robust matching weight estimators (Li and Greene,
2013), and the overlap weight estimator (Li, Morgan, and Zaslavsky, 2017).
Next we describe the estimation procedures for the methods and the estimands
targeted by each method.
3.3.1 PENCOMP and Rubin’s Combining Rules
PENCOMP is a robust multiple imputation based approach to causal inference.
Since each subject receives one treatment, we observe the potential outcome under
the observed treatment but not the potential outcome under alternative treatment,
as described in Chapter 2. We estimate causal effects by imputing the potential
outcomes that are not observed using regression models that include splines on the
logit of the propensity to be assigned that treatment as well other covariates that
are predictive of the outcome. We then draw inferences based on comparisons of the
imputed and observed outcomes between treatment groups. Here we describe the
implementation of PENCOMP.
(a) For d = 1, · · · , D, generate a bootstrap sample S(d) from the original data S
by sampling units with replacement. Then carry out steps (b)-(d) for each sample
S(d):
(b) Estimate the propensity score model for the distribution of Z given X, with
regression parameters γz. The propensity to be assigned treatment Z = z is de-
noted as Pˆz(X) = Pr(Z = z|X, γˆ(d)z ), where γˆ(d)z is the ML estimate of γz. Define
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Pˆ ∗z =log[Pˆz(X)/(1− Pˆz(X))].
(c) Check for balance and assess whether the propensity score model is adequate
as described below in Section 3.4. The best propensity score model can be selected
based on how well it balances the observed covariates between treatment groups. In
addition, include the covariates and/or higher order terms in the prediction models
to account for residual confounding.
(d) For each z = 0, 1, using the cases assigned to treatment group z, estimate a
normal linear regression of Y z on X, with mean
E(Y z|X,Z = z, θz, βz) = s(Pˆ ∗z|θz) + gz(X; βz),
where s(Pˆ ∗z|θz) denotes a penalized spline with fixed knots (Eilers and Marx, 1996;
Ngo and Wand, 2004; Wand, 2003), with parameters θz, and gz() represents a para-
metric function of covariates predictive of the outcome, including covariates that are
adequately balanced by the estimated propensity score models, indexed by parame-
ters βz. A different spline function is fitted for each treatment group, since there is no
a priori reason to assume that the relationship between the potential outcomes under
different treatment arms and the propensity of treatment assignment is the same. We
consider a penalized B spline, which can be easily fitted with gam function in the R
package mgcv.
(e) For z = 0, 1, impute the values of Y z for subjects in treatment group 1 − z
in the original data set with draws from the predictive distribution of Y z given X1
from the regression in (c), with ML estimates θˆ
(d)
z , βˆ
(d)
z substituted for the parameters
θz, βz, respectively.
(f) Let ∆ˆd and V d denote the difference in treatment means and associated pooled
variance estimate, based on the observed and imputed values of Y in each treatment
group. The MI estimate of ∆ is then ∆¯D =
1
D
∑D
d=1 ∆ˆd, and the MI estimate of
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the variance of ∆¯D is TD = V¯D + (1 + 1/D)BD, where V¯D =
∑D
d=1 V
d/D,BD =∑D
d=1(∆ˆ
d− ∆¯D)2/(D− 1). The estimate ∆ is t distributed with degree of freedom v,
(∆− ∆¯D)T
−1
2
D ∼ tv, where v = (D − 1)(1 + V¯D/((D + 1)×BD))2.
3.3.2 Estimands with PENCOMP
By using matching and truncation, we can obtain the ATE, ATM, ATO and
both truncated estimands. Matching and truncation can be viewed as preprocessing
techniques to reduce model dependence and avoid extrapolation outside the region
that is supported by the data. This could be an important step when there is limited
overlap in the distributions across treatment groups. If the entire sample is used in the
analysis, PENCOMP estimate the ATE estimand. Otherwise, a restricted estimand
is computed based on either truncation, pair matching or ATO weight.
3.3.2.1 Truncation
The truncation method restricts the sample to the set of cases defined by either
S(α) (based on the quantile of the propensity distributions) or S∗(α) (based on the
propensity score itself). The PENCOMP is then computed on this restricted sub-
sample to obtain the truncated estimand.
3.3.2.2 Matching
The ATM estimand is obtained by selecting the treated and control subjects to
form matched pairs. Each treated subject is paired with the closest control that is
within the prespecified caliper and has not been matched yet. The caliper size governs
the bias-variance tradeoff. If the caliper size is too large, the matched pairs would not
be comparable so would increase the bias of the causal estimate. On the other hand,
when the caliper size is too small, many subjects are dropped and the variance of the
estimate increases. Here we set the caliper size at 0.25 times the logit of propensity
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scores. Although matching can be based on covariates, here we focus on propensity
score-based matching. PENCOMP estimates are calculated on the matched set. By
combining with pair matching, PENCOMP method can improve upon pair matching
by adjusting for residual imbalance in the matched set.
3.3.2.3 ATO
Since the ATO estimand targets the a population that is a combination of both the
treated and control populations, it can only be obtained by weighting the individual
treatment effects by the ATO weights. Each treated subject is weighted by Wi1(Xi) =
1 − Pzi1=1(Xi) and the control by Wi0 = Pzi1=1(Xi). The treatment effect is the
weighted mean of the individual treatment effects after imputation. Specifically, let
δi = Y
1 − Y 0 denote the treatment effect for subject i, where Y 1 or Y 0 can be
imputed or observed. In Section 3.3.1, in step f, ∆ˆd =
∑n
i=1Wi × δi/
∑n
i=1Wi and
the associated variance of the weighted mean is V d =
∑n
i=1W
2
i × σ2δi/(
∑n
i=1 Wi)
2.
3.3.3 Weighting Estimators: IPTW, Matching Weight and ATO
Each subject i is weighted by the balancing weight Wi = ωi/
{
ZiPzi=1(Xi) + (1−
Zi)(1 − Pzi=1(Xi))
}
. The treatment effect ∆ for a population of interest is defined
as follows (Mao, Li and Greene, 2018):
∆ˆweighted =
∑n
i=1WiZiYi∑n
i=1WiZi
−
∑n
i=1Wi(1− Zi)Yi∑n
i=1Wi(1− Zi)
Different specifications of ωi yield average treatment effects for different subpopula-
tions. For the estimand ATE, ωi is 1 which defines the IPTW estimator. For the
estimand ATO, ωi is Pzi=1(Xi) × Pzi=0(Xi). For the truncated estimands, ωi is set
as I{i ∈ S(α) or i ∈ S∗(α)}, where I is the indicator. For the estimand ATM, ωi
is set as min
(
Pzi=1(Xi), Pzi=0(Xi)
)
. In addition to using the balancing weight ωi,
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another way to obtain the ATM estimand is by combining IPTW with pair matching.
When calculating the IPTW estimates on the matched set, the propensity scores are
reestimated after matching.
The ∆ˆ for each estimand is computed on the original data S. The standard errors
are estimated using bootstraps. The procedures are as follows.
(a) For d = 1, · · · , D, generate a bootstrap sample Sd from the original data S by
sampling units with replacement. Then carry out steps (b)-(d) for each sample Sd:
(b) Select and estimate the propensity score model as described below.
(c) Check for balance and assess whether the propensity score model is adequate
as described in Section 3.4. The best propensity score model can be selected based
on how well it balances the weighted covariates.
(d) Estimate the weighted estimator on each bootstrap sample, ∆d.
(e) The standard errors sˆdD for ∆ˆ based on D bootstrap samples are computed
as follows.
sˆd
2
D =
D∑
d=1
(∆ˆd − ∆ˆ∗. )2/(D − 1)
where ∆ˆ∗. =
∑D
d=1 ∆ˆd/D. The 95% confidence intervals are computed as ∆ˆ±1.96sˆdD.
3.3.4 Augmented Weighted Estimators
For each weighting estimator as described in Section 3.3.3, an augmented weight-
ing estimator can be defined as follows (Mao, Li and Greene, 2018) :
∆ˆaug =
∑n
i=1 ωi{m1(Xi, α1)−m0(Xi, α0)}∑n
i=1 ωi
+
∑n
i=1WiZi{Yi −m1(Xi, α1)}∑n
i=1WiZi
−
∑n
i=1Wi(1− Zi){Yi −m0(Xi, α0)}∑n
i=1Wi(1− Zi)
where m1(Xi, α1) = E(Yi|Xi, Zi = 1) and m0(Xi, α1) = E(Yi|Xi, Zi = 0). Through-
out the paper, we refer the augmented estimator with ωi = 1 as AIPTW. Similar
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procedures based on bootstrap samples are used to estimate the standard error for
∆ˆaug.
3.4 Balance Checking
To assess whether the propensity score model is adequately specified, we assess
whether the covariate distributions between the treated and control are balanced,
after conditioning on the propensity scores, such as weighting, matching or regressing.
One measure of balance is the absolute standardized mean difference in each covariate
between the treated and control groups. The methods we consider here have different
ways of assessing balance. For matching, the absolute standardized mean difference
in covariate x is calculated on the matched set:
dmatch =
∣∣∣∣x¯1 − x¯0∣∣∣∣/
√
s21 + s
2
0
2
where s2z is the variance of the original covariate in the entire treated or control groups
before adjusting for propensity scores. For the weighting estimators, covariate balance
is assessed by the absolute standardized weighted mean difference as follows:
dweight =
∣∣∣∣∑ni=1wi1zixi∑n
i=1wi1zi
−
∑n
i=1 wi0(1− zi)xi∑n
i=1wi0(1− zi)
∣∣∣∣/
√
s21 + s
2
0
2
where the weights wi1 and wi0 are different across the weighting methods and defined
in Section 3. As an analog to the above measures, we assess balance as follows with
PENCOMP:
dpencomp =
∣∣∣∣x¯res1 − x¯res0∣∣∣∣/
√
s21 + s
2
0
2
where xres is the residual after regressing the original covariates on the spline of
propensity score. Here for comparison across the different measures, we use the same
s21 and s
2
0, which are calculated on the original dataset.
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3.5 Simulation
In this section we explore the performance of our proposed approach combining
with truncation or matching to alternative weighting approaches and matching, as
discussed in Section 3.3. We propose 1) combining PENCOMP(IPTW, AIPTW)
with truncation at an α quantile level or at propensity α level, referred to as PEN-
COMP(IPTW, AIPTW)α and PENCOMP(IPTW, AIPTW)α∗; 2) combining PEN-
COMP (IPTW, AIPTW) with caliper matching, referred to as PENCOMP(IPTW,
AIPTW)+match. The three additional weighting approaches we compare with are
3) matching weights, both standard and the doubly robust version, referred as match
weight and match weight DR respectively; and 4) the overlap weights (ATO). We
compare the methods using empirical bias, root mean squared error (RMSE), 95%
coverage, ratio of empirical bias as a fraction of empirical RMSE, and mean 95%
confidence interval width. We compare the methods when the prediction and/or
propensity models are correct. Specifically, we compare the following cases: A) cor-
rectly specified prediction and propensity models; B) incorrectly specified prediction
model but correctly specified propensity model; and C) correctly specified prediction
model but incorrectly specified propensity model.
In our simulation, we assess the influence of these three factors on the relative per-
formance of the methods. The first factor is the degree of overlap in the propensity
score distributions between the treatment groups. The second factor is the relative
importance of each covariate in predicting the treatment assignment and the outcome.
There are three types of covariates: covariates are predictive of only the treatment or
the outcome, and true confounders-covariates that are predictive of both the treat-
ment and outcome. We consider two scenarios: 1) aligned-the same set of covariates,
and 2)misaligned-different set of covariates predicting the outcome and treatment.
The third factor considers whether treatment effects are heterogeneous or not. In the
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case of homogeneous treatment effects, all the methods estimate the same quantity.
Otherwise, the estimands are different and each method is evaluated based on its own
truth.
For the heterogeneous treatment effects case, we simulate each dataset as described
below. Each simulated dataset contains three baseline covariates, X = [X1, X2, X3],
which are independently and normally distributed as N(0, 1). The treatment Z is
Bernoulli distributed with probability of being assigned Z = 1 depending on X1 and
X2. The outcomes Y
1 and Y 0 are normally distributed with variance of 1 and means
that depend on X1 and X2 in the aligned case and X2 and X3 in the misaligned case.
Table 3.1 details the simulation scenarios.
Intercept X1 X2 X1X2 X
2
1 X
2
2 X3 X
2
3
Treatment Assignment
Low 0 1.5 1.5 0.75
High 0 0.1 0.1 0.05
Aligned and Parallel
Y0 0 1 3 2 2
Y1 5 1 3 2 2
Aligned and Not Parallel
Y0 0 1 3
Y1 5 1 3 2 2
misaligned and Parallel
Y0 0 3 2 1 2
Y1 5 3 2 1 2
misaligned and Not Parallel
Y0 0 3 1
Y1 5 3 2 1 2
Table 3.1: Simulation Scenarios: logistic regression model for treatment assignment,
and linear outcome model parameters.
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Figure 3.1: Parallel surface and Misaligned: Empirical RMSE, sample size of 200.
(A)-Both propensity and prediction models are correct; (B) Prediction models are in-
correct; (C) Propensity models are incorrect. Top Panel-Low overlap in the propensity
distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure 3.2: Parallel surface and Aligned: Empirical RMSE, sample size of 200. (A)-
Both propensity and prediction models are correct; (B) Prediction models are incor-
rect; (C) Propensity models are incorrect. Top Panel-Low overlap in the propensity
distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure 3.3: Nonparallel surface and Misaligned: Empirical RMSE, sample size of
200. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure 3.4: Nonparallel surface and Aligned: Empirical RMSE, sample size of 200.
(A)-Both propensity and prediction models are correct; (B) Prediction models are in-
correct; (C) Propensity models are incorrect. Top Panel-Low overlap in the propensity
distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure 3.5: Parallel surface and Misaligned: 100 * 95% non coverage rate, sample size
of 200. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure 3.6: Parallel surface and Aligned: 100 * 95% non coverage rate, sample size of
200. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure 3.7: Nonparallel surface and Misaligned: 100 * 95% non coverage rate, sample
size of 200. (A)-Both propensity and prediction models are correct; (B) Prediction
models are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in
the propensity distributions; Bottom Panel-high overlap in the propensity distribu-
tions.
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Figure 3.8: Nonparallel surface and Aligned: 100 * 95% non coverage rate, sample size
of 200. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
Figures 3.1-3.8 show the results for sample size of 200. The results on empirical
RMSEs are shown in Figures 3.1-3.4. For Figures 3.1-3.2, the outcome surfaces were
parallel so the ATE and restricted estimands were the same. When there was a
high degree of overlap in the propensity distribution, restricted estimands such as
ATM, ATO and truncated, didn’t improve the RMSE much, and as expected, the
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ATE estimand could be estimated reliably. The methods that didn’t incorporate the
outcome model–pair matching, IPTW, truncated IPTW, ATO, and match weight–
performed similarly when the compared groups overlapped sufficiently. The robust
methods that incorporate the outcome models had smaller RMSEs than the methods
that did, but less so when the outcome models were misspecified. When the overlap
was low as shown in the top panels in Figures 3.1-3.2, the performance of the methods
varied more greatly, especially when the outcome models were misspecified. The
RMSEs of the restricted estimands had smaller RMSE than that of the ATE estimand,
especially when the overlap was low and the outcome models were misspecified. For
example, in Figure 3.2, the RMSE of IPTW for the ATE estimand reduced from over
1.2 to less than 0.8 for restricted estimands. Similarly, the RMSE of AIPTW for the
ATE estimand went from over 1.2 to less than 0.8, and PENCOMP went from 0.8
to less than 0.5. When the outcome models were correct, as seen in (A) and (C)
in Figures 3.1-3.2, the ATE estimands had similar RMSE as the retricted estimands.
Overall, PENCOMP had comparable or smaller RMSEs than the augmented weighted
estimators for both the ATE and restricted estimands.
Figures 3.3-3.4 show the results for nonparallel surfaces. Similar patterns were
observed: restricting inference to subpopulations improved RMSE when the overlap
was low, especially when the outcome models were misspecifed as well. Unlike the
parallel surfaces, the ATE and restricted estimands were different. Furthermore,
the restricted estimands also changed with the specifications of the propensity score
models. Hence, in Figure 3.3-3.4 (C), restricting estimands could increase the RMSEs
since misspecifying the propensity score models altered the estimands.
Figures 3.5-3.8 show the noncoverage rates of all the methods. As expected,
the coverage rates for all the methods were close to the nominal coverage when the
overlap in the propensity distributions was high, compared to when the overlap was
low. In the presence of low overlap, the IPTW for the ATE estimand had very low
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coverage rates and restricting estimands improved the coverage rates significantly.
Low overlap could also affect the coverage rates of the robust weighting methods but
less so, since the outcome models attenuated some of the effects of low overlap. As
seen in our previous studies, PENCOMP tended to have more conservative coverage
rates than the weighting estimators. Furthermore, when the propensity models were
misspecified, dropping subjects yielded poor coverage rates since the empirical biases
were larger and the subpopulations were not correctly defined, as seen in Figure
3.7-3.8 (C).
The results on empirical bias are shown in the Appendix B.1-B.4. Overall, the
empirical biases associated with restricted estimands tended to be smaller than that
of the ATE estimand. As expected, when the outcome models were correct, the biases
were negligible. When the overlap was high, all the methods had very small empir-
ical biases, regardless whether the outcome models were incorporated or not. For
Figures B.3-B.4, the restricted estimands under the misspecified propensity models
were different from those under the correctly specified propensity scores. Hence, the
empirical biases for the restricted estimands increased significantly, as seen in Figures
B.3-B.4 (C).
Lastly, in the Appendix Figure B.5-B.16 present the results on the RMSEs, empir-
ical bias, and coverage rates for sample size of 1000. Similar patterns as before were
observed. Overall, the coverage rates and RMSEs were better when the sample sizes
increased. PENCOMP tended to have comparable or smaller RMSE than AIPTWs.
When the overlap between the compared treatment groups was low, restricting in-
ference to subpopulations that were more supported by the data tended to perform
better. PENCOMP provides a viable alternative for estimating both the ATE and
restricted estimands considered here.
75
3.6 Application
The Multicenter AIDS Cohort study (MACS) was started in 1984 (Kaslow et al,
1987). A total of 4,954 gay and bisexual men were enrolled in the study and followed
up semi-annually. At each visit, data from physical examination, questionnaires about
medical and behavioral history, and blood test results were collected. The primary
outcome of interest was the CD4 count, a continuous measure of how well the immune
system functions. We used this dataset to analyze the short term (1 year) effects of
using antiretroviral treatment on disease progression. Here we restrict our analyses to
the period between visit 7 and 12, after the first antiretroviral treatment zidovudine
(AZT) was approved for use and before the advent of highly active antiretroviral
therapy (HAART). Treatment was coded to 1 if the patient reported taking any
of antiretroviral treatment (ART) or enrolling in clinical trials of such drugs. We
estimate the short-term (6-month) effects of using any antiretroviral treatment for
HIV+ subjects. We excluded subjects with missing values on any of the covariates
included in the models. We log-transformed the blood counts in this analysis.
Here we treat each visit as a single time point treatment. Let t = 1 denote the
time when the treatment was administered, and t = 2 the time 6-month later when
the outcome was measured. In addition, let t = −1,−2,−3 denote 1, 2, and 3 visits
away from the current visit t = 1. Let X(t = 1,−1,−2,−3) denote the blood count
histories prior to treatment assignment. Let Z be the binary treatment indicator. Let
Y (t = 2) be the CD4 count 6 months after the treatment. For the propensity score
model, we considered blood counts-CD4, CD8, white blood cell (WBC), red blood
cell (RBC), and platelets and treatment histories from the most recent 4 visits, as well
as demographic variables-college education, age, and race. The treatment assignment
Z was modeled as a logistic regression. For the outcome model, we considered the
last two CD4 counts and their squared terms. We estimated the mean CD4 count
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difference between the treated and the control at each visit, denoted as ∆, from visit
7 to visit 12. For PENCOMP, we replaced the simulated/imputed transformed CD4
values that were < 0 with 0 (i.e. below detection level). A total of 15 equally spaced
knots and B spline were used.
As shown in Figure 3.9, we see that over time the treated and control subjects
became more disimilar. The propensity score distributions became more and more
skewed, as the treated had propensity of treatment close 1 and the control close to
0. We measured the proportion of subjects in the control group whose propensity
scores were between the 1− α and α quantiles of the propensity score distribution of
the treated group, denoted as pi1−αz=0 = Fz=0(F
−1
z=1(1−α))−Fz=0(F−1z=1(α)), where F is
the cumulative distribution. Inside this region it is easier to impute missing potential
outcomes Y 0 because there are more observations. Similarly, for pi1−αz=1 . The small
proportions suggested difficulty in imputing missing potential outcomes. Since the
propensity score distributions were extreme and the overlap was low, the sample sizes
after matching were much smaller than before, as seen in Table 3.2.
Table 3.2: Sample sizes before and after trimming and matching. The measure of
overlap of the original data at each visit: pi1−αz=1 and pi
1−α
z=0 for α = 5%.
Trimming
All quantile α = 0.02 α = 0.02 Matching Overlap
Visit treat control treat control treat control treat control pi0.95z=1 pi
0.95
z=0
visit 7 98 575 86 404 56 467 69 69 0.42 0.51
visit 8 127 468 102 375 44 256 58 58 0.28 0.51
visit 9 160 418 136 362 55 236 65 65 0.25 0.42
visit 10 194 412 159 378 81 269 69 69 0.24 0.38
visit 11 227 287 227 283 177 198 116 116 0.67 0.54
visit 12 302 209 125 193 69 87 65 65 0.17 0.25
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Figure 3.9: Propensity distribution for visit 7-12.
One important step in building the propensity score models is to check for balance
in the covariates. At each visit, we checked for covariate balance between the treated
and control groups, as described in Section 3.4. As shown in Figure 3.10, trimming
or matching first reduced the standardized mean differences in the baseline covariates
between the treatments groups. As expected, the ATO weights achieved the best
balance.
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Figure 3.10: Absolute standardized mean differences across all the visits 7-12.
We estimated the short term effect of antiretroviral treatment on CD4 count using
pair matching, PENCOMP, both the weighted and augmented weighted estimators.
The results for visit 7-12 are summarized in Figure 3.11. The standard errors were
obtained using 1000 bootstrap samples. For PENCOMP, 1000 complete datasets were
created. The naive estimators were negative, suggesting a harmful effect of antiretro-
viral treatment on CD4 count. This is likely due to uncontrolled confounding by indi-
cation, in that sicker subjects with lower CD4 counts were more likely to be assigned
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to treatment. All the treatment effect estimates, seen in the first column of Figure
3.11, suggested less harmful effects. The weighted estimators and pair matching per-
formed worse than the robust methods–the augmented estimators and PENCOMP,
especially for the ATE estimand. For the ATE estimand, PENCOMP had smaller
standard errors than the augmented weighted estimator when the weights were vari-
able, as found in Chapter 2. With pair matching, many subjects were dropped due to
extreme propensity scores and the sample sizes became very small, as shown in Table
3.2. The re-estimated propensity scores could potentially became more extreme so
the IPTW(AIPTW)+match estimators performed worse in terms of standard errors.
Thus, here we used the match weights as described in Section 3.3.3. For PENCOMP,
we also used the match weights to weight the individual causal effects. The match
weight estimators performed better than pair matching because there was low overlap
in the propensity scores and many subjects were dropped. For the alternative causal
estimands–ATM, ATO and truncated estimands, PENCOMP had a comparable per-
formance to the augmented weighted estimators, with PENCOMP having slightly
smaller standard errors than the augmented weighted estimators for the truncated
estimands.
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Figure 3.11: Treatment effect estimates and standard error (SE) for the ATE, ATM,
and truncated estimands for visit 7-12. Truncated*: truncating at quantile level
α = 0.02 of the propensity score distributions. Truncated: truncating at α level
of propensity score. Naive estimates(SE) for visit 7-12 were -7.7(0.7), -7.0(0.6), -
6.8(0.6), -6.3(0.6), -5.5(0.6), and -8.2(0.6), respectively. The IPTW estimates(SE)
for ATE estimand were 1.9(1.7), 2.0(2.8), 2.2(3.0), 2.7(3.0), 0.2(0.9), and 7.3(5.1),
respectively.
3.7 Discussion
Here we show that PENCOMP has the flexibility of estimating different estimands
when needed and its performances can improve for restricted estimands when the
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overlap is low. In general, it tends to outperform the weighted estimator for the
ATE estimand and has comparable performance for restricted estimands, in terms of
RMSE and coverage rate.
All the previous approaches described above rely on estimated propensity scores to
determine the subpopulation. Trimming off extreme propensities to increase precision
of an estimator could be harmful if deleted subjects are of interest to investigators
(Lechner 2008). One alternative to trimming is to provide nonparametric bounds
(Lechner 2008). Because lack of overlap is a small sample problem, subjects with ex-
treme propensities might still be relevant and if more samples were taken, there would
be subjects in the other treatment group who have similar propensity scores. In addi-
tion, defining the subpopulation in term of estimated propensity scores might not be
meaningful to investigators who are more interested in identifying that subpopulation
in term of observed covariates.
The propensity score plays an important role in identifying the common support
region. However, its performance depends on what variables are included in the
model. A small set of covariates W ∈ X might exist such that 0 < Pr(Z = z|W ) < 1
and the ignorability assumption (Y 1, Y 0) |= Z|W still hold. Hill and Su (2013) define
0 < Pr(Z = z|W ) < 1 as common causal support, where W is the set of covariates
such as (Y 1, Y 0) |= Z|W holds. Thus, it might not be necessary to require common
support on all the covariates X. For example, a propensity score model based only
on treatment assignment can be inefficient, as it prioritizes variables predictive of the
treatment but not necessarily predictive of the outcome. Common support on such
predictors are not relevant since these predictors are not confounders. Furthermore,
dropping subjects due to lack of overlap on such predictors could increase variance of
the estimate, since including such predictors in the propensity model could potentially
shrink the overlap region of the propensity scores, especially in a high dimensional
setting. It is much harder to have overlap in many covariates, so it is more important
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to consider a more sparse propensity score model that satisfies the assumption of un-
confoundedness. Chapter 4 addresses the issue of model selection in causal inference.
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CHAPTER IV
Variable Selection in Causal Inference
4.1 Introduction
The propensity score, which is defined as the probability of treatment assignment
given covariates, plays an important role in bias reduction for estimation of causal
effects from nonrandomized studies. The propensity score has the balancing property:
conditional on the propensity score, the observed covariates and treatment assignment
are conditionally independent (Rosenbaum and Rubin, 1983). The balancing property
of propensity score implies that adjusting for the propensity score can remove the
bias due to differences in all observed confounders between the treatment groups
(Rosenbaum and Rubin, 1983). One important assumption needed for propensity
score-based methods to make valid inference about causual effects is that all the
confounders are observed and included in the propensity model. Since excluding
important confounders in the model can lead to biased estimates, many covariates
are often included, for fear of excluding some important confounders. Rubin (2007)
notes that only pretreatment covariates should be included in the propensity model
and argues that the model should be selected without accounting for the relationship
between covariates and outcome. This approach helps maintain objectivity when
making inference from nonrandomized studies.
However, for propensity score-based methods to work reliably, there should be
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sufficient overlap in the propensity score distributions for the compared treatment
groups. Estimating the causal effects for units outside the overlap region depends
entirely on extrapolation, and hence is vulnerable to model misspecification. The
variables included in the propensity score model influence the degree of overlap. For
example, including strong predictors of the treatment that are not predictive of the
outcome in the propensity score model could potentially shrink the overlap region.
Removing such predictors from the model could increase the overlap region. Recent
work has also shown that including such covariates can inflate the variance of the
causal estimate and may also induce bias (Brookhard et al, 2006). On the contrary,
including covariates that are associated with the outcome only can improve efficiency,
since it reduces random covariate imbalance in finite samples (Brookhard et al, 2006).
Glymour et al (2008) argues for controlling only common causes of the treatment and
outcome. VanderWeele and Shpitser (2011) propose controlling for covariates that are
causes of the treatment and/or outcome. Thus, a propensity score model based only
on the treatment can be inefficient, as it prioritizes variables associated with treatment
but not necessarily with outcome. Balancing such covariates using propensity score
is unnecessary since these covariates are not confounders. Recently researchers have
started looking at how to select variables for the propensity model by taking into
account the relationship between the covariates and outcome (Shortreed and Ertefaie
2017, de Luna, Waernbaum and Richardson 2011). In this paper, we extend the
same idea to a recently proposed propensity score-based multiple imputation based
approach, called penalized spline of propensity method for treatment comparison
(PENCOMP), and propose a new variant of PENCOMP via bagging, and compare
the performances of PENCOMP with that of inverse probability treatment weighted
approach (IPTW) in the presence of variable selection.
A useful class of propensity score-based methods is based on estimating the
propensity of treatment assignment, given potential confounding variables, and then
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using the estimated propensity as a weight, or as a predictor in regression models for
the outcome under alternative treatment assignments. The IPTW method controls
for confounding by weighting subjects by the inverse of the probability of receiving
the observed treatment sequence. The weights in effect create a pseudo-population
that is free of treatment confounders. PENCOMP controls for confounding by in-
cluding a penalized spline of the logit of the propensity to be assigned that treatment
in regression models. It has both the propensity and prediction models and is robust
to misspecification in the propensity model or the prediction model.
Here we focus on the issue of model selection for our proposed method PEN-
COMP and IPTW. We compare the performance of two confounder selection meth-
ods: with and without considering the outcome-covariate relationship. Furthmore,
often a propensity score model is selected based on how well it balances the observed
covariates and inferences are made based on a single model. This simple approach
ignores the model uncertainty regarding what variables should be included. Failure
to account for uncertainty could affect estimation accuracy. Hence, we also address
the issue of model uncertainty when making inference and propose a new version of
PENCOMP based on bagging. For PENCOMP, we consider two methods for esti-
mating standard errors and confidence intervals: (a) bootstrap method that takes
into account model selection, proposed by Efron (2014), and (b) multiple imputation
based on Rubin’s combining rules.
The outline of this paper is as follows. In Section 4.2, we describe the estimands
and assumptions of the approach we consider. In Section 4.3, we describe two versions
of (PENCOMP) for estimating causal effects: one based on multiple imputation and
the other based on bootstrap smoothing, as well as a review of inverse probability
treatment weighted and adaptive lasso. In Section 4.4, we describe variable selection
techniques for both the propensity and prediction models. In Section 4.5, we examine
using simulation studies how variable inclusion affects the performance of propensity
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score-based methods-PENCOMP, AIPTW and IPTW. We also evaluate the impact
of accounting for model uncertainty in propensity score and prediction models. In
Section 4.6, we illustrate our methods using the Multicenter AIDS Cohort study
(MACS) to estimate the effect of antiretroviral treatment on CD4 counts in HIV
infected patients. We conclude with a discussion of the results and present some
possible future work.
4.2 Estimands and Assumptions
Let Xi denote the vector of baseline covariates and Zi ∈ (0, 1) denote a binary
treatment with Zi = 1 for treatment and Zi = 0 for control, for subject i = 1, · · · , N ,
respectively. Let Y Zii be the potential outcome under treatment Zi. Here we focus
on the estimand of interest-the average treatment effects for the entire population
(ATE), denoted as E(Y 1 − Y 0). Thus, we compute the subject-level causal effect
as the difference between the potential outcome under treatment and the potential
outcome under control for the same subject. The average treatment effect for the
entire population is estimated by averaging all the subject-level causal effects across
the entire population. In this chapter, we focus on the estimand ATE, but the same
idea can be applied to other estimands. See Chapter 3 for other estimands.
In order to estimate the causal effects, we make the following assumptions:
1) SUTVA (Angrist, Imbens and Rubin, 1996) states that a) the observed out-
comes under a specific treatment sequence is equal to the potential outcomes as-
sociated with that treatment sequence, and b) the potential outcomes for a given
subject are not influenced by the treatment assignments of other subjects (Rubin,
1980; Angrist, Imbens, Rubin, 1996)
2) Positivity states that each subject has a positive probability of being assigned
to either treatment of interest: 0 < Pr(Zi = zi|Xi) < 1.
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3) Ignorable treatment assumption states that (Y 1, Y 0) |= Z|X; that is, treatment
assignment is as if randomized conditional on the covariates. In general, it is possible
that there exists a subset of covariates W ∈ X such as (Y 1, Y 0) |= Z|W .
4.3 Methods
4.3.1 PENCOMP and Multiple Imputation
PENCOMP is a robust multiple imputation based approach to causal inference,
under Rubin’s potential outcome framework (1974). Since each subject receives a
single treatment, we observe the potential outcome under the observed treatment
but not the potential outcomes under other treatments. We assume a single binary
treatment setting, although the approach could be extended to multiple treatments.
We estimate causal effects by imputing the potential outcomes that are not observed
using regression models that include splines on the logit of the propensity to be
assigned that treatment as well as other covariates that are predictive of the outcome.
We then draw inferences based on comparisons of the imputed and observed outcomes
between treatment groups.
PENCOMP relies on the balancing property of propensity score, in combination
with mean model for the outcome. Under the assumptions stated above, PENCOMP
has a double robustness property for causal effects. Specifically, if either 1) the
model for the propensity score and the relationship between the outcome and the
propensity score are correctly specified through penalized spline, or 2) the outcome
model is correct, the causal effect of the treatment will be consistently estimated.
Here, we describe the estimation procedures based on multiple imputation with
Rubin’s combining rules.
(a) For d = 1, · · · , D, generate a bootstrap sample Sd from the original data S
by sampling units with replacement, stratified based on treatment group. Then carry
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out steps (b)-(d) for each sample Sd:
(b) Select and estimate the propensity score model as described in Section 4.4 for
the distribution of Z given X, with regression parameters γz. The propensity to be
assigned treatment Z = z is denoted as Pˆz(X) = Pr(Z = z|X, αˆ(d)z ), where αˆ(d)z is the
ML estimate of αz. Define Pˆ ∗z =log[Pˆz(X)/(1− Pˆz(X))].
(c) For each z = 0, 1, using the cases assigned to treatment group z, estimate a
normal linear regression of Y z on X, with mean
E(Y z|X,Z = z, θz, βz) = s(Pˆ ∗z|θz) + gz(X; βz),
where s(Pˆ ∗z|θz) denotes a penalized spline with fixed knots (Eilers and Marx, 1996;
Ngo and Wand, 2004; Wand, 2003), with parameters θz, and gz() represents a para-
metric function of covariates predictive of the outcome, including covariates that
are adequately balanced by the estimated propensity score models, indexed by pa-
rameters βz. A different spline function is fitted for each treatment group, since
there is no a priori reason to assume that the relationship between the potential out-
comes under different treatment arms and the propensity of treatment assignment
is the same. For simplicity, a penalized spline with truncated linear basis is used,
s(Pˆ ∗z|θz) = θ0 + θ1Pˆ ∗z +
∑K
k=1 θ1k(Pˆ
∗
z − Kk)+, where K1, · · · , KK are fixed knots,
and (Pˆ ∗z −Kk)+ = (Pˆ ∗z −Kk) if Pˆ ∗z > Kk ; and = 0 if Pˆ ∗z ≤ Kk. The spline model
can be formulated as a linear mixed model (Wand, 2003),
Y z = C1β + C2θ + ,
 θ

 ∼

 0
0
 ,
 σ2θI 0
0 σ2 I

 ,
where β = (β0, β1, β2, · · · , βp) denote fixed effects, and θ = (θ11, · · · , θ1K) are random
basis coefficients. REML estimates of the parameters of this model can be easily
fitted in statistical software, such as PROC MIXED in SAS or lme in R. The fitted
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values of Y z are yˆz = C(CTC + λˆD)−1CTy, where λˆ = σˆ2/σˆ
2
θ is the REML estimator
of λ and
D =
 0(p+1)×(p+1) 0
0 IK×K

(d) For z = 0, 1, impute the values of Y z for subjects in treatment group 1 − z
in the original data set with draws from the predictive distribution of Y z given X
from the regression in (c), with ML estimates θˆ
(d)
z , βˆ
(d)
z substituted for the parameters
θz, βz, respectively. Repeat the above procedures to produce D complete data sets.
Let ∆ˆ(d) and W (d) denote the difference in treatment means and associated pooled
variance estimate, based on the observed and imputed values of Y in each treatment
group. The MI estimate of ∆ is then ∆¯D =
1
D
∑D
d=1 ∆ˆd, and the MI estimate of the
variance of ∆¯D
TD = W¯D + (1 + 1/D)BD (4.1)
where W¯D =
∑D
d=1 W
(d)/D,BD =
∑D
d=1
(
∆ˆ(d) − ∆¯D
)2
/(D − 1). The estimate ∆ is
t distributed with degree of freedom v, (∆ − ∆¯D)T
−1
2
D ∼ tv, where v = (D − 1)(1 +
W¯D/((D + 1) ∗BD))2.
4.3.2 PENCOMP and Bagging
As an alternative to using multiple imputation combining rules, we can draw
inference about causal effects based on bootstrap smoothing, also called bagging. The
bagging estimator, a form of model averaging, accounts for model uncertainty. Efron
(2014) proposes standard error and confidence interval for the bootstrap smoothed
estimator.
Let S = (S1, S2, · · · , SN) denote the original data for N subjects. A nonpara-
metric bootstrap sample with replacement is denoted as Sd = (Sd1 , S
d
2 , · · · , SdN). The
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causal estimate based on the original data S is ∆ˆs. In most cases, the nonparametric
standard error sˆdD for ∆ˆs based on D bootstrap samples is
sˆdD =
D∑
d=1
(∆ˆd − ∆˜)2/(D − 1) (4.2)
where ∆˜ =
∑D
d=1 ∆ˆd/D. The standard 95% confidence intervals ∆ˆs ± 1.96sˆdD or the
percentile (∆ˆ0.025d , ∆ˆ
0.975
d ) based on the 2.5th and 97.5th percentiles of the D bootstrap
estimates. However, in the presence of model selection, the bootstrap estimates can
be “jumpy and erratic” and the standard methods assume smooth distribution. As an
alternative, the bootstrap estimate ∆˜ and associated confidence interval ∆˜± 1.96s˜dD
are used. The standard error s˜dD is calculated as follows.
s˜dD = (
n∑
j=1
ˆcov2j)
1/2 (4.3)
ˆcov2j =
D∑
d=1
(Q∗dj −Q∗.j)(∆ˆd − ∆˜)/D
where Q∗.j =
∑D
d=1Q
∗
dj/D and Q
∗
dj = #{Sd = Sj} is the number of times that data
point j of the original data S is selected in dth bootstrap sample Sd.
The procedures for PENCOMP are similar as described above, except in steps
(e). In step (e), the imputations are carried out on each bootstrap sample Sd, instead
of the original data S. Inference is made using the bootstrap smoothed estimator
∆˜ and confidence interval ∆˜ ± 1.96s˜dD, instead of the Rubin’s multiple imputation
combining rules.
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4.3.3 Inverse Probability Treatment Weighted Estimator IPTW
The IPTW estimator estimates the ATE and is defined as
∆ˆIPTW =
N∑
i=1
ZiYi
Pˆzi=1(Xi, αˆ)
−
N∑
i=1
(1− Zi)Yi
1− Pˆzi=1(Xi, αˆ)
The causal IPTW estimate on the original data S is ∆ˆIPTW . The standard errors are
estimated based on bootstraps. The procedures are as follows.
(a) For d = 1, · · · , D, generate a bootstrap sample Sd from the original data S by
sampling units with replacement. Then carry out steps (b)-(d) for each sample Sd:
(b) Select and estimate the propensity score model as described in Section 4.4.
(d) Estimate ∆dIPTW for each bootstrap sample.
The standard approach for computing the standard errors sˆdD is based on Eq 4.2
and the 95% confidence intervals are computed as ∆ˆIPTW ± 1.96sˆdD. The bootstrap
smoothed estimate is ∆˜IPTW =
1
D
∑D
d=1 ∆ˆ
d
IPTW , and the confidence intervals ∆˜IPTW±
1.96s˜dD, where s˜dD is computed based on Eq 4.3.
4.3.4 Augmented Inverse Probability TreatmentWeighted Estimator (AIPTW)
Each subject i is weighted by the balancing weight Wi = 1/
{
ZiPzi=1(Xi, αˆ)+(1−
Zi)(1−Pzi=1(Xi, αˆ))
}
. The AIPTW estimate ∆AIPTW is defined as follows (Mao, Li
and Greene, 2018):
∆ˆAIPTW =
∑n
i=1 ωi{m1(Xi, β1)−m0(Xi, β0)}∑n
i=1 ωi
+
∑n
i=1WiZi{Yi −m1(Xi, β1)}∑n
i=1WiZi
−
∑n
i=1Wi(1− Zi){Yi −m0(Xi, β0)}∑n
i=1 Wi(1− Zi)
where m1(Xi, β1) = E(Yi|Xi, Zi = 1) and m0(Xi, β1) = E(Yi|Xi, Zi = 0). Similar
procedures based on bootstrap samples are used to estimate the standard error for
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∆ˆAIPTW .
4.3.5 Adaptive Lasso
Let X denote the design matrix X = [X1, · · · , Xp] for p predictors. We assume
that the outcome of interest Y is continuous with a mean that is a linear function of
the predictors: E(Y ) = β1X1 + · · · + βpXp. Here we assume the data are centered
so that the intercept is not included. Suppose the model is sparse, that is, the true
model depends only on a small subset of the predictors. Let A = {j : βj 6= 0} and
|A| = p0 < p. The adaptive lasso is defined as (Zou, 2006):
βˆAL = argminβ||y −
p∑
j=1
Xjβj||2 + λ
p∑
j=1
wˆj(βˆj)|βj|
where wj = 1/|βˆj|γ and γ > 0, and βˆ are from ordinary least square or ridge regression.
The adaptive lasso has the oracle properties: 1) it identifies the right subset covariates
with probability tending to one: limn P (An = A) = 1, where An = {j : βˆj 6=
0}; 2) it estimates the nonzero coefficients as if the true model were known, i.e.
√
n(βˆA − βA)→d N(0,Σ), where Σ is the covariance matrix under the true model.
4.4 Model Selection for Propensity and Prediction
In observational studies, both the propensity and prediction models need to be
estimated from the data. Including all available covariates in both models can lead to
highly unstable estimates of treatment assignment and/or outcomes if sample sizes are
small, and may be highly inefficient if covariates are not predictive of both treatment
and outcome-that is, they are potential confounders. We consider scenarios where
there are some variables that are predictors of outcome, and some that are predictors
of treatment, some that are predictors of both treatment and outcome, and some
that are spurious, in the sense that they affect neither the propensity or the outcome.
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We assume that both the propensity and prediction models depend only on a small
subset of the variables. Using the notations as in Shortreed and Ertefaie (2017), let
C denote the true confounders, P predictors of outcome, I predictors of treatment,
and S spurious covariates. The objective is to select out the relevant variables. We
consider two strategies of building the propensity models: 1) separating the outcome
from the design (Rubin 2007), and 2) taking into account the information in the
outcome.
For strategy 1, one simple approach is to use the stepwise variable selection al-
gorithm with the Bayesian Information Criterion (BIC) to select the variables that
are predictive of treatment, regardless of how well they predict outcome. Separately,
we use the same stepwise algorithm to select the prediction model for PENCOMP.
The algorithm is abbreviated as SW. Instead of the stepwise algorithm with BIC
criterion, we also carry out an adaptive lasso algorithm to select both the propensity
and prediction models separately. This adaptive lasso algorithm is referred to as AL.
For outcome Y and treatment Z, the adaptive lasso estimates are defined as follows:
βˆAL = argminβ||y −
p∑
j=1
Xjβj||2 + λ
p∑
j=1
wˆβj |βj| (4.4)
αˆAL = argminα
n∑
i=1
−Zi(XTi α) + log(1 + eX
T
i α) + λn
p∑
j=1
wˆαj |αj| (4.5)
where wαj = 1/|αˆj|, wβj = 1/|βˆj|, and αˆ and βˆ are estimated from ridge regression.
Both SW and AL satisfy Rubin’s criterion by separating the outcome from the design.
In strategy 2, we consider taking into account the relationship between covariates
and outcome when building the propensity model. Shortreed and Ertefaie (2017) pro-
pose an outcome adaptive lasso approach for variable selection. Their approach takes
into account the covariate-outcome relationships when selecting propensity model. It
tends to select covariates that are true confounders and predictors of the outcome
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and improves statistical efficiency. The outcome adaptive lasso estimates for the
propensity model are defined as:
αˆOAL = argminα
n∑
i=1
−Zi(XTi α) + log(1 + eX
T
i α) + λn
p∑
j=1
wˆαj |αj| (4.6)
where wαj = 1/|βˆj|γ such that γ > 1 and minimizes the mean weighted standardized
difference between the treated and control. βˆ are the coefficient estimates by regress-
ing the outcome Y on the covariates and the treatment indicator. By penalizing the
covariates depending on the strength of the covariate and outcome relationship, the
outcome adaptive lasso selects covariates that are predictive of the outcome and does
not select covariates that are associated with the treatment but not with the outcome.
In our setting, the outcome adaptive lasso is designed to select the covariates denoted
by P and C, i.e. A = {j : j ∈ P ∪ C}.
De Luna, Waernbaum and Richardson (2011) show how to identify subsets of the
covariates such that given the subset, the unconfoundedness assumption still holds.
They propose two algorithms to identify the reduced subsets. First, remove the
covariates that are not associated with outcome, given the others, and then remove
the covariates that are not associated with the treatment, given a smaller subset
of the covariates selected at the first step. Alternatively, reverse the order by first
removing the covariates that are not associated with the treatment and then removing
the covariate that are not associated with the outcome. Dimension reduction in this
manner can further reduce the variance of the casual estimate and improve the overlap
in the propensity score distributions between treatment groups.
Building on the two-stage approach as in de Luna, Waernbaum and Richardson
(2011), we use a two-stage adaptive lasso approach. In the first stage, we select a
subset of covariates that are predictive of the outcome using adaptive lasso. In the
second stage, we use the subset of covariates found in the first stage in the propen-
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sity model, denoted as Step-ALY. Similarly, we can reverse the steps by performing
outcome adaptive lasso for the propensity model first and then the prediction model,
denoted as Step-ALT. Unlike SW and AL algorithms, OAL, Step-ALT and Step-ALY
all take into account the outcome information during model selection. By using a
two-stage approach, in finite samples, we can further reduce the probability of select-
ing any irrelevant covariates. The models from the two-stage appraoch could be more
sparse that the models selected by the outcome adaptive lasso approach proposed in
Shortreed and Ertefaie (2017).
4.5 Simulation
We simulate each dataset as described in Zigler and Dominici (2014) and Shortreed
and Ertefaie (2017). Each simulated dataset contains n subjects and p covariates X.
The treatment Z1 is Bernoulli distributed with logit of P (Z1 = 1|X) =
∑p
j=1 γjXj.
The outcome of interest Y is normally distributed with a mean of ηZ1 +
∑p
j=1 βjXj
and a variance of 1. The treatment effect η is equal to 0, without loss of generality.
We set all the coefficients 0, except the first 6 covariates X1, · · · , X6. X1 and X2
are the true confounders; X3 and X4 are predictors of the outcome but not of the
treatment; and X5 and X6 are predictors of the treatment but not of the outcome;
all the other d − 6 covariates are spurious. We vary the strengh of relationships
between covariates, outcome and treatment. In the first scenario, β and γ are set as:
β = (0.6, 0.6, 0.6, 0.6, 0, 0, 0, · · · , 0), and γ = (1, 1, 0, 0, 1, 1, 0, · · · , 0). In the second
scenario, confounders X1 and X2 have a weaker relationship with the treatment:
β = (0.6, 0.6, 0.6, 0.6, 0, 0, 0, · · · , 0) and γ = (0.4, 0.4, 0, 0, 1, 1, 0, · · · , 0). In the third
scenario, confounders X1 and X2 have a weaker relationship with the outcome: β =
(0.2, 0.2, 0.6, 0.6, 0, 0, 0, · · · , 0) and γ = (1, 1, 0, 0, 1, 1, 0, · · · , 0). We also simulate the
sample sizes, n=200 and n=1000.
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As in the real world setting, we consider scenarios where we treat all variables as
potential confounders. We compare these variable selection techniques:
(a) SW: stepwise variable selection algorithm with the Akaike Information Criterion
(BIC) separately for the propensity and prediction models.
(b) AL: adaptive lasso selection technique separately for the propensity and prediction
models.
(c) OAL: outcome adaptive lasso proposed by Shortreed and Ertefaie (2017) for the
propensity model, and adaptive lasso for the prediction model.
(d) Step-ALT: outcome adaptive lasso for the propensity model at the first stage
and then adaptive lasso for the prediction model at the second stage using only the
variables that are selected at the first stage.
(e) Step-ALY: adaptive lasso for the prediction model at the first stage and then
logistic regression model with all the variables selected at the first stage for the
propensity model.
(f) allLasso: all the variables that are selected for the propensity and prediction
models, as described in VanderWeele and Shpitser (2011).
In addition to the variable selection techniques, we present results for four propen-
sity (PS) models that include the same covariates across simulations: (1)True includes
the true propensity models that are used to generate the data, i.e. X1, X2, X5, and
X6; (2) trueConf includes only the true confounders X1 and X2; (3) outcomePred
includes both the confounders and the predictors of outcome; (4) allPoten includes
all 20 variables. For these four PS models, the prediction models for PENCOMP are
also correctly specified.
For each simulation scenario and for each of the two methods PENCOMP and
IPTW, we compare the performance of the variables selection techniques described
above for both PENCOMP and IPTW, in terms of empirical bias (BIAS), the em-
pirical standard error (Emp.SE), mean of estimated standard error (Est.SE), average
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length of 95% confidence intervals (Ave. CI), and empirical coverage rate of the 95%
confidence interval (Cov) over 500 simulated data sets. For each dataset, the esti-
mated standard errors and confidence intervals are calculated based on 1000 bootstrap
samples. For PENCOMP, we compare the two methods of standard error estimations:
multiple imputation (MI) as in Eq 1 and bootstrap smoothing (Boot) based as in Eq
3. For IPTW, we compare the standard approach based in Eq 2 with the bootstrap
smoothing.
4.5.1 Results
Tables 4.1-4.4 show the results for sample size of 200 and Tables 4.5-4.8 for sam-
ple size of 1000. By comparing the four (PS) models that do not involve variable
selections: true, trueConf, outcomePred, and allPotent, we can see that excluding
variables associated only with treatment reduced the RMSE, and including variables
associated only with outcome further reduced the RMSE. For IPTW estimates, out-
comePred had the smallest RMSE and mean confidence interval widths. The esti-
mated standard errors (SE) were closer to the empirical standard errors (SE) and
the coverage was close to the nominal coverage of 95%. The trueConf PS model
performed slightly worse than the outcomePred PS model, since including variables
associated only with outcome improves efficiency. The more spurious variables were
added as in allPotent model, the wider the confidence intervals got. Figure 4.3 shows
that outcomePred PS model had the smallest variability across the 1000 bootstrap
estimates, while allPotent had the biggest variability. This pattern was observed in
PENCOMP and AIPTW but less pronounced than in IPTW, since the prediction
model in PENCOMP and AIPTW attenuated the effect of including variables not
associated with the outcome. In addition, PENCOMP tended to perform better than
AIPTW in terms of RMSEs, when the propensity score models included many irrel-
evant covariates. As shown in Figure 4.2, the variables associated with the outcome
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were selected about 99% of the time, but in small samples, the confounders that were
weakly associated with the outcome were selected less than 80% of the time, as seen
in scenario 3.
Out of the five variable selection techniques, the two-stage techniques: Step-ALT
and Step-ALY performed the best. For PENCOMP, AIPTW and IPTW, both Step-
ALT and Step-ALY had RMSEs that were closer to the RMSEs of outcomePred PS
models. Both Step-ALT and Step-ALY were more effective at excluding spurious
variables and including variables associated only with outcome, compared to the
outcome adaptive lasso (OAL), stepwise selection with BIC (SW), and adaptive lasso
(AL) procedures, as seen in Figure 4.1. For example, for the sample size of 200 in
scenario 1, all the variable selection techniques selected the confounders X1 and X2
about 99% of the time. Step-ALY, Step-ALT, and OAL selected the non-confounders
X3 and X4 about 99% of the time. In contrast, AL and SW selected X3 and X4
about 40-60% of the time. AL and SW selected the non-confounders X5 and X6
about 99% of the time. In contrast, OAL selected X5 and X6 about 30% of the time,
but Step-ALY and Step-ALT selected them around 8% of the time. Lastly, Step-ALY
and Step-ALT selected the spurious variables at about 8% of the time, while SW,
OAL, and AL selected them about 40%, 34% and 60%, respectively. In scenario 2,
because the confounders X1 and X2 had a weaker relationship with treatment, they
were selected about 80% of the time for sample size of 200. A larger sample size
is needed to detect those confounders, as seen in Figure 4.1. In scenario 3 where
the confounders had a weak relationship with the outcome, the outcome adaptive
selection procedures performed worse than SW and AL. Step-ALT and Step-ALY
selected the weak confounders X1 and X2 about 50% of the time, while OAL selected
them around 80% of the time. Excluding weak confounders increases the bias as
seen in Table 4.3 for Step-ALT and Step-ALY, although the reduction in variance by
excluding many spurious variables was big enough that the RMSEs were still better.
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In summary, excluding predictors of the treatment only and including predictors of
the outcome, even the ones not associated with treatment, can improve the efficiency
of the estimators without substantially increasing the bias.
As shown in Table 4.1-4.4, the bootstrap smoothing with Efron’s formula tended
to perform better than MI(PENCOMP) and the standard method (AIPTW, IPTW)
for sample size of 200: the estimated SE were closer the empirical SE, the coverage
rates were closer the nominal 95% coverage, and confidence interval widths were
smaller. The gain of using Efron’s formula was more pronouced for SE, OAL, and AL.
This was probably due to the fact that the bootstrap estimates were more variable-
many different models and causal estimates were obtained across the bootstraps.
The distributions of the bootstrap estimates were thus more “jumpy and erratic”.
As shown in Figures 4.3-4.5, the 1000 bootstrap estimates for one simulated dataset
were more variable for sample size of 200 than for sample size of 1000, especially for
SW, AL and OAL selection procedures, which tended to select many more spurious
variables. In the presence of high variability across the bootstrap estimates, Efron’s
formula provided tighter confidence intervals.
As the sample size increased to 1000, the gain of using Efron’s formula disap-
peared, as seen in Tables 4.4-4.8. The standard procedure of calculating the confi-
dence intervals in the case of IPTW and AIPTW, and using multiple imputation-
based PENCOMP performed better than using Efron’s formula. When there is no
much variability in the estimates, using Efron’s formula can lead to greater confi-
dence interval widths and overcoverage. Figure 4.3-4.5 shows that for sample size of
1000, all the models had similar variability in the bootstrap estimates and the level
of variability was much less, compared to that for sample size of 200. In summary,
using Efron’s formula is advantagous when the sample size is smaller and the data
are more noisier and the model selection is more variable across bootstrap samples.
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Figure 4.1: Proportions of each variable selected for propensity model across 500
simulated datasets and 1000 bootstrap samples for each simulated dataset for sample
size of 200 and 1000. X1 and X2 are the true confounders; X3 and X4 are predictors of
the outcome but not of the treatment; and X5 and X6 are predictors of the treatment
but not of the outcome; all the other 14 covariates are spurious. Average across the
spurious variables.
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Figure 4.2: Proportions of each variable selected for prediction model across 500
simulated datasets and 1000 bootstrap samples for each simulated dataset for sample
size of 200 and 1000. X1 and X2 are the true confounders; X3 and X4 are predictors of
the outcome but not of the treatment; and X5 and X6 are predictors of the treatment
but not of the outcome; all the other 14 covariates are spurious. Average across the
spurious variables.
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Table 4.1: 100× RMSE with sample size of 200. The treatment effects η=2. S1, S2,
and S3 denote scenario 1, 2, and 3, respectively.
.
100× Empirical RMSE
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 21 19 21 28 24 28 41 31 34
Bagging allPotent 22 20 22 25 23 25 34 29 30
Standard/Rubin true 21 19 21 22 20 22 36 29 31
Bagging true 21 19 21 21 19 21 33 28 29
Standard/Rubin outcomePred 16 14 16 16 14 16 19 15 17
Bagging outcomePred 16 14 16 16 14 16 19 15 17
Standard/Rubin trueConf 16 14 16 16 14 16 22 19 21
Bagging trueConf 16 14 16 16 14 16 22 19 21
Standard/Rubin SW 21 19 21 25 23 25 38 32 33
Bagging SW 22 20 22 23 22 23 33 28 28
Standard/Rubin AL 21 19 21 26 24 27 39 30 32
Bagging AL 22 19 22 24 22 24 33 28 29
Standard/Rubin allLasso 18 17 18 18 17 19 22 18 20
Bagging allLasso 18 17 18 18 17 19 21 18 19
Standard/Rubin OAL 18 17 18 18 17 19 22 18 20
Bagging OAL 18 17 18 18 17 19 21 18 19
Standard/Rubin Step-ALT 16 15 18 17 15 23 19 15 24
Bagging Step-ALT 16 15 18 17 15 18 19 15 19
Standard/Rubin Step-ALY 16 15 18 16 14 24 19 15 25
Bagging Step-ALY 16 15 18 17 15 18 19 15 19
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Table 4.2: 100× noncoverage rate with sample size of 200. The nominal coverage
is 95%. The treatment effects η=2. S1, S2, and S3 denote scenario 1, 2, and 3,
respectively.
.
100× Noncoverage Rate
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 1 2 1 2 2 2 1 1 1
Bagging allPotent 3 4 3 4 5 4 6 3 4
Standard/Rubin true 2 3 2 4 5 4 7 6 6
Bagging true 3 4 3 3 4 3 7 6 5
Standard/Rubin outcomePred 3 4 3 4 4 4 6 4 6
Bagging outcomePred 2 3 2 4 3 4 5 3 5
Standard/Rubin trueConf 3 4 3 4 5 4 5 4 3
Bagging trueConf 2 3 2 3 4 3 4 2 3
Standard/Rubin SW 1 2 1 1 2 1 1 1 1
Bagging SW 3 4 3 4 5 4 6 4 5
Standard/Rubin AL 1 2 1 1 2 1 2 1 1
Bagging AL 4 4 4 4 5 4 6 4 4
Standard/Rubin allLasso 1 3 2 2 3 3 2 2 2
Bagging allLasso 3 4 3 4 4 4 4 3 4
Standard/Rubin OAL 2 3 2 2 3 2 2 2 2
Bagging OAL 3 4 3 4 4 4 4 3 4
Standard/Rubin Step-ALT 2 3 3 4 4 10 4 2 11
Bagging Step-ALT 2 2 5 4 3 6 4 3 7
Standard/Rubin Step-ALY 2 3 3 3 3 10 4 2 11
Bagging Step-ALY 3 2 5 4 3 6 4 3 7
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Table 4.3: 1000× empirical bias with sample size of 200. The treatment effects η=2.
S1, S2, and S3 denote scenario 1, 2, and 3, respectively.
.
1000× Empirical Bias
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 5 -2 5 2 4 2 60 11 26
Bagging allPotent 2 -6 2 2 2 2 63 5 26
Standard/Rubin true 6 4 6 6 3 6 61 11 27
Bagging true 3 1 3 5 3 5 82 18 33
Standard/Rubin outcomePred 10 7 10 8 7 8 33 9 19
Bagging outcomePred 7 4 7 8 7 8 39 9 21
Standard/Rubin trueConf 8 7 8 8 7 8 32 6 18
Bagging trueConf 5 4 5 8 7 8 39 6 20
Standard/Rubin SW 5 -2 6 4 -4 7 66 39 33
Bagging SW 2 -5 3 1 0 5 68 37 27
Standard/Rubin AL 6 -2 11 5 -0 19 71 15 29
Bagging AL 6 -3 7 2 1 11 72 16 29
Standard/Rubin allLasso 2 -3 21 4 -1 17 35 2 26
Bagging allLasso 3 -3 20 2 -1 23 46 4 32
Standard/Rubin OAL 6 0 25 4 -1 17 35 2 26
Bagging OAL 5 -1 22 2 -1 23 47 5 33
Standard/Rubin Step-ALT 2 -4 65 7 6 132 33 8 146
Bagging Step-ALT 3 -3 65 3 -3 66 40 2 83
Standard/Rubin Step-ALY 2 -4 70 8 7 138 33 9 160
Bagging Step-ALY 2 -4 70 2 -3 70 36 1 90
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Table 4.4: 10× mean 95% confidence interval width with sample size of 200. The
treatment effects η=2. S1, S2, and S3 denote scenario 1, 2, and 3, respectively.
.
10× Mean 95% Confidence Width
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 13 10 13 13 11 13 20 16 17
Bagging allPotent 10 8 10 10 9 10 14 12 12
Standard/Rubin true 10 8 10 8 7 8 12 10 11
Bagging true 9 8 9 8 8 8 12 11 11
Standard/Rubin outcomePred 7 6 7 7 6 7 8 6 7
Bagging outcomePred 7 6 7 7 6 7 8 6 7
Standard/Rubin trueConf 7 6 7 7 6 7 9 8 8
Bagging trueConf 7 6 7 7 6 7 9 8 9
Standard/Rubin SW 13 10 13 12 10 12 18 15 15
Bagging SW 9 8 9 9 8 9 13 11 11
Standard/Rubin AL 13 10 13 13 11 13 19 15 16
Bagging AL 9 8 9 9 8 9 13 11 11
Standard/Rubin allLasso 9 8 9 8 8 9 11 9 10
Bagging allLasso 8 7 8 8 7 8 9 8 8
Standard/Rubin OAL 9 8 9 8 7 9 11 9 10
Bagging OAL 8 7 8 8 7 8 9 8 8
Standard/Rubin Step-ALT 8 7 8 7 6 8 9 7 8
Bagging Step-ALT 7 7 8 7 6 7 8 7 7
Standard/Rubin Step-ALY 8 7 8 7 6 8 9 7 8
Bagging Step-ALY 7 7 8 7 6 7 8 7 7
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Table 4.5: 100× RMSE with sample size of 1000. The treatment effects η=2. S1, S2,
and S3 denote scenario 1, 2, and 3, respectively.
.
100× Empirical RMSE
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 9 8 9 13 9 13 18 11 15
Bagging allPotent 9 8 9 12 9 12 17 11 14
Standard/Rubin true 9 8 9 12 9 12 19 12 16
Bagging true 9 8 9 11 9 11 18 12 15
Standard/Rubin outcomePred 7 6 7 7 6 7 9 6 8
Bagging outcomePred 7 6 7 7 6 7 9 6 8
Standard/Rubin trueConf 7 6 7 7 6 7 10 8 10
Bagging trueConf 7 6 7 7 6 7 10 8 10
Standard/Rubin SW 9 8 9 13 9 13 19 12 16
Bagging SW 9 8 9 12 9 12 17 11 14
Standard/Rubin AL 9 8 9 12 9 12 18 12 15
Bagging AL 9 8 9 11 9 11 16 11 13
Standard/Rubin allLasso 8 7 8 8 7 8 9 7 9
Bagging allLasso 8 7 8 8 7 8 9 7 8
Standard/Rubin OAL 8 7 8 8 7 8 9 7 9
Bagging OAL 8 7 8 8 7 8 9 7 8
Standard/Rubin Step-ALT 7 6 8 7 6 9 9 6 11
Bagging Step-ALT 7 6 8 7 6 8 9 6 9
Standard/Rubin Step-ALY 7 6 8 7 6 9 9 6 11
Bagging Step-ALY 7 6 8 7 6 8 9 6 9
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Table 4.6: 100× noncoverage rate with sample size of 1000. The nominal coverage
is 95%. The treatment effects η=2. S1, S2, and S3 denote scenario 1, 2, and 3,
respectively.
.
100× Noncoverage Rate
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 3 4 3 5 4 5 7 5 5
Bagging allPotent 1 1 1 1 1 1 3 1 0
Standard/Rubin true 4 3 4 6 4 6 9 5 5
Bagging true 0 1 0 1 1 1 3 0 1
Standard/Rubin outcomePred 5 5 5 5 4 5 6 5 6
Bagging outcomePred 0 0 0 1 0 1 1 1 1
Standard/Rubin trueConf 5 5 5 5 4 5 5 6 5
Bagging trueConf 0 0 0 1 0 1 1 1 1
Standard/Rubin SW 3 4 3 5 4 5 8 4 5
Bagging SW 1 1 1 1 1 1 3 1 1
Standard/Rubin AL 3 4 3 6 4 6 9 5 5
Bagging AL 1 1 1 1 1 1 3 1 1
Standard/Rubin allLasso 2 3 3 3 2 3 3 2 3
Bagging allLasso 0 0 0 1 0 1 1 0 1
Standard/Rubin OAL 2 3 3 3 2 3 3 2 3
Bagging OAL 0 0 0 1 0 1 1 0 1
Standard/Rubin Step-ALT 4 4 2 5 4 6 6 4 8
Bagging Step-ALT 0 0 0 1 0 0 1 1 1
Standard/Rubin Step-ALY 4 4 2 5 4 6 6 4 8
Bagging Step-ALY 0 0 0 1 0 0 1 1 1
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Table 4.7: 1000× empirical bias with sample size of 1000. The treatment effects η=2.
S1, S2, and S3 denote scenario 1, 2, and 3, respectively.
.
1000× Empirical Bias
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 4 1 4 4 1 4 20 4 11
Bagging allPotent 5 1 5 4 1 4 24 4 13
Standard/Rubin true 4 2 4 5 2 5 25 5 14
Bagging true 5 2 5 5 2 5 33 7 17
Standard/Rubin outcomePred 0 -0 0 2 -0 2 14 1 7
Bagging outcomePred 1 0 1 2 -0 2 16 1 7
Standard/Rubin trueConf 0 -0 0 2 -0 2 16 0 8
Bagging trueConf 1 0 1 2 0 2 17 1 9
Standard/Rubin SW 4 1 4 3 1 3 17 4 9
Bagging SW 5 1 5 4 1 4 25 5 13
Standard/Rubin AL 4 1 5 5 2 7 27 7 15
Bagging AL 5 2 5 4 1 5 33 8 16
Standard/Rubin allLasso 2 1 3 4 1 5 17 2 9
Bagging allLasso 2 0 3 3 1 5 21 3 12
Standard/Rubin OAL 2 0 3 4 1 5 17 2 9
Bagging OAL 3 1 4 3 1 5 21 3 12
Standard/Rubin Step-ALT 1 -0 20 2 -0 22 14 1 39
Bagging Step-ALT 0 -1 20 2 -0 21 16 1 36
Standard/Rubin Step-ALY 1 -0 21 2 -0 23 14 1 40
Bagging Step-ALY 0 -1 21 2 -0 22 16 1 36
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Table 4.8: 10× mean 95% confidence interval width with sample size of 1000. The
treatment effects η=2. S1, S2, and S3 denote scenario 1, 2, and 3, respectively.
.
10× Mean 95% Confidence Interval Width
PENCOMP AIPTW IPTW
Model Select S1 S2 S3 S1 S2 S3 S1 S2 S3
Standard/Rubin allPotent 4 3 4 4 4 4 6 5 5
Bagging allPotent 5 5 5 6 5 6 9 6 7
Standard/Rubin true 4 3 4 4 3 4 6 5 6
Bagging true 5 5 5 6 5 6 9 7 8
Standard/Rubin outcomePred 3 3 3 3 3 3 3 3 3
Bagging outcomePred 4 4 4 4 4 4 5 4 4
Standard/Rubin trueConf 3 3 3 3 3 3 4 3 4
Bagging trueConf 4 4 4 4 4 4 6 5 5
Standard/Rubin SW 4 3 4 4 4 4 6 5 6
Bagging SW 5 5 5 6 5 6 9 6 7
Standard/Rubin AL 4 3 4 4 4 4 6 5 5
Bagging AL 5 5 5 6 5 6 8 6 7
Standard/Rubin allLasso 3 3 3 3 3 4 4 3 4
Bagging allLasso 5 4 5 5 4 5 5 4 5
Standard/Rubin OAL 3 3 3 3 3 4 4 3 4
Bagging OAL 5 4 5 5 4 5 5 4 5
Standard/Rubin Step-ALT 3 3 3 3 3 3 3 3 4
Bagging Step-ALT 4 4 5 4 4 5 5 4 5
Standard/Rubin Step-ALY 3 3 3 3 3 4 3 3 4
Bagging Step-ALY 4 4 5 4 4 5 5 4 5
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Figure 4.3: Distributions of 1000 bootstrap IPTW estimates for one simulated dataset
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Figure 4.4: Distributions of 1000 bootstrap AIPTW estimates for one simulated
dataset
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Figure 4.5: Distributions of 1000 bootstrap PENCOMP estimates for one simulated
dataset
4.6 Application
The Multicenter AIDS Cohort study (MACS) was started in 1984 (Kaslow et al,
1987). A total of 4,954 gay and bisexual men were enrolled in the study and followed
up semi-annually. At each visit, data from physical examination, questionnaires about
medical and behavioral history, and blood test results were collected. The primary
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outcome of interest was the CD4 count, a continuous measure of how well the immune
system functions. We used this dataset to analyze the short term effects of using
antiretroviral treatment. Here we restrict our analyses to visit 12. Treatment was
coded to 1 if the patient reported taking any of antiretroviral treatment (ART) or
enrolling in clinical trials of such drugs. We estimate the short-term (6-month) effects
of using any antiretroviral treatment for HIV+ subjects. We excluded subjects with
missing values on any of the covariates included in the models. We log-transformed
the blood counts in this analysis.
Here we treat each visit as a single time point treatment. Let t = 1 denote the
time when the treatment was administered, and t = 2 the time 6-month later when
the outcome was measured. In addition, let t = −1,−2,−3 denote 1, 2, and 3 visits
away from the current visit t = 1. Let X(t = 1,−1,−2,−3) denote the blood count
histories prior to treatment assignment. Let Z be the binary treatment indicator.
Let Y (t = 2) be the CD4 count 6 months after the treatment. For the outcome
model, we considered blood counts-CD4, CD8, white blood cell (WBC), red blood
cell (RBC), and platelets and treatment histories from the last 4 visits. For the
propensity model, we considered the same covariates as those in the outcome model,
as well as demographic variables-college education, age, and race. The treatment
assignment Z was modeled as a logistic regression. We estimated the mean CD4
count difference between the treated and the control at each visit, denoted as ∆. For
PENCOMP, we replaced the simulated/imputed transformed CD4 values that were
< 0 with 0 (i.e. below detection level). A total of 15 equally spaced knots and B
spline were used.
As shown in Figure 4.6, we see that the treated and control subjects were very
disimilar. The propensity score distributions were very skewed, as the treated had
propensity of treatment close 1 and the control close to 0. Here we considered the
variable selection methods in the simulation studies to select the relevant variables
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for the propensity score model. To quantify the amount of overlap, we measured the
proportion of subjects in the control group whose propensity scores were between
the 95th and 5th quantiles of the propensity score distribution of the treated group,
denoted as pi0.95z=0 = Fz=0(F
−1
z=1(0.95)) − Fz=0(F−1z=1(0.05)), where F is the cumulative
distribution. Similarly, pi0.95z=1 denotes the proportion of the treated subjects whose
propensity scores were between the 95th and 5th quantiles of the propensity score
distribution of the control group. Including only the covariates that were selected
more than 20% of times by Step ALT among 1000 bootstrap samples improved the
overlap, as shown in Figure 4.6. Table 4.9 shows the proportion that each variable
was selected across 1000 bootstrap samples. Subjects who got treatment at the recent
visits were more likely to receive treatments again. Thus, recent treatment histories
were highly predictive of the subsequent treatment, but weakly associated with the
outcome. Recent CD4 counts were much more predictive of the future CD4 counts.
Thus, when we accounted for the outcome-covariate relationship during propensity
model building, as in Step-ALT and Step-ALY, recent past treatment variables were
selected less than 10% of the times, compared to close to 100% of the time in SW
and AL, and 58% of the time in OAL. As seen in simulation studies, compared to the
OAL, the two-stage selection procedures were more effective at excluding variables
not or weakly associated with the outcome.
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Figure 4.6: Propensity score distributions between the treated (grey) and control
(black) if (A) including all covariates in the propensity score model, pi0.95z=1 = 18% and
pi0.95z=0 = 22%; (B) if including only the covariates that were selected more than 20%
of times by Step ALT among 1000 bootstrap samples, pi0.95z=1 = 33% and pi
0.95
z=0 = 49%
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Table 4.9: Proportion of each variable selected for prediction model across 1000 boot-
strap samples.
Outcome Model Propensity Model
Covariate SW AL SW AL OAL Step ALT Step ALY
CD4 t=-1 100 100 26 47 100 100 100
CD4 t=1 100 100 100 100 100 100 100
CD8 t=-1 71 20 20 35 77 20 20
RBC t=1 65 28 35 56 76 30 28
RBC t=-2 64 7 41 64 81 8 7
WBC t=1 59 24 16 39 61 23 25
college 57 9 19 22 38 8 9
CD4 t=-2 52 36 19 48 58 32 36
platelet t=-1 49 14 37 59 65 12 14
CD8 t=1 46 13 62 59 56 14 13
treat t=-3 43 7 38 58 59 6 6
treat t=-1 42 11 100 100 58 12 11
treat t=-2 41 7 80 94 42 9 7
platelet t=-3 37 4 21 34 38 3 4
WBC t=-1 30 1 17 36 40 2 1
age 24 2 28 28 15 1 2
CD8 t=-2 23 1 11 34 35 2 1
RBC t=-1 22 3 17 44 45 5 3
white 21 1 25 21 13 1 1
platelet t=1 19 1 20 40 36 1 1
CD4 t=-3 18 3 12 40 39 3 3
CD8 t=-3 17 2 28 37 25 2 2
WBC t=-2 14 1 19 37 30 1 1
WBC t=-3 13 1 29 37 25 1 1
platelet t=-2 12 1 15 32 27 1 1
RBC t=-3 10 0 21 38 15 1 0
Table 4.10: Treatment effect estimates and 95% confidence intervals.
.
IPTW AIPTW PENCOMP
allPotent Rubin/standard 7.5 (-2.2, 17.1) 1.3 (-0.7, 3.3) 0.7 (-1.4, 2.7)
Bagging 5.8 (-3.0, 14.6) 0.9 (-0.9, 2.6) 0.7 (-1.0, 2.4)
SW Rubin/standard 11.9 (1.4, 22.4) 2.7 (-0.03, 5.4) 0.9 (-1.9, 3.7)
Bagging 6.7 (-2.7, 16.0) 1.7 (-0.5, 3.9) 0.9 (-1.3, 3.1)
AL Rubin/standard 11.7 (1.6, 21.9) 2.8 (-0.7, 6.3) 0.9 (-1.6, 3.4)
Bagging 6.1 (-2.7, 15.0) 2.3 (-0.6, 5.3) 0.9 (-1.3, 3.1)
OAL Rubin/standard 2.5 (-6.6, 11.5) 0.9 (-2.1, 3.9) 0.6 (-1.5, 2.7)
Bagging 4.9 (-3.2, 13.0) 1.6 (-0.9, 4.1) 0.6 (-1.3, 2.5)
Step-ALT Rubin/standard 0.5 (-6.9, 7.9) -0.4 (-2.5, 1.7) -0.05 (-1.8, 1.7)
Bagging 2.0 (-5.0, 9.0) 0.4 (-1.6, 2.3) -0.04 (-1.6, 1.5)
Step-ALY Rubin/standard 0.5 (-7.0, 7.9) -0.4 (-2.4, 1.6) -0.09 (-1.8, 1.7)
Bagging 1.9 (-5.3, 9.0) 0.3 (-1.6, 2.2) -0.08 (-1.7, 1.6)
We estimated the short term effect of antiretroviral treatment on CD4 count using
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PENCOMP, AIPTW and IPTW, shown in Table 4.10. The standard errors were ob-
tained using 1000 bootstrap samples. For PENCOMP, 1000 complete datasets were
created. Overall, the IPTW estimates had the biggest confidence interval widths. In-
corporating the outcome models as in AIPTW and PENCOMP decreased the stan-
dard errors and interval widths significantly. PENCOMP tended to have slightly
smaller interval widths than AIPTW. The IPTW bootstrap estimates were much
more variable, compared to the PENCOMP or AIPTW bootstrap estimates. As seen
in the simulation studies, the bagging estimators tended to have smaller standard
errors and confidence interval widths than the standard approach for IPTW and
AIPTW, or the MI-based approach with Rubin’s combining rules for PENCOMP.
Excluding irrelevant covariates from the propensity score model, as seen in Step-ALT
and Step-ALY, improved the performance of IPTW significantly, in terms of the stan-
dard errors and confidence interval widths. Incorporating the outcome models in the
AIPTW and PENCOMP attenuated some of the effect of including such covariates.
4.7 Discussion
We propose a new version of PENCOMP via bagging that could have better per-
formance, in terms of SE, confidence interval width and coverage, than the original
version of PENCOMP with Rubin’s multiple imputation combining rules. The bag-
ging PENCOMP estimator have smaller standard errors, confidence interval width,
and better nominal coverage than the MI pencomp estimator when the data are noisy.
This can occur when there is limited overlap in the propensity score distributions be-
tween the treated and control. Lastly, we modeled PENCOMP as a mixed model
in our empirical work, but it would be interesting to compare it with the alternative
version, particularly via Bayesian approach (PENCOMP-Bayes), which as a Bayesian
method might have attractive small-sample properties. Bagging is a form of model
averaging, which can improve the performance of the estimators when the data are
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noisy. One future topic of research would be to compare it with Bayesian model
averaging combined with PENCOMP-Bayes.
Our simulation studies show that excluding strong predictors of the treatment
but not of the outcome, or spurious variables, helps improve the performance of the
propensity score-based methods, especially for the IPTW estimator. The doubly ro-
bust PENCOMP and AIPTW are not as heavily affected by including such variables.
However, one shortcoming of using outcome adaptive approach to propensity score
model building is that in small samples, it can miss many weak confounders. While
the outcome adaptive approach can decrease the standard errors of the estimates,
by excluding spurious variables and strong predictors of the treatment but not of
the outcome, it can potentially increase bias by excluding variables that are weakly
associated with the outcome, especially in small samples. This is a bias-variance
trade off problem. In addition, for the IPTW and AIPTW estimators, the bagging
approach incorporates model selection so performs better than the standard approach
in terms of bias, since it improves the chance that weak confounders are selected in
some bootstrap samples. This effect is not seen in PENCOMP, since the multiple
imputation-based approach already incorporates model selection. Whether using an
outcome adaptive approach can be beneficial depends on specific studies. In the pres-
ence of many weak confounders in the data, the reduction in variance from using an
outcome adaptive approach might not offset the increase in bias.
On the other hand, in high dimensional setting, including all the observed variables
in the propensity model can lead to highly unstable or even infeasible estimation. One
criticism of focusing on confounders rather than just predictors of treatment assign-
ment (i.e. balancing covariates between the treatment arms) is that incorporating the
outcome in the estimation procedure, whether via prognostic score (Hansen, 2008) or
as we have done here, violates the principle that causal inference methods using ob-
servational data should mimic as closely as possible randomized trial designs, where
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outcomes are not considered until the final estimation step. Following such a rule
avoids both overt and inadvertent attempts to bias model building toward preferred
outcomes (“the garden of forking paths” Gelman and Loken, 2013). However, with
the advent of advanced “automatic” penalized regression methods such as adaptive
lasso, the risk of such “model shopping” may be sufficiently reduced–though not elim-
inated, so that analysts that follow the approach outlined here should endeavor to
pre-specify to the extent possible the covariates to be used before the analysis begins.
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CHAPTER V
Summary and Future Work
In this dissertion, we have proposed PENCOMP as a new, straightforward method
to estimate treatment effects in single time-point and in two-time point treatment
situations with time-dependent confounders. PENCOMP has the double robust-
ness property for causal effects, which means that PENCOMP offers the analyst two
chances to make correct inferences about treatment effects, either by correctly spec-
ifying the propensity score model or by correctly specifying the prediction models.
In simulation studies, we show that PENCOMP is less sensitive to extreme weights,
and flexibile for estimating different estimands such as ATE, ATM and truncated,
by restricting to the appropriate subpopulation. We show that excluding variables
associated only with treatment reduces the RMSE, and including variables associated
only with outcome further reduces the RMSE. Compared with IPTW, PENCOMP
as a doubly robust method is less sensitive to the side effects of including strong
predictors of the treatment only.
We propose two versions of PENCOMP: 1) PENCOMP-MI–based on the multiple
imputation (MI) and MI combining rules for inference; and 2) PENCOMP-bagging–
based on bagging. Through simulation studies, we have shown that PENCOMP-
bagging could have better performance than PENCOMP-MI, in terms of confidence
interval widths and coverage, when the data are noisy, such as in small samples and
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in the presence of variable selection.
Our next step would be to create a R package so that applied researchers can
easily implement our method. Here we also propose some future directions to explore
for PENCOMP.
5.1 Missing Data and PENCOMP
PENCOMP is built on Penalized Spline of Propensity Prediction (PSPP) for
missing-data problems (Zhang and Little, 2009; Little and An, 2004). Let R denote
the response indicator for Y , taking the value 1 if Y is observed and 0 if Y is missing.
Let X = (X1, ..., Xp) denote a set of p fully-observed variables. PSPP first estimates
the propensity to respond given X, using a method appropriate for a binary outcome
such as logistic regression. The method then predicts the missing values of Y using a
linear model that includes as predictors a penalized spline of the estimated propensity
to respond and a linear function of other covariates X that are predictive of Y . For
the applications considered in this dissertation, we analyzed the treatment effects
on complete data sets to focus on the problem of causal inference. However, the
estimates on the complete data sets were probably biased, since the subjects who
were lost to follow up were probably sicker with lower CD4 counts. In the future, we
would consider a more realistic approach that accounts for missing data. We propose
using PSPP to impute the missing covariates to create D complete datasets. For
each data set d = 1, · · · , D, use PENCOMP-bagging or PENCOMP-MI to impute all
the missing potential outcomes, and then combine the D complete datasets with all
missing potential outcomes imputed for inference. PENCOMP has the advantage of
easily incorporating missing data. Simluation studies would be carried out to assess
the performance of such procedure.
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5.2 Bayesian PENCOMP
For both versions of PENCOMP, PENCOMP-bagging and PENCOMP-MI, the
spline models are fitted via REML. Instead of REML, we can estimate the spline
model using a fully Bayesian approach. There we describe the Baysian penalized
spline with truncated linear bases.
Y z1 = C1β + C2θ + ,
 θ

 ∼

 0
0
 ,
 σ2θI 0
0 σ2 I

 ,
where β = (β0, β1, β2, · · · , βp) denote fixed effects, and θ = (θ11, · · · , θ1K) are random
basis coefficients. Specify a diffuse prior for β as P (β) ∼ 1; and prior distributions
for the variances σ2θ and σ
2
 as P (σ
2
θ) ∼ IG(Aθ, Bθ) and P (σ2 ) ∼ IG(A, B). To have
non-formative priors, the hyperparameters need to be small.
The posterior distributions for P (β, θ|Y, σ2 , σ2θ) ∼ N(ΣCTY, σ2Σ), where Σ =
(CTC + σ2/σ
2
θD)
−1. The posterior distribution for P (σ2 |Y, β, θ, σ2θ) ∼ IG(A +
n/2, B + 1/2||y − C1β − C2θ||2). The posterior distribution for P (σ2θ |Y, β, θ, σ2 ) ∼
IG(Aθ + K/2, Bθ + 1/2||θ||2). Compared to the mixed model framework, a fully
Bayesian approach takes into account the variability in hyperparameters. Future
studies would be done to investigate the performances of these versions of PEN-
COMP.
5.3 Extension of PENCOMP to Survival Outcome
Through this dissertation, we focus on continous outcome. Another important
topic for future research is to extend PENCOMP to non-normal outcomes. For ex-
ample, we can extend PENCOMP to address the problem of truncation by death.
Suppose we are interested in estimating the effect of a treatment on Quality of Life
(QOL) that is truncated by death (Rubin, 2002). Some patients die after treatment
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is assigned and before QOL is measured. For those patients who die, their outcomes
QOL are not defined. It is not approriate to treat truncated outcome as a missing
data problem, since those outcomes are neither censored or missing. In the presence
of censoring by death, the framework of principal stratification can be applied to esti-
mate causal effects (Frangakis and Rubin 2002). The idea is to stratify subjects into
four principal strata: subjects who would live under both treatments (LL), subjects
who live under treatment and die under control (LD), subjects who die under treat-
ment and live under control (DL), and those who die under both treaments (DD).
Since causal effects should be drawn on the same set of people, and subjects who die
do not have well defined Quality of Life measure, the causal effects in this case should
be defined only for the group LL.
However, since each subject can receive one treatment at a time and only one
potential outcome is observed, the principal strata are not unknown. Large sample
bounds for causal effects within the principal strata can be obtained with some as-
sumptions (Zhang and Rubin, 2003). Likelihood based approach with EM algorithm
was used to estimate causal effects within the principal strata (Zhang and Rubin,
2009). However, with PENCOMP, we can impute the missing survival outcomes
and the missing potential outcomes of interest if survived in a single time-point and
multiple time-point treatments scenarios, similar to what’s done in Chapter 2.
For simplicity, we illustrate our approach to the two time-point treatments. Let
t = 1 denote the baseline. At time t = 2, we first impute the missing survival status S2
and if S2 = 1 (alive), impute the missing intermediate outcome X2. Similarly, at time
t = 3, we first impute the survival status S3, and if S3 = 1, impute missing potential
outcome Y jk. More specifically, the implementations are described as follows:
(a) For d = 1, · · · , D, generate a bootstrap sample B(d) from the original data S
by sampling units with replacement, stratified on treatment group. Then carry out
steps (b)-(g) for each sample d:
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(b) Estimate a logistic regression model for the distribution of Z1 given baseline
covariates X1, with regression parameters γ1. Estimate the propensity to be assigned
treatment Z1 = z1 as Pˆz1(X1) = Pr(Z1 = z1|X1, γˆ(d)z1 ), where γˆ(d)z1 is the ML estimate
of γz1 . Denote Pˆ
∗
z1
=log [Pˆz1(X1)/(1− Pˆz1(X1))].
(c) Using the cases assigned to treatment group Z1 = z1, estimate a logistic
regression of for the survival Sz12 on X1, with mean
logit(P (Sz12 = 1|X1, Z1 = z1, S1 = 1, θz1 , βz1)) = s(Pˆ ∗z1|θz1) + gz1(X1; βz1), (5.1)
and normal linear regression of Xz12 on X1, with mean
E(Xz12 |X1, Z1 = z1, S2 = L, θz1 , βz1) = s(Pˆ ∗z1|θz1) + gz1(X1; βz1), (5.2)
where s(Pˆ ∗z1|θz1) denotes a penalized spline with fixed knots with parameters θz1 , and
gz1() represents a parametric function of other predictors of the outcome, indexed by
parameters βz1 . One of the covariates might be omitted to avoid collinearity. Note
that a distinct model is fitted for each treatment regimen.
(d) For z1 = 0, 1, impute the survival status of S
z1
2 and for S2 = 1, then impute
the values of Xz12 for subjects in treatment group 1− z1 in the original data set with
draws from the predictive distribution of Xz12 given X1 from the regression in (c),
with ML estimates θˆ
(d)
z1 , βˆ
(d)
z1 substituted for the parameters θz1 , βz1 .
(e) Estimate the propensity to be assigned treatment Z2 = z2 given Z1, X¯2 as
Pˆz2(X¯2, Z1) = Pr(Z2 = z2|X¯2, Z1 = z1, γˆ(d)z2 , S2 = 1) , where γˆ(d)z2 is the ML estimate
of γz2 . The probability of treatment regimen (Z1 = z1, Z2 = z2, S1 = 1) is denoted
as Pˆz¯2 = Pˆz1(X1)Pˆz2(X¯2, Z1)Pˆz1(S2, X1), where Pˆz1(S2, X1) = Pˆ (S2 = 1|X1, Z1 = z1)
Denote Pˆ ∗z¯2 =log[Pˆz¯2/(1− Pˆz¯2)].
(f) Using the cases assigned to treatment group Z¯2 = z¯2, given past covariate and
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treatment histories X¯2, Z¯2, estimate a logistic regression of S
z¯2 with mean
logit(P (S z¯23 = 1|X¯2, Z¯2 = z¯2, S2 = 1, θz¯2 , βz¯2) = s(Pˆ ∗z¯2|θz¯2) + gz¯2(X¯2, Z¯2; βz¯2)
and a normal linear regression of Y z¯2 with mean
E(Y z¯2|X¯2, Z¯2 = z¯2, S3 = 1, θz¯2 , βz¯2) = s(Pˆ ∗z¯2 |θz¯2) + gz¯2(X¯2, Z¯2; βz¯2)
where s(Pˆ ∗z¯2|θz¯2) denotes a penalized spline with fixed knots with parameters θz¯2 , and
gz¯2() represents a parametric function of other predictors indexed by parameters βz¯2 .
One of the covariates might need to be omitted from gz¯2() to avoid collinearity in the
covariates.
(g) For each combination of z¯2 = (z1, z2), first impute the missing survival status
S3 = 1 and for subjects with S3 = 1, impute the values of Y
z¯2 for subjects not assigned
this treatment combination in the original data set with draws from the predictive
distribution of Y z¯2 from the regression in (f), with ML estimates θˆ
(d)
z¯2 , βˆ
(d)
z¯2 substituted
for the parameters θz¯2 , βz¯2 . From the imputed values, we can infer which principal
stratum each subject belongs to.
(h) Use Rubin’s Combining rule to combine all the complete datasets with poten-
tial outcomes filled in. We can compare the survival probabilities for both treatments,
in addition to comparing the mean difference of Y for the revelant principal stratum.
5.4 Extension of PENCOMP to Longitudinal Treatments
In Chapter 2, we focused on two-time point treatment situation. An important
question is how PENCOMP can be applied to longitudinal data sets with more than
two time points. For example, in the MACS data we analyzed, there are 16 time
points, so there are over 30,000 (215) possible treatment combinations, nearly all of
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which are not seen in the data. Providing simple and interpretable causal conclusions
in such a setting requires careful thought and modeling. In such hign dimensional
setting, reparametrization and some form of dimension reduction are needed. For
example, restrict inference to the subset of “relevant combinations” judged to have
sufficient data to provide meaningful estimates. Propensity models can then be fitted
sequentially over time on historical data, including prior treatment assignments and
outcomes as potential covariates. The outcomes of relevant combinations can then
be imputed as a function of a spline of the propensity and other predictive covariates
in the history, with the propensity for each relevant combination obtained by multi-
plying the sequence of propensities at the set of earlier time points. Some modeling
of the resulting treatment effects is likely to be needed to provide parsimonious infer-
ences. For example, a plot of treatment effects against the number of prior ”dosages”
may suggest a model with a parametric form for the treatment effect as a function
of dosage. To maintain stable estimates and enhance interpretability, some form of
dimension reduction and variable selection, for example, a summary measure of treat-
ments and other time varying covariates, will typically required. Implementing such
strategies is a topic for future research.
5.5 Variable Selection for Propensity Score Model
In Chapter 4, we proposed two-stage techniques: Step-ALY and Step-ALT. For
Step-ALY, in the first stage, we select a subset of covariates that are predictive of the
outcome using adaptive lasso. In the second stage, we use the subset of covariates
found in the first stage in the propensity score model. Similarly, for Step-ALT, we
reverse the steps by performing outcome adaptive lasso for the propensity model first
and then the prediction model. Future studies could be conducted to see if combining
the variable selection for the propensity score and prediction models into a single joint
selection model would be more efficient than using these two-stage techniques.
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APPENDICES
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APPENDIX A
Penalized Spline of Propensity Methods for
Treatment Comparison
A.1 Double Robustness of PENCOMP
A.1.1 Single Time Point Treatment Assignment
Let X1 denote the baseline covariates that affect treatment assignment Z1. Sup-
pose Z1 ∈ {0, 1} denotes assignment to control (0) or treatment (1). Let Y Z1 denotes
the potential outcome associated with treatment Z1.
Result 1: The ignorable treatment assignment implies that (Y 1, Y 0) |= Z1|Pz1(X1)
(Rosenbaum and Rubin 1983), where Pz1(X1) = Pr(Z1 = z1|X1) denotes the propen-
sity of being assigned z1.
In the single time point treatment setting, suppose Y 0 is observed only for subjects
i = 1, · · · , n0, while Y 1 is observed only for subjects i = n0 + 1, · · · , n. We are
interested in estimating the causal effect ∆ = E(Y 1−Y 0). Under SUTVA, ignorability
and positivity assumptions, we can estimate causal effects from the regression models
on covariates X1: E(Y |X1, Z1 = 1) and E(Y |X1, Z1 = 0), or from regression models
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on a summary measure of the covariates-propensity score Pz1(X1): E(Y |Pz1(X1), Z1 =
1) and E(Y |Pz1(X1), Z1 = 0).
E(Y 1 − Y 0) = E(E(Y 1 − Y 0|X1))
= E(E(Y 1|X1))− E(E(Y 0|X1))
= E
(
E(Y |X1, Z1 = 1)
)
− E
(
E(Y |X1, Z1 = 0)
)
by ignorability
= E
(
E(Y |Pz1(X1), Z1 = 1)
)
− E
(
E(Y |Pz1(X1), Z1 = 0)
)
by Result 1
Alternatively, the mean E(Y 1) can be written as E(Y 1) = P (Z1 = 1)E(Y
1|Z1 =
1) + P (Z1 = 0)E(Y
1|Z1 = 0), estimated as:
Eˆ(Y 1) =
n0
n
∗ 1
n0
n0∑
i=1
Yˆ 1i +
n1
n
∗ 1
n1
n∑
i=(n0+1)
Y obsi
=
1
n
∗
( n0∑
i=1
Yˆ 1i +
n∑
i=n0+1
Y obsi
)
where E(Y 1|Z1 = 1) = Y obs and E(Y 1|Pz1(x1), Z1 = 0) = Yˆ 1.
PENCOMP imputes the missing potential outcomes Y z1=1 for subjects i = 1, · · · , n0
from the mean model E(Y z1|X1, Z1 = z1, θz1 , βz1) = s(Pˆ ∗z1 ; θz1) + gz1(Pˆ ∗z1 , X1; βz1),
where Pˆ ∗z1 = log [Pˆz1(X1)/(1− Pˆz1(X1))]. Zhang and Little (2009) showed that this
imputation model is equivalent to a centered version of the form E(Y z1|X1, Z1 =
z1, θz1 , βz1) = s(Pˆ
∗
z1 ; θz1) + gz1(Pˆ
∗
z1 , X1 − sx1(Pˆ ∗z1 ;ωz1); βz1), where sx1(Pˆ ∗z1 ;ωz1) =
E(X1|Pˆ ∗z1) is the spline of X1 on the logit of the propensity score, denoted as, Pˆ ∗z1
as shown in Little and An (2004). Specifically, in the centered version, the residuals
from the spline regressions of covariates X1 on Pˆ ∗z1 enter the parametric g function.
Both Zhang and Little (2009) and Little and An (2004) showed that both imputation
models in the missing data context yields a consistent estimate for E(Y 1). Here we
show the double robustness property of PENCOMP using the centered version for
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simplicity.
a) When the mean model of Y 1 given (Pˆ ∗z1 , X1) are correctly specified, the
marginal mean of Y 1 from the imputation model is consistent, as a consequence
of the properties of a well-defined regression model.
b) When the prediction model given X1 is misspecified, and the propensity and
the spline models are correctly specified, the marginal mean of Y 1 is consistent. Here
we prove the case for linear g function. In the case of a nonlinear g function, we can
approximate it using linear terms and the results will still hold.
E
(
Yˆ 1|P ∗z1
)
= sy
(
P ∗z1
)
+ E
[
g
(
P ∗z1 , X1 − sx1(P ∗z1)
)
|P ∗z1
]
= sy
(
P ∗z1
)
+ g
(
P ∗z1 , E
(
X1 − sx1(P ∗z1)
∣∣∣∣P ∗z1))
≈ sy
(
P ∗z1
)
+ g
(
P ∗z1 , 0,
)
= sy
(
P ∗z1
)
= E
(
Y 1|P ∗z1
)
= E(Y 1|P ∗z1 , Z1 = 1)
= E(Y 1|P ∗z1 , Z1 = 0)
where the last two equalities again follow from Result 1.
Thus, for the subjects who actually received controls, the marginal mean of the
imputed values Yˆ 1 from our imputation model is consistent even when the prediction
model on covariates is misspecified: 1
n0
∑n0
i=1 Yˆi
1 → E(Y 1|Z1 = 0) as n0 →∞. Similar
approaches can be used to estimate E(Y 0|Z1 = 1) and thus estimated E(Y 0).
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A.1.2 Longitudinal Treatment Assignments
Suppose treatments are assigned at T discrete time points: t = 1, . . . , T . Let
X¯t and Z¯t denote the covariate and treatment history, respectively, up to and in-
cluding time point t. Let Y z¯T denote the potential outcome under treatment regime
z¯T = (z1, · · · , zT ). The final outcome of interest Y z¯T is measured after time point
T . Suppose, each zt is binary treatment. For a particular treatment regime z¯T =
(z1, z2, · · · , zt, zt+1, · · · , zT ), under SUTVA, sequential ignorability and positivity as-
sumptions, for all t = 1, · · · , T , the following results hold.
Result 2: Y z¯T |= I(Zt = zt)|Pzt(X¯t, z¯t−1), where I(.) is the indicator function, and
Pzt(X¯t, z¯t−1) = P (Zt = zt|X¯t, Z¯t−1), as a direct extension of the single time point
treatment (Rosenbaum and Rubin 1983).
Result 3: Y z¯T |= I(Z¯t = z¯t)|Pz¯t , where I(.) is the indicator function, Pz¯t =
∏t
k=1 P (Zk =
zk|Z¯k−1 = z¯k−1, X¯k), which is the propensity of being assigned treatment regime z¯t,
conditional on the past treatment and covariate history. In other words, the treat-
ment regime Z¯t up to and including time point t is independent of potential outcomes
Y z¯T given the propensity of receiving that treatment regime Z¯t, for all t = 1, · · · , T .
The proof is outline here.
P
(
I(Z¯t = z¯t)|Y z¯T , Pz¯t
)
= P
(
I(Z¯t = z¯t)|Pz¯t
)
= Pz¯t
P
(
I(Z¯t = z¯t)|Y z¯T , Pz¯t
)
= E
(
I(Z¯t = z¯t)|Y z¯T , Pz¯t
)
= E
[
E
(
I(Z¯t = z¯t)|Y z¯T , X¯t, Z¯t−1, Pz¯t
)
|Y z¯T , Pz¯t
]
= E
[
I(Z¯t−1 = z¯t−1)E
(
I(Zt = zt)|X¯t, Z¯t−1, Pz¯t
)
|Y z¯T , Pz¯t
]
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by sequential ignorability assumption
= E
[
I(Z¯t−1 = z¯t−1)Pzt(X¯t, z¯t−1)|Y z¯T , Pz¯t
]
= E
[
E
(
I(Z¯t−1 = z¯t−1)Pzt(X¯t, z¯t−1)|Y z¯T , X¯t−1, Z¯t−2, Pz¯t
)∣∣∣∣Y z¯T , Pz¯t]
= E
[
I(Z¯t−2 = z¯t−2)Pzt(X¯t, z¯t−1)E
(
I(Zt−1 = zt−1)|Y z¯T , X¯t−1, Z¯t−2, Pz¯t
)
∣∣∣∣Y z¯T , Pz¯t]
= E
[
I(Z¯t−2 = z¯t−2)Pzt(X¯t, z¯t−1)Pzt−1(X¯t−1, z¯t−2)
∣∣∣∣Y z¯T , Pz¯t]
= E
[
Pz¯t |Y z¯T , Pz¯t
]
by the same argument for each Zt
= Pz¯t
By the same argument but without the need for the sequential ignorability assump-
tion, P
(
I(Z¯t = z¯t)|Pz¯t
)
= Pz¯t . Thus, P
(
I(Z¯t = z¯t)|Y z¯T , Pz¯t
)
= p
(
I(Z¯t = z¯t)|Pz¯t
)
Suppose we want to impute the missing potential outcomes X113 for subjects
1, · · · , n0 and subjects i = n0 + 1, · · ·n receive treatment combination (1, 1). As
shown below, we can build a model for X113 from the subjects with observed treat-
ment sequence of (1, 1) to impute missing potential outcomes X113 for other subjects.
Similar to single time point treatment, we can estimate causal effects from the regres-
sion models on the covariates or on the propensity scores.
E
(
X113
)
= E
[
E(X113 |X¯2)
]
= E
[
E(X3|X¯2, Z1 = 1, Z2 = 1)
]
by sequential ignorability
= E
[
E(X3|Pz¯2=(11), Z1 = 1, Z2 = 1)
]
by result 3
Alternatively, the meanE(X113 ) can be written as E(X
11
3 ) = P (Z¯2 = (1, 1))E(X
11
3 |Z¯2 =
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(1, 1)) + P (Z¯2 6= (1, 1))E(X113 |Z¯2 6= (1, 1)), estimated as:
Eˆ(X113 ) =
n00
n
∗ 1
n00
n00∑
i=1
Xˆ3
11
+
n01
n
∗ 1
n01
n00+n01∑
i=n00+1
Xˆ3
11
+
n10
n
∗ 1
n10
n00+n01+n10∑
i=n00+n01+1
Xˆ3
11
+
n∑
i=n00+n01+n10+1
Xobs3
=
1
n
∗
(n00+n01+n10∑
i=1
Xˆ3
11
+
n∑
i=n00+n01+n10+1
Xobs3
)
where Xˆ113 = Eˆ(X
11
3 |Pz¯2 , Z1 6= 1, Z2 6= 1).
PENCOMP imputes the first missing intermediate outcomes X2 first, X3, and
continue forward to the final outcome Y . By induction, we can show PENCOMP
has double robustness property in longitudinal study. We have shown double robust-
ness property for the base case t = 1 as in the single treatment. Suppose PEN-
COMP has the double robustness property in imputing missing potential outcomes
Xt. We want to show that the double robustness property also holds for the miss-
ing potential outcomes Xt+1, Suppose we are interested in estimating X
z¯t
t+1, where
z¯t = (z1, · · · , zt) and subjects i = 1, · · · , n0 do not treatment sequence Z¯t that
match z¯t. Thus, to impute the missing potential outcomes X
z¯t
t+1 for the subjects
whose treatment sequence did not match z¯t, we draw values from the mean model
E(X z¯tt+1|X¯t, Z¯t = z¯t, θz¯t , βz¯t , γz¯t) = sxt+1(Pˆ ∗z¯t ; θz¯t) + g
[
Pˆ ∗z¯t , X1, · · · , Xt; βz¯t
]
, which is
equivalent to the mean model E(X z¯tt+1|X¯t, Z¯t = z¯t, θz¯t , βz¯t , γz¯t) = sxt+1(Pˆ ∗z¯t ; θz¯t) +
g
[
Pˆ ∗z¯t , X1−sx1(Pˆ ∗z¯t ;ωz¯1t ), · · · , Xt−sxt(Pˆ ∗z¯t ;ωz¯tt); βz¯t
]
, where Pˆ ∗z¯t = log
(
Pˆz¯t/(1− Pˆz¯t)
)
.
Here we need to show the double robustness property of PENCOMP with the centered
version.
a) When the mean model of X z¯tt+1 given the covariate history X¯t are correctly
specified, the marginal mean of X z¯tt+1 from the imputation model is consistent, as a
consequence of well-defined regression models.
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b) When the prediction model given X¯t is misspecified, and all the propensity
models up to and including time point t and the spline models are correctly specified,
the marginal mean of X z¯tt+1 is consistent. Again we prove the case for linear g function.
We can approximate a nonlinear g function with using linear terms and the results
will still hold.
E
(
Xˆ z¯tt+1|P ∗z¯t
)
= sxt+1
(
P ∗z¯t
)
+ E
[
g
(
P ∗z¯t , X1 − sx1(P ∗z¯t), · · · , Xt − sxt(P ∗z¯t
)
|P ∗z¯t
]
= sxt+1
(
P ∗z¯t
)
+ g
[
P ∗z¯t , E
(
X1 − sx1(P ∗z¯t)|P ∗z¯t
)
, · · · , E
(
Xt − sxt(P ∗z¯t)|P ∗z¯t
)]
≈ sxt+1
(
P ∗z¯t
)
+ g
[
P ∗z¯t , 0, · · · , 0
]
= sxt+1
(
P ∗z¯t
)
= E
(
X z¯tt+1|P ∗z¯t
)
= E(X z¯tt+1|P ∗z¯t , Z¯t 6= z¯t)
= E(X z¯tt+1|P ∗z¯t , Z¯t = z¯t)by result 4
where the last two equalities follow from Result 3.
Thus, 1
n0k
∑n0k
i=1 Xˆ
z¯k
k+1,i → E(X z¯kk+1|Z¯k 6= z¯k) as n0k → ∞, where n0k is the sample
size of the observations for which Z¯k 6= z¯k, and we assume that the observations are
ordered that the first n0 corresponds to the observations for which Z¯k 6= z¯k. Thus,
by induction, PENCOMP has double robustness property in longitudinal study.
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A.2 Implementations of the IPTW and the AIPTW Estima-
tors
A.2.1 IPTW
Let Oi = (X¯iT , Z¯iT , Yi) denote the observed data for subject i, where i = 1, · · · , n.
The likelihood of the observed data can be factored into two components P (O) =
Q0g0, whereQ0 = P (Y |X¯T , Z¯T = z¯T )
∏T
t=1 P (Xt|X¯t−1, Z¯t−1) and g0 =
∏T
t=1 P (Zt|Z¯t−1, X¯t−1).
Denote the MLE of Q0 and g0 as Qn and gn respectively.
From the IPTW estimating equation
∑n
i=1DIPTW (Oi|β, gn) = 0, we can obtain
Eˆ(Y z1) =
∑n
i=1
I(Z1i=z1i)
Pˆ (Z1i=z1i|X1i))
−1∑n
i=1
Z1iYi
Pˆ (Z1i|X1i) . Thus, the estimated causal effect ∆ˆ
in a single time point is
∆ˆIPTW = (
n∑
i=1
Z1i
Pˆ (Z1i|X1i)
)−1
n∑
i=1
Z1iYi
Pˆ (Z1i|X1i)
−(
n∑
i=1
1− Z1i
1− Pˆ (Z1i|X1i)
)−1
n∑
i=1
(1− Z1i)Yi
(1− Pˆ (Z1i|X1i))
Similarly, in a two time points treatment, the estimated causal effects ∆ˆz1z2 are
∆ˆIPTWz1z2 = (
n∑
i=1
I(Z1i = z1, Z2i = z2)
P (Z1i|X1i)P (Z2i|X1i, X2i, Z1i))
−1
n∑
i=1
I(Z1i = z1, Z2i = z2)Yi
P (Z1i|X1i)P (Z2i|X1i, X2i, Z1i)
− (
n∑
i=1
I(Z1i = 0, Z2i = 0)
P (Z1i|X1i)P (Z2i|X1i, X2i, Z1i))
−1
n∑
i=1
I(Z1i = 0, Z2i = 0)Yi
P (Z1i|X1i)P (Z2i|X1i, X2i, Z1i)
A.2.2 AIPTW
To solve the estimating equation
∑n
i=1DAIPTW (Oi|β, gn, Qn) = 0 in the single
treatment assignment setting, we proceeds as follows.
(a) For d = 1, · · · , D, generate a bootstrap sample S(d) from the original data S
by sampling units with replacement, stratified on treatment group. Then carry out
steps (b)-(h) for each sample d:
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(b) Estimate a logistic regression model for the distribution of Z1 given X1, with
regression parameters γz1 . Estimate the propensity to be assigned treatment Z1 = z1
as Pˆ (Z1 = z1|X1, γˆz1 (d)) , where γˆz1 (d) is the ML estimate of γz1 .
(c) For z1 = 0, 1, using the cases assigned to treatment group z1, estimate the
distribution Y given X1 and Z1, Pˆ (Y |X1 = x1, Z1 = z1), using a normal linear
regression with mean E(Y |X1, Z1 = z1, βz1) = gz1(X1; βz1), where gz1() represents a
parametric function of X1 and Z1 indexed by parameters βz1 .
(d) Estimate the distributions of baseline covariates P (X1) using the empirical
distributions from the data, denoted as Pˆ (X1).
e) Estimate βˆmcn = (βˆ
mc
0 , βˆ
mc
1 ) using the g-computation to generate 10, 000 number
of Y0 and Y1 from their respective counterfactual reference distributions. Specifically,
draw x∗1 from the empirical distribution of X1, Pˆ (X1). Set Z1 = z1 and generate
draws y∗ from Pˆ (Y |X1 = x∗1, Z1 = z1). Then fit the MSM model E(Y Z1) = β0 +β1Z1
to this collection of (y∗, 1) and (y∗, 0) to obtain βˆmcn .
f) Using Qn, gn and βˆ
mc
n , estimate EQn,gn [DIPTW (Oi|βˆmcn , gn)|Z1i = z1i, X1i = x1i]
for each subject i as follows. Given (Z1i = z1i, X1i = x1i), generate 2,000 draws of
Y mci from Pˆ (Y |X1i = x1i, Z1i = z1i) and compute
Dmci =
hˆ(Z1i)
Pˆ (Z1i|X1i)
(Y mci − (βˆmc0 + βˆmc1 Z1i))
where hˆ(Z1i) =
dE(Y Z1i )
dβ
Pˆ (Z1i). Take the mean of 2000 Monte Carlo values as the
estimate.
g) Similarly estimate EQn,gn [DIPTW (Oi|βˆmcn , gn)|X1i = x1i]. Given X1i = x1i,
first generate draws of zmc1i from Pˆ (Z1i|X1i = x1i), then generate draws of Y mci from
Pˆ (Y |X1i = x1i, Z1i = zmc1i ) and compute Dmci . Take the mean of 2000 Monte Carlo
values Dmci as the estimate.
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h) Let pˆii = EˆQn,gn [DIPTW (O|βˆmcn , gn)|Z1i, X1i]− EQn,gn [DIPTW (O|βˆmcn , gn)|X1i].
Solve (β0, β1) using Newton Raphson algorithm
n∑
i=1
DAIPTW (Oi|β, gn, Qn) =
n∑
i=1
DIPTW (Oi|β, gn)− pˆii = 0
The treatment effect is ∆ˆ
AIPTW
=
∑D
d=1 βˆ
(d)
1 /D. Estimate the variance by bootstrap
and obtain the 95% confidence interval from the bootstrap samples.
Similarly to solve the AIPTW estimating equation in a two time points treatment,
the steps proceeds as follows. Let β = (β0, β1, β2, β3).
(a) For d = 1, · · · , D, generate a bootstrap sample S(d) from the original data S
by sampling units with replacement, stratified on treatment group. Then carry out
steps (b)-(i) for each sample d:
(b) Estimate a logistic regression model for the distribution of Z1 given X1, with
regression parameters γz1 . Estimate the propensity to be assigned treatment Z1 = z1
as Pˆ (Z1 = z1|X1, γˆ(d)z1 ) , where γˆ(d)z1 is the ML estimate of γz1 .
(c) Estimate the distributions of baseline covariates P (X1) as the empirical dis-
tributions from the data, denoted as Pˆ (X1).
(d) Using the cases assigned to treatment group Z1 = z1, estimate Pˆ (X2|X1, Z1)
using a normal linear regression with mean
E(Xz12 |X1, Z1 = z1, θz1 , βz1) = gz1(X1, Z1, βz1) (A.1)
where gz1() represents a parametric function of X1, and Z1 indexed by parameters
βz1 .
(e) Estimate a logistic regression model for the distribution of Z2 given X¯2, Z1,
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with regression parameters γz2 . Estimate the propensity to be assigned treatment
Z2 = z2 given Z1, X¯2 as Pˆ (Z2 = z2|X¯2, Z1, γˆ(d)z2 ) , where γˆ(d)z2 is the ML estimate of γz2 .
(f) Using the cases assigned to treatment regime Z¯2 = z¯2, estimate Pˆ (Y |X¯2, Z¯2)
using a normal linear regression with mean
E(Y z¯2|X¯2, Z¯2 = z¯2, βz¯2) = gz1z2(X¯2, Z¯2; βz¯2)
where gz¯2() represents a parametric function indexed by parameters βz¯2 .
g) Estimate βˆ
mc
n = (βˆ
mc
0 , βˆ
mc
1 , βˆ
mc
2 , βˆ
mc
3 ) using the g-computation to generate
10, 000 draws of the potential outcomes Y 00,Y 01,Y 11,Y 10 from their respective coun-
terfactual distributions. Specifically, first generate a draw x∗1 from the empirical dis-
tribution Pˆ (X1). Set Z1 = z1 and generate a draw x
∗
2 from Pˆ (X2|X1 = x∗1, Z1 = z1).
Then set Z2 = z2 and generate draws y
∗ from Pˆ (Y |X1 = x∗1, Z1 = z1, X2 = x∗2, Z2 =
z2). Then fit the model E(Y
Z¯2) = β0 + β1Z1 + β2Z2 + β3Z1Z2 to this collection of
(y∗, 0, 0), (y∗, 1, 0), (y∗, 0, 1) and (y∗, 1, 1) to obtain βˆmcn .
h) Using Qn, gn and βˆ
mc
n , estimate EQn,gn [DIPTW (Oi|βˆmcn , gn)|Z¯2i = z¯2i, X¯2i = x¯2i]
for each subject i as follows. Given (Z¯2i = z¯2i, X¯2i = x¯2i), generate 2,000 draws of
Y mci from P (Y |Z¯2i = z¯2i, X¯2i = x¯2i) and compute Dmci . Take the mean of the 2,000
Monte Carlo values as the estimate.
Dmci =
hˆ(Z¯2i)
Pˆ (Z1i|X1i)Pˆ (Z2i|Z1i, X¯2i)
(Y mci − (βˆmc0 + βˆmc1 Z1i + βˆmc2 Z2i + βˆmc3 Z1iZ2i))
where hˆ(Z¯2i) =
dE(Y Z¯2i )
dβ
Pˆ (Z1i)Pˆ (Z2i|Z1i). Follow the similar procedures to esti-
mate the other three conditional expectations.
i) Solve the estimating equation using Newton Raphson algorithm
n∑
i=1
DAIPTW (Oi|β, gn, Qn) =
n∑
i=1
DIPTW (Oi|β, gn)− pˆii = 0 (A.2)
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where,
pˆii =
j=2∑
j=1
EQn,gn [DIPTW (O|βˆmc, gn)|Z¯j, X¯j]− EQn,gn [DIPTW (O|βˆmc, gn)|X¯j]
The treatment effects are ∆ˆAIPTW11 =
∑D
d=1 ∆ˆ
AIPTW (d)
11 /D, ∆ˆ
AIPTW
10 =
∑D
d=1 ∆ˆ
AIPTW (d)
10 /D,
and ∆ˆAIPTW01 =
∑D
d=1 ∆ˆ
AIPTW (d)
01 /D, where ∆ˆ
AIPTW (d)
11 = βˆ1+βˆ2+βˆ3; ∆ˆ
AIPTW (d)
10 = βˆ1;
∆ˆ
AIPTW (d)
01 = βˆ2. Estimate the variance and obtain the 95% confidence interval from
D bootstrap samples.
A.3 Supplemental Tables from the Simulation Study
Table A.1: 100 * Ratio of bias over RMSE of IPTW (A), under (A) correctly-specified
propensity and prediction models; (B) a correctly-specified propensity model only; (C)
a correctly-specified prediction model only, based on 1000 simulations with sample
size of 200. The treatment effects ∆s under linear and nonlinear outcome models
were 5 and 9, respectively.
.
∆ = E(Y 1)− E(Y 0)
100 * Empirical Bias / RMSE IPTW(A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 1 14 25 4 3 4
g-computation(A) -0 -0 -1 6 4 3
AIPTW(A) 0 0 2 2 2 2
PENCOMP(A) 0 2 2 2 3 3
IPTW(A) 1 14 25 4 3 4
g-computation(B) 79 357 303 41 225 225
AIPTW(B) 0 18 29 -1 3 5
PENCOMP(B) 11 2 5 -1 -37 -52
IPTW(C) 82 375 340 46 250 273
g-computation(A) -0 -0 -1 6 4 3
AIPTW(C) 0 0 0 2 2 1
PENCOMP(C) -0 0 0 2 2 1
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Table A.2: 100*Ratio of empirical RMSE over RMSE of IPTW (A), denoted as
RMSE/RMSE IPTW(A), under (A) correctly-specified propensity and prediction
models; (B) a correctly-specified propensity model only; (C) a correctly- specified
prediction model only, based on 1000 simulations with sample size of 200.
.
∆ = E(Y 1)− E(Y 0)
100 * RMSE / RMSE IPTW(A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 100 100 100 100 100 100
g-computation(A) 80 51 37 75 61 51
AIPTW(A) 78 59 47 73 63 55
PENCOMP(A) 78 57 46 73 62 54
IPTW(A) 100 100 100 100 100 100
g-computation(B) 168 367 307 124 246 240
AIPTW(B) 81 89 90 95 99 97
PENCOMP(B) 83 65 56 91 97 102
IPTW(C) 181 389 347 130 273 290
g-computation(A) 80 51 37 75 61 51
AIPTW(C) 78 53 39 73 60 51
PENCOMP(C) 78 54 40 73 61 51
141
Table A.3: Empirical 95% non-coverage rate*100 (nominal noncoverage of 5), under
(A) correctly-specified propensity and prediction models; (B) a correctly-specified
propensity model only; (C) a correctly-specified prediction model only, based on 1000
simulations with sample size of 200.
.
∆ = E(Y 1)− E(Y 0)
100 * 95% Non-coverage Rate
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 5 6 12 5 6 7
g-computation(A) 4 5 6 5 6 5
AIPTW(A) 4 6 6 5 6 5
PENCOMP(A) 4 3 3 4 5 3
IPTW(A) 5 6 12 5 6 7
g-computation(B) 10 99 100 6 64 81
AIPTW(B) 3 8 13 5 6 7
PENCOMP(B) 0 0 1 2 5 6
IPTW(C) 10 96 99 6 63 82
g-computation(A) 4 5 6 5 6 5
AIPTW(C) 4 5 7 5 6 6
PENCOMP(C) 4 4 5 5 5 5
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Table A.4: 100 * Ratio of empirical mean 95% confidence interval width to that of
IPTW (A), denoted as mean 95% interval width/mean 95% interval width IPTW(A),
under (A) correctly-specified propensity and prediction models; (B) a correctly-
specified propensity model only; (C) a correctly-specified prediction model only, based
on 1000 simulations with sample size of 200.
.
∆ = E(Y 1)− E(Y 0)
100 * mean 95% interval width/mean 95% interval width IPTW(A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 100 100 100 100 100 100
g-computation(A) 80 53 42 74 64 57
AIPTW(A) 79 60 60 73 66 67
PENCOMP(A) 80 69 68 74 70 72
IPTW(A) 100 100 100 100 100 100
g-computation(B) 136 84 64 114 105 95
AIPTW(B) 84 89 93 96 97 100
PENCOMP(B) 124 102 102 113 120 130
IPTW(C) 147 103 82 118 117 113
g-computation(A) 80 53 42 74 64 57
AIPTW(C) 79 55 44 73 64 58
PENCOMP(C) 79 58 50 73 65 61
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Table A.5: 100 * Ratio of bias over RMSE of IPTW (A), under (A) correctly-specified
propensity and prediction models; (B) a correctly-specified propensity model only; (C)
a correctly-specified prediction model only, based on 1000 simulations with sample
size of 500. The treatment effects ∆s under linear and nonlinear outcome models
were 5 and 9, respectively.
.
∆ = E(Y 1)− E(Y 0)
100 * Empirical Bias / RMSE IPTW (A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 1 4 16 -5 -8 -1
g-computation(A) 0 -0 -1 -0 -0 -0
AIPTW(A) -0 -2 0 -2 -3 -1
PENCOMP(A) -0 -0 0 -3 -2 -1
IPTW(A) 1 4 16 -5 -8 -1
g-computation(B) 123 482 406 58 333 327
AIPTW(B) 1 6 16 -8 -9 -4
PENCOMP(B) 15 -1 2 -2 -46 -67
IPTW(C) 125 510 458 62 367 396
g-computation(A) 0 -0 -1 -0 -0 -0
AIPTW(C) -0 0 -0 -2 -2 -1
PENCOMP(C) -1 -0 -0 -3 -2 -1
Table A.6: 100*Ratio of empirical RMSE over RMSE of IPTW (A), denoted as
RMSE/RMSE IPTW(A), under (A) correctly-specified propensity and prediction
models; (B) a correctly-specified propensity model only; (C) a correctly- specified
prediction model only, based on 1000 simulations with sample size of 500.
.
∆ = E(Y 1)− E(Y 0)
100 * RMSE / RMSE IPTW(A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 100 100 100 100 100 100
g-computation(A) 82 45 31 72 54 44
AIPTW(A) 79 54 42 70 56 49
PENCOMP(A) 79 49 38 70 55 47
IPTW(A) 100 100 100 100 100 100
g-computation(B) 184 487 408 128 345 336
AIPTW(B) 79 85 92 94 94 98
PENCOMP(B) 82 59 51 90 93 101
IPTW(C) 193 517 462 134 382 406
g-computation(A) 82 45 31 72 54 44
AIPTW(C) 79 46 32 70 53 44
PENCOMP(C) 79 46 33 70 53 44
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Table A.7: Empirical 95% non-coverage rate*100 (nominal noncoverage of 5), under
(A) correctly-specified propensity and prediction models; (B) a correctly-specified
propensity model only; (C) a correctly-specified prediction model only, based on 1000
simulations with sample size of 500.
.
∆ = E(Y 1)− E(Y 0)
100 * 95% Non-coverage Rate
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 5 6 11 5 6 6
g-computation(A) 5 6 6 4 4 4
AIPTW(A) 4 6 7 3 4 4
PENCOMP(A) 4 4 3 3 3 2
IPTW(A) 5 6 11 5 6 6
g-computation(B) 15 100 100 7 96 100
AIPTW(B) 4 7 13 5 6 6
PENCOMP(B) 0 1 1 3 6 10
IPTW(C) 12 100 100 7 97 100
g-computation(A) 5 6 6 4 4 4
AIPTW(C) 4 6 5 3 4 4
PENCOMP(C) 4 4 4 3 3 3
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Table A.8: 100 * Ratio of empirical mean 95% confidence interval width to that of
IPTW (A), denoted as mean 95% interval width/mean 95% interval width IPTW(A),
under (A) correctly-specified propensity and prediction models; (B) a correctly-
specified propensity model only; (C) a correctly-specified prediction model only, based
on 1000 simulations with sample size of 500.
.
∆ = E(Y 1)− E(Y 0)
100 * mean 95% interval width/mean 95% interval width IPTW(A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 100 100 100 100 100 100
g-computation(A) 84 52 38 77 61 53
AIPTW(A) 81 58 51 74 63 60
PENCOMP(A) 81 61 54 75 64 61
IPTW(A) 100 100 100 100 100 100
g-computation(B) 141 82 57 116 101 88
AIPTW(B) 82 88 92 95 95 96
PENCOMP(B) 120 92 85 107 108 113
IPTW(C) 151 98 73 119 113 105
g-computation(A) 84 52 38 77 61 53
AIPTW(C) 81 52 39 74 60 53
PENCOMP(C) 81 55 43 74 61 55
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Table A.9: 100 * Ratio of bias over RMSE of IPTW (A), under (A) correctly-specified
propensity and prediction models; (B) a correctly-specified propensity model only; (C)
a correctly-specified prediction model only, based on 1000 simulations with sample
size of 1000. The treatment effects ∆s under linear and nonlinear outcome models
were 5 and 9, respectively.
.
∆ = E(Y 1)− E(Y 0)
100 * Empirical Bias / RMSE IPTW (A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) -1 3 11 -2 -3 -1
g-computation(A) 2 2 1 -2 -1 -0
AIPTW(A) 2 1 0 -3 -2 -2
PENCOMP(A) 3 2 1 -2 -1 -1
IPTW(A) -1 3 11 -2 -3 -1
g-computation(B) 182 674 517 92 459 420
AIPTW(B) 2 7 14 -2 -1 -0
PENCOMP(B) 21 1 3 6 -36 -61
IPTW(C) 181 706 578 95 502 505
g-computation(A) 2 2 1 -2 -1 -0
AIPTW(C) 1 1 0 -3 -2 -1
PENCOMP(C) 3 2 1 -2 -1 -1
Table A.10: 100*Ratio of empirical RMSE over RMSE of IPTW (A), denoted as
RMSE/RMSE IPTW(A), under (A) correctly-specified propensity and prediction
models; (B) a correctly-specified propensity model only; (C) a correctly- specified
prediction model only, based on 1000 simulations with sample size of 1000.
.
∆ = E(Y 1)− E(Y 0)
100 * RMSE / RMSE IPTW(A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 100 100 100 100 100 100
g-computation(A) 85 45 29 79 58 44
AIPTW(A) 80 53 45 74 59 52
PENCOMP(A) 80 49 36 74 56 45
IPTW(A) 100 100 100 100 100 100
g-computation(B) 233 678 518 151 468 427
AIPTW(B) 81 90 94 96 94 94
PENCOMP(B) 85 59 50 92 88 96
IPTW(C) 238 711 581 153 513 512
g-computation(A) 85 45 29 79 58 44
AIPTW(C) 80 45 30 74 54 42
PENCOMP(C) 80 45 30 74 54 42
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Table A.11: Empirical 95% non-coverage rate*100 (nominal noncoverage of 5), under
(A) correctly-specified propensity and prediction models; (B) a correctly-specified
propensity model only; (C) a correctly-specified prediction model only, based on 1000
simulations with sample size of 1000.
.
∆ = E(Y 1)− E(Y 0)
100 * 95% Non-coverage Rate
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 5 6 12 4 6 6
g-computation(A) 6 5 5 6 5 5
AIPTW(A) 5 5 6 5 6 6
PENCOMP(A) 5 5 4 5 5 5
IPTW(A) 5 6 12 4 6 6
g-computation(B) 26 100 100 12 100 100
AIPTW(B) 4 7 13 6 6 6
PENCOMP(B) 1 1 2 3 4 8
IPTW(C) 24 100 100 11 100 100
g-computation(A) 6 5 5 6 5 5
AIPTW(C) 5 5 6 5 5 5
PENCOMP(C) 5 4 4 5 5 5
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Table A.12: 100 * Ratio of empirical mean 95% confidence interval width to that of
IPTW (A), denoted as mean 95% interval width/mean 95% interval width IPTW(A),
under (A) correctly-specified propensity and prediction models; (B) a correctly-
specified propensity model only; (C) a correctly-specified prediction model only, based
on 1000 simulations with sample size of 1000.
.
∆ = E(Y 1)− E(Y 0)
100 * mean 95% interval width/mean 95% interval width IPTW(A)
Linear Outcome NonLinear Outcome
Method Low Mod High Low Mod High
IPTW(A) 100 100 100 100 100 100
g-computation(A) 88 54 36 79 63 51
AIPTW(A) 81 59 50 74 63 57
PENCOMP(A) 82 60 49 74 63 56
IPTW(A) 100 100 100 100 100 100
g-computation(B) 144 83 54 118 103 84
AIPTW(B) 82 87 90 95 95 95
PENCOMP(B) 119 90 79 105 106 106
IPTW(C) 152 99 69 120 113 98
g-computation(A) 88 54 36 79 63 51
AIPTW(C) 81 52 37 74 60 50
PENCOMP(C) 81 54 39 74 61 51
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A.4 Supplemental Table from Application
Table A.25: The number of subjects with observed treatment regimen (1, 1), (1, 0),
(0, 1), and (0, 0), denoted as no11, no10, no01, and no00, respectively in each three-
visit window, as well as the number of subjects kept in the estimation of ∆11, ∆10,
and ∆00, after trimming, denoted as no ∆11, no ∆10, and no ∆01, respectively. The
total is the total number of subjects with complete data on blood count measures
considered in the models in each window.
.
sample size observed sample size after trimming
Window no11 no10 no01 no00 no ∆11 no ∆10 no ∆01 Total
Window1 88 11 82 638 772 731 770 819
Window2 138 16 88 620 770 794 785 862
Window3 178 23 76 550 635 700 721 827
Window4 160 42 134 352 612 459 603 688
Window5 265 13 114 292 509 458 518 684
Window6 390 26 59 348 773 749 756 823
Window7 401 13 41 322 694 648 686 777
Window8 397 12 43 299 717 655 564 751
Window9 389 14 30 281 541 518 544 714
Window10 373 14 48 245 516 462 476 680
Window11 356 21 37 225 590 545 562 639
Window12 310 36 16 217 552 514 532 579
Window13 254 45 24 220 504 395 437 543
Window14 216 31 30 203 420 410 353 480
Window15 197 14 39 182 374 365 373 432
Table A.26: Summary of the stabilized weights.
Stabilized Weights
Window Mean(SD) Minimum/Maximum
Window1 1.091 ( 1.97 ) 0.1103 / 40.3
Window2 1.065 ( 3.20 ) 0.1026 / 91.5
Window3 6.160 ( 146.78 ) 0.2010 / 4220.5
Window4 4.662 ( 83.11 ) 0.1391 / 2163.2
Window5 0.966 ( 1.11 ) 0.3274 / 15.2
Window6 2.378 ( 37.86 ) 0.4039 / 1083.5
Window7 3.052 ( 59.23 ) 0.1692 / 1651.0
Window8 23.893 ( 618.50 ) 0.1102 / 16949.0
Window9 4.085 ( 63.72 ) 0.2095 / 1541.6
Window10 6.937 ( 106.37 ) 0.1468 / 2307.3
Window11 1.586 ( 11.11 ) 0.2741 / 250.8
Window12 1.731 ( 12.57 ) 0.2944 / 266.1
Window13 1.336 ( 7.32 ) 0.1705 / 164.7
Window14 1.033 ( 1.67 ) 0.1935 / 17.6
Window15 1.046 ( 2.05 ) 0.2134 / 32.0
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Table A.27: Summary of overlap proportions at both time points.
First Time Point Second Time Point
pi0.951 pi
0.95
0 pi
0.95
11 pi
0.95
10 pi
0.95
01 pi
0.95
00
Window1 81 40 73 86 89 51
Window2 60 38 63 96 83 45
Window3 50 37 41 96 86 38
Window4 36 28 34 42 69 39
Window5 45 78 45 79 92 39
Window6 40 31 40 92 84 35
Window7 36 19 34 82 87 17
Window8 21 14 22 85 61 18
Window9 22 12 23 78 70 14
Window10 8 6 12 74 31 15
Window11 27 19 33 79 62 21
Window12 38 25 40 67 51 28
Window13 22 52 34 57 73 49
Window14 42 51 38 85 52 57
Window15 32 51 34 96 82 41
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Figure A.1: For each of the three-visit windows 1, · · · , 15, the estimates and standard
errors (SE) of the treatment effects ∆11, ∆10, and ∆01 of the four methods: PEN-
COMP, AIPTW, IPTW, and Naive. Here 1st% and 99th% weight truncation was
done for IPTW and AIPTW. PENCOMP estimates were computed on the overlap-
ping regions, as described in Section 2.4. Since the propensity score distributions were
very skewed for some windows, restricting to the quantiles c(α, 1 − α) (for example
α = 0.025) of the propensity score distributions can significantly reduce the variances
without changing the estimates much (results not shown here). Note the estimands
are different.
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B.1 Supplementary Tables from the Simulation Study
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Figure B.1: Parallel surface and Misaligned: absolute bias in percentage, sample size
of 200. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.2: Parallel surface and Aligned: absolute bias in percentage, sample size of
200. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.3: Nonparallel surface and Misaligned: absolute bias in percentage, sample
size of 200. (A)-Both propensity and prediction models are correct; (B) Prediction
models are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in
the propensity distributions; Bottom Panel-high overlap in the propensity distribu-
tions.
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Figure B.4: Nonparallel surface and Aligned: absolute bias in percentage, sample size
of 200. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.5: Parallel surface and Misaligned: Empirical RMSE, sample size of 1000.
(A)-Both propensity and prediction models are correct; (B) Prediction models are in-
correct; (C) Propensity models are incorrect. Top Panel-Low overlap in the propensity
distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.6: Parallel surface and Aligned: Empirical RMSE, sample size of 1000. (A)-
Both propensity and prediction models are correct; (B) Prediction models are incor-
rect; (C) Propensity models are incorrect. Top Panel-Low overlap in the propensity
distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.7: Nonparallel surface and Misaligned: Empirical RMSE, sample size of
1000. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.8: Nonparallel surface and Aligned: Empirical RMSE, sample size of 1000.
(A)-Both propensity and prediction models are correct; (B) Prediction models are in-
correct; (C) Propensity models are incorrect. Top Panel-Low overlap in the propensity
distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.9: Parallel surface and Misaligned: absolute bias in percentage, sample size
of 1000. (A)-Both propensity and prediction models are correct; (B) Prediction mod-
els are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.10: Parallel surface and Aligned: absolute bias in percentage, sample size of
1000. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
175
PENCOMP
PENCOMP0.05*
PENCOMP0.05
PENCOMP+match
PENCOMP+ATO
AIPTW
AIPTW0.05*
AIPTW0.05
AIPTW+match
match weight DR
ATO DR
IPTW
IPTW0.05*
IPTW0.05
IPTW+match
match weight
pair matching
ATO
Low: A
0 1 2 3 4 5 6
Low: B
0 1 2 3 4 5 6
Low: C
0 1 2 3 4 5 6
PENCOMP
PENCOMP0.05*
PENCOMP0.05
PENCOMP+match
PENCOMP+ATO
AIPTW
AIPTW0.05*
AIPTW0.05
AIPTW+match
match weight DR
ATO DR
IPTW
IPTW0.05*
IPTW0.05
IPTW+match
match weight
pair matching
ATO
High: A
0 1 2 3 4 5 6
High: B
0 1 2 3 4 5 6
High: C
0 1 2 3 4 5 6
Figure B.11: Nonparallel surface and Misaligned: absolute bias in percentage, sample
size of 1000. (A)-Both propensity and prediction models are correct; (B) Prediction
models are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in
the propensity distributions; Bottom Panel-high overlap in the propensity distribu-
tions.
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Figure B.12: Nonparallel surface and Aligned: absolute bias in percentage, sample
size of 1000. (A)-Both propensity and prediction models are correct; (B) Prediction
models are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in
the propensity distributions; Bottom Panel-high overlap in the propensity distribu-
tions.
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Figure B.13: Parallel surface and Misaligned: 100 * 95% non coverage rate, sample
size of 1000. (A)-Both propensity and prediction models are correct; (B) Prediction
models are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in
the propensity distributions; Bottom Panel-high overlap in the propensity distribu-
tions.
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Figure B.14: Parallel surface and Aligned: 100 * 95% non coverage rate, sample size of
1000. (A)-Both propensity and prediction models are correct; (B) Prediction models
are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in the
propensity distributions; Bottom Panel-high overlap in the propensity distributions.
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Figure B.15: Nonparallel surface and Misaligned: 100 * 95% non coverage rate,
sample size of 1000. (A)-Both propensity and prediction models are correct; (B)
Prediction models are incorrect; (C) Propensity models are incorrect. Top Panel-Low
overlap in the propensity distributions; Bottom Panel-high overlap in the propensity
distributions.
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Figure B.16: Nonparallel surface and Aligned: 100 * 95% non coverage rate, sample
size of 1000. (A)-Both propensity and prediction models are correct; (B) Prediction
models are incorrect; (C) Propensity models are incorrect. Top Panel-Low overlap in
the propensity distributions; Bottom Panel-high overlap in the propensity distribu-
tions.
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